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ABSTRACT 
The termi na 1 enzyme in the 1 i no 1 eoy 1-CoA desaturase enzyme camp 1 ex, 
delta-6-desaturase was implied in the control of cell prol iferation in 
cancer ce 11 s. One of the aims of this study was to isolate the 
terminal enzyme. It was decided that in order to isolate th is enzyme 
it was first necessary to isolate the entire complex and then to 
enzymatically solubilise the first two components of the complex i e 
cytochrome b5 reductase and cytochrome b5 from the complex resulting 
in a pure delta-6-desaturase . The first two components were isolated 
and purified using simplified and easily reproducible methodologies 
which could be utilised in the final purification of delta-6-
desaturase. The entire en~yme complex, linoleoyl-CoA desaturase was 
also isolated in a pure form and this pure complex was used to attempt 
to i solate delta-6-desaturase. The terminal enzyme was isolated with 
some cytochrome b5 still bound to it. The methods used had proven to 
be successful and with some modifications should yield a pure enzyme. 
Zinc and GLA were known to play a role in the inhibition of cancer 
cell proliferation and zinc was hypothesised to inh ibit cell growth by 
stimu lating the activity of the linol eoyl-CoA desaturase enzyme 
complex which is involved in the regulation of cell proliferation. 
GLA i s the product of the reaction that this enzyme complex cata lyses 
and GLA has been shown to inhibit cancer ce ll growth. The effect of 
• 
i i 
GLA on cell growth and linoleoyl-CoA desaturase activity was thus 
investigated. Results showed that both zinc and GLA inhibited cell 
growth and that the combined addition of zinc and GLA generally 
resulted in the inhibition of cell growth and the activation of 
linoleoyl-CoA desaturase activity in the BL-6 cells while having a 
less pronounced effect on the LLCMK cells. The results of this study 
support the hypothesis that zinc may be a cofactor of linoleoyl-CoA 
desaturase. 
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CHAPTER 1 
LITERATURE REVIEW 
1.1 The Aetiology of Cancer 
Cancer is defined by the Concise Medical Dictionary as 11 arising from 
the abnormal and uncontrolled division of cells that then invade and 
destroy the surrounding tissues 11 • 
in or on a part of the body 11 (1) . 
A tumour is 11 any abnormal swelling 
A tumour may be either malignant 
or benign. A malignant tumour is one 11 Which invades and destroys the 
tissue in which it originates and can spread to other sites in the 
body i e metastasises 11 • Benign tumours are defined as 11 those that do 
not invade the tissues in which they originate or spread 11 (1). From 
these definitions it can be seen that cancer refers only to malignant 
tumours and not to benign. 
Malignant tumours metastasise from the primary tumour via the 
bloodstream, the lymphatic canals or across body cavities such as the 
pleural and peritoneal spaces to initiate secondary tumours. There 
are three main types of malignant tumours namely; carcinomas, 
sarcomas and a heterogeneous group. The carcinomas originate in the 
epithelium of the skin, and internal organs of the body, for examp le, 
the respiratory tract, gut, breast, pancreas and thyroid. It is 
possible, but not normally concurrently, for an organ to manifest more 
than one type of carcinoma, for example, in the cervix an 
adenocarcinoma and a squamous carcinoma may occur. The sarcomas 
originate in connective tissue. They can arise in fibrous tissue, 
-2-
muscle, fat, bone, cartilage, synovium, blood, lymphatic vessels and 
other tissues. These tumours arise in t~e tissues that constitute an 
organ rather than being restricted to a particular organ. The third 
type of malignant tumours consist of a heterogeneous group of tumours 
which originate in the cells that produce the leucocytes and the 
lymphocytes i e, the white blood cells and cells involved in the 
immune system. This third group includes the leukemias, the lymphomas 
and Hodgkin's disease. The leukemias are classified according to the 
type of white blood cell from which they originate i e, that cell type 
which is proliferating abnormally. The lymphomas are classified as 
"any malignant tumour of the lymph nodes excluding Hodgkin's disease". 
Hodgkin's disease is a disease of the lymphatic tissues which involves 
the lymph nodes (1,2). 
Cancer is the result of a combination of factors exerted on the body 
by procarc i nogens, carcinogens, initiators, deoxyribonucleic acid 
(DNA) -repair drugs, promoters, cocarcinogens and anticarcinogens 
(see Fig .l) . A procarcinogen is a substance that requires a chemical 
modification in order to act as an i nducer of cancer. A carci nogen 
is a chemical, physical or biological agent with an initiator effect 
that increases the incidence of cancer. An initiator is an external 
stimulus or agent producing a cell that becomes malignant under 
certain conditions while a promotor is an agent that causes an 
initiated cell to produce a tumour. A cocarcinogen is an agent 
that augments tumour induction and an anticarcinogen is a substance 
-3-
that inhibits or eliminates the activity of a carcinogen (3-8). 
DIRECT CARCINOGEN 
Binding to DNA 
Inactivation+----! 
Elimination ---1 
DNA in normal cells 
PROCARCINOGEN---+--MUTAGEN----DNA-inducation 
Metabolic activation 
Death of cell DNA-repair 
DNA-replication 
Mutated DNA in initiated cell, 
gene activation 
1 
z 
0 
.... 
!< 
.... 
I-
... 
z 
.... 
resting tumour cell 
PROMOTOR 
resting tumour cell 
INDIRECT CARCINOGEN 
MODIFIER - - -----.bETECTABLE TUMOUR 
Figure 1. The chain or reactions Including lnteracdon between external 
Influences and the response or the organism wblcb can result In cancer (4) . 
The aetiology of cancers is known to be multifactorial with the result 
that it is a complex problem to decide the significance of certain 
agents and their roles in the initiation and promotion of cancers . 
The initiation of malignancy of a cell results from a genetic 
mutation. 
irreversible. 
The process of initiation is considered to be 
These genetic mutations can be in the form of .point 
mutations, frame shift mutations or transposed DNA. An initiated 
cell is considered to be a latent tumour cell. This cell wi ll only 
-4-
become malignant if it is consequently acted upon by a promotor. 
Promotion of the cancer process can only occur on an initiated cell. 
The process of promotion is considered to be a reversible process and 
cannot by itself produce a tumour . The malignant transformation of a 
cell can be halted by DNA-repair mechanisms and anticarcinogens. 
There are a variety of initiators and promotors and these include 
various forms of radiation, such as ultra-violet, X-rays and 
rad ioactivity; chemicals such as benzpyrene, aromatic dyes and 
aflatoxins; viral oncogenes such as those carried in the retroviruses 
and for example, the src oncogene; mammalian oncogenes; and viruses 
(1-9). 
It is believed that factors from the environment, including diet, are 
responsible for 80-90% of all forms of cancer found in man. From 
this statement it can be seen that diet plays a very signif icant role 
in the study of cancer and will be discussed in more deta i l in 
subsequent sections in this chapter (3-11). 
1.2 Differences between Tumours and Normal Tissues 
In the treatment of cancer, it is preferable to find a characterist ic 
unique to the cancer cells and to utilise this characteristic in the 
fight against the disease. This would allow drugs, etc to be 
targeted to the cancer cells only, and thus would cause no harm to the 
normal host cells. Some of the possible characterist ics are cell 
-5-
division (2,3,12-16), membranes (15,17-20), metabolic changes in, for 
example, carbohydrates, proteins and lipids (12,13), tumour 
vascularisation (14,21) and metastasis (12-14). Cell division and 
lipid metabolism, with respect to its role in membrane structure and 
function, are two characteristics of great interest in the treatment 
of cancer and of particular interest in this study. 
1.2.1 Membranes and Lipids 
The protein and lipid composition of membranes is greatly altered in 
cancer cells which drastically alters the membrane characteristics 
since phospholipids and proteins are important components of 
membranes. 
tumours. 
Some of the membrane alterations are unique to specific 
The membrane alterations generally allow greater 
permeability of nutrients into, and products out of, cancer cells 
(15,17-20). 
In cancer cells the mitochondrial function is almost completely lost 
because of membrane changes. The shape of cancer ce 11 s is totally 
different to that of normal cells, as the rigidity of the cell 
membranes has been destroyed. By altering membrane structures, the 
activities of various enzymes are either modified or destroyed. This 
modification of enzyme activity is a specific result of the alteration 
of the viscosity of the membrane lipid component, the degree of lipid 
peroxidation, the composition of polyunsaturated fatty acids (PUFAs) 
within membranes, the relative amount of phospholipids within a 
membrane and the ratio of lipid weight to protein weight within a 
-6-
membrane (15,17-20). The significance of an alteration of a specific 
enzyme activity, linoleoyl-Coenzyme A desaturase (linoleoyl-CoA 
desaturase) is of particular interest to this study and will be 
discussed in detail later. 
1.2.2 Cell Division 
While it is true that a large proportion of cancers have a greatly 
increased rate of cell division, it is not true for all cancers 
(3,15,16). In normal mature cells, cell division usually occurs to 
replace those cells that have died, but in tumours there is generally 
an increased cell growth (2,12,13). It is also true that the growth 
of cancer cells can be out of synchrony with normal cells, which have 
a synchronous growth (12). 
If there is increased cell division, this is shown by increased DNA 
synthesis and an elevated activity of the enzymes involved in this 
synthesis. The enzyme DNA polymerase III has an activity which is 
five to six times greater in certain cancer cells than normal· cells. 
It is not known whether the concentration of this enzyme is increased 
or if its activity is increased (2,3,12-16). Thymidine kinase is an 
enzyme involved in the salvage pathway of DNA synthesis. A pool of 
nuc leosides resulting from DNA turnover is found in most cells. When 
this pool reaches a critical level, the excess nucleosides are 
normally catabolised and excreted, but when cells divide rapidly or 
greater DNA synthesis is required, these nucleosides can be phosphory-
-7-
1 a ted to form nuc 1 eot ides. The nuc 1 eot ides can then be used to 
synthesise DNA. Thymidine kinase is one of the phosphorylating 
enzymes, and it appears to be a rate controlling enzyme in this 
pathway . The enzyme thymidine kinase has little activity in normal 
cells but a larger quantity of activity is present in most cancer 
cells. The increased activity of the salvage pathway results in an 
increased synthesis of DNA . This enzyme has, as a result, become a 
target for cancer therapy (12,13). 
Another enzyme that is thought to play a role in the control of cell 
division is 
controlling 
pathway. 
1 i no leoyl-CoA desaturase. This enzyme is the rate 
enzyme in the essential fatty acid (EFA) synthetic 
Horrobin (5) has stated that this enzyme appears to be 
absent in cancer cells. It has since been shown that it is present 
in certain cancer cells at least, but even when it is present it has 
reduced activity compared to normal cells (22-24). Linoleoyl-CoA 
desaturase plays a role in the control of cell division since the 
eicosanoids (e g prostaglandins (PGs)) are synthesised from 
intermediates in this essential fatty acid pathway and certain 
prostaglandins regulate cyclic adenosine monophosphate (cAMP) which 
in turn has been shown to influence the rate of cell division in many 
cells (cited in 22,25-30). (See Fig. 2) . 
Linoleic acid 
(18:2 w-6) 
-8-
1 -Linolenic acid --------~ (18:3 w-6) 
1:!6-desaturase 
Elongase 
Arachidonic acid 1:!5-desaturase 
(20:4
1 
w-6) 
Dihomo-1-linolenic 
acid (20rw-6) 
2-series prostaglandins 1-series prostaglandins 
e.g. PGE2 e.g. PGE1 
I 
I 
I 
.J, Adenyl 
ATP ------~cAMP 
cyclase 
Figure 2. An outline of the conversion of w-6-EF AS to prostaglandins 
indicating the link with cAMP synthesis and cell proliferation (25). 
= metabollc pathways 
- - ~ = suggested effects 
I 
I 
I 
t 
Cell proliferation 
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The role that linoleoyl-CoA desaturase plays in the control of cell 
proliferation and the methods by which this control is maintained will 
be discussed in much greater detail later in this review. 
Since this study concentrates largely on the role of essential fatty 
acids in cancer therapy and the control of EFA synthesis, the general 
pathway of EFA and PG synthesis as well as the possible involvement 
' of zinc in this synthesis, and the importance will now be considered. 
1 . 3 The Metabolism of Dietary EFAs and Zinc 
Two nutrients of interest in this study, with respect to their 
involvement with cancer, are EFAs and zinc. The general background 
and metabolism of these nutrients will be discussed and their 
relationship to tumour growth will then be considered. 
1.3.1 The Omega-6-Essential Fatty Acids and the Eicosanoids 
There are two groups of naturally occurring EFAs in the body, the w-6-
and the w-3- EFAs. The w-6- EFAs are derived from linoleic acid 
(18:2 w-6) and the w-3- EFAs are derived from a-linolenic acid (18:3 
w-3), and differ in the carbon number at which the first 
double bond occurs within the EFA numbering from the of the 
EFA chain. The eicosanoids encompass both the 1 ipoxygenase and 
cyclo-oxygenase products of the two EFA pathways. One of the 
lipoxygenase products are called leukotrienes and the products from 
cycle-oxygenase are called prostaglandins, thromboxanes and 
-10-
prostacyclin (31-42). In this review only the w-6- EFA pathway will 
be considered in detail and henceforth the term EFA will be used 
referring to the w-6- EFAs. When w-3- EFAs are discussed they will 
be specifically referred to. 
1. 3.1.1 The Biosynthesis of the Omega-6-Essential Fatty Acids 
and the Eicosanoids 
Figure 3 shows the biosynthesis of the w-6- EFAs, w-3- EFAs and the 
eicosanoids (35). As can be seen from Fig. 3, the EFAs are derived 
from their parent fatty acids via desaturations and chain elongations. 
All the double bonds are in the cis form and are methylene interrupted 
(34,38). 
As illustrated in Fig. 3, both of the EFA pathways utilise the same 
enzymes. The conversion of linoleic acid (LA) to gamma-linolenic 
acid (GLA) is catalised by the enzyme complex linoleoyl-CoA desaturase 
[EC 1.14.99.25]. This enzyme complex was only classified in 1986 at 
the request of the author . It should be noted that there is an error 
in the classification , in that it is stated that the more common name 
for this complex is delta-6-desaturase (~6-desaturase). ~6-
desaturase is in fact only a component of the complex being the 
terminal enzyme in the linoleoyl-CoA desaturase complex, the complex 
consisting of cytochrome b5, cytochrome bs reductase [EC 1.6.2.2] and 
~6-desaturase (43-45) . 
-11-
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+2C-&elongase PGE3,PGF3,PGD3 JIIIII""+2C.(), elongase 
PGIJ,TXA3, 10 docosapentaenoic acid docosatetraenoic acid 
(C22:4 ~&~-6) 
~COOH 
-2H ~ l!.-4-desaturase 
docosapentaenoic acid 
(C22:5 ~&~-6) 
~COOH 
p..TAs,LTBs,LTCs. (CZ2:S ~&~-3 ) 
~OOH 
-2H {), l!.-4-desaturase 
docosahexaeno1c acid 
(C22:6 ~&~-3) 
~OOH 
Flpre 3. Etseotlal Fatty Add and Eicosanoid Metabolism (35). 
The termloaJ enzymes In the desaturase complexes are cited lo 
tbla Ogure and not the entire complexes. 
PG "" prosta&laod.lo 
TX a thrombomne 
LT = leukotrle.ne 
CO • C)'clo-GlQ'Be.DISe 
10 • llpoX)'Ienase 
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In the biosynthesis of the w-6- EFAs and the eicosanoids the rate 
limiting step is the conversion of LA into GLA (43-45). The 
linoleoyl-CoA desaturase enzyme complex catalysing this step and the 
effects of zinc and GLA on the complex are the subjects of this 
thesis. 
LA is unable to be synthesised in mammals and as such has to be 
present in the diet (34,38-40). For omnivores the main source of LA 
is p 1 ants; for earn i vores the only source is the LA present in the 
meat eaten. LA is a 1 so present in dairy products, organ meats e g 
liver, human milk and many vegetable seed oils (33,39). The average 
adult daily intake is 23g in Europe and North America. GLA is 
present in human milk as 0.3-1.0% of its fat. It is also found in 
very sma 11 quantities in cows milk. This is generally more than an 
adequate source of the EFA for a baby. GLA is known to occur in oats 
and barley. GLA is found in large quantities in the seed oil of the 
evening primrose, but makes up only 0.2% of the total fat intake of an 
adult, which is an insufficient intake. 
(DGLA) is found in moderate amounts 
adrena 1 s, the testes and the kidneys. 
Dihomo-gamma-linolenic acid 
in human milk, liver, the 
Arachidonic acid (AA) is 
present in moderate amounts in human mi 1 k, in sma 11 amounts in cows 
milk and substantial amounts in meat, egg yolks, some seaweeds and 
shrimps. The average daily intake of AA in several European cities 
is 100-190mg which is more than adequate to account for the total 
daily production of PGs, which is estimated to be approximately lmg. 
However, this intake of AA is insufficient to meet all the 
requirements for AA (39). 
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Animal experiments show that males require 2-5 times as much EFAs as 
do females, but little research in this regard has been done on 
humans. Trans-fatty acids are known to interfere with EFA metabolism 
and result in a greatly increased requirement for EFAs. It is 
thought that the trans-fatty acids interfere directly with linoleoyl-
CoA desaturase . In general, therefore, adult humans require a 
dietary supply of LA from which the other EFAs can be synth~s i sed 
(33,34,36,38-40). 
It has been shown that the rate contra ll i ng enzyme in this system, 
linoleoyl-CoA desaturase, has defective function in the fol lowing 
human diseases; diabetes, hypercholesterolemia, Crohn 1 s disease, 
hepatic cirrhosis, cystic fibrosis, Sjogren-Larsson syndrome , atopic 
eczema, non-cancerous breast diseases, Sjogren 1 s syndrome, 
scleroderma, and u 1 cerat i ve co 1 it is. It has a 1 so been shown to be 
defective in aging cells, in the premenstrual syndrome and in the 
irritable bowel syndrome (5,39,46-49). 
1.3.1.2 The History of the Omega-6- EFAs and the Eicosanoids 
There are various reasons why the importance of EFAs has only been 
elucidated in the last century. It has been known since 1877 that 
carbohydrates can be converted into fat in the body, so it was not 
obvious that fat deficiency could occur. In 1918 Aron deduced that 
fats must have a specific role in nutrition as he showed that rats 
would grow when fed a diet consisting of casein, wheat bran, wheat 
starch and butter, but if butter was removed from the diet the rats no 
longer grew. Fatty acids are required in very small quantities and 
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this made it difficult to determine which were necessary i e 
essential. EFAs are PUFAs which are essential for growth, but cannot 
be synthesised by the body. In the initial experiments carried out 
to determine whether fat was necessary in the diet, it was not 
realised that certain supposedly fat reduced diets contained EFAs, and 
this led to erroneous results (1,cited in 50). 
Evans and Burr in 1928 further purified diets and utilised an 
experimental diet which contained pure casein, purified sucrose and 
salts , a small amount of yeast and three drops of cod liver oil 
daily . 
rats. 
This diet produced subnorma 1 growth and ovu 1 at ion in young 
This indicated that researchers were getting closer to a fat 
deficient or fat free diet. It was confirmed in 1929 that rats on a 
very low fat diet did not grow normally and half of the rats had 
kidney complications. In 1929 Burr and Burr further purified the 
diet they had used previously and showed that the rats did not grow 
ormally on this diet and they also developed a scaly skin, caudal 
crasis of the tail and lesions were found in the kidneys and urinary 
t~t . Burr and Burr were therefore the first researchers to really 
acheve fat deficiency and to show that these fats were essential in 
the Giet (cited in 50,51,52) . In the following year they noticed that 
there Was a large increase in water consumption by rats on their fat 
deficient diet, but there was not the expected increase in urine. 
The d f · e 1Ciency symptoms were found to be cured by LA. LA, thus 
became the first EFA to be discovered . They also tried to cure the 
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deficiency symptoms by using oils which did not contain LA, but these 
oils had no effect. They hypothesised that warm blooded animals 
could not synthesise any appreciable quantities of LA . The fats 
necessary for growth had by this time been shown to be PUFAs (cited 
in 31,51,52,cited in 53). In 1932 a breakthrough was made when Evans 
utilised sucrose in experimental diets instead of starch , which was 
shown to contain EFAs (1, cited in 50). 
Burr and Burr initially suggested that alpha-l inolenic acid (ALA), 
which they had also found to be an EFA, was as effective in curing 
the fat deficiency symptoms as LA. It was however found that ALA is 
only about one-sixth as effective as LA in curing the deficiency 
symptoms. Turpei nen stated that the most important fat deficiency 
symptoms were a retardation and a gradual complete cessation of 
growth, scaly skin, renal lesions (often resulting in blood in the 
urine), excessive water consumption and ovulation irregularities. 
Gestation, lactation and male reproductive functions were also shown 
to be greatly impaired (54). 
In 1909 Hartley named the PUFA that he isolated as AA . This was a 20 
carbon molecule with four double bonds (55). AA has been found to be 
widely distributed throughout the body. It was subsequently found 
that AA depressed the growth of rats on a fat deficient diet which was 
supplemented with LA and ALA (cited in 31, cited in 50). This work 
was repudiated in 1938 by Turpeinen who showed that AA was more 
effective than LA in curing deficiency symptoms (54) . As has been 
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In the late 1940's it had been noted that liver enzyme activities 
could be dramatically altered by dietary conditions. It was then 
suggested that the deficiency symptoms resulting from a fat free diet 
noted by Burr and Burr could be a result of altered enzyme 
activities. If this was true, then the addition of EFAs could result 
in the resumption of normal enzyme activities. Further evidence for 
this hypothesis came from the results of an experiment which showed 
that rats suffering from fat deficiency had a much higher metabolic 
rate than rats on a fat sufficient diet. It was found that 
starvation resulted in a lowering of the acti vity of pl asma 
phosphatase. This activity reverted to normal upon the addition of 
PUFAs, but saturated fatty acids, proteins and carbohydrates had no 
effect on the enzyme level (cited in 63). Kunkel and Williams in 1950 
showed that the rate of transport on the electron transport chain and 
of oxidative phosphorylation were linked to PUFA deficiency. When a 
rat was suffering from PUFA deficiency there was greatly increased 
activity of cytochrome oxidase. This increase in activity could be 
reversed if the rat was supplemented with LA (64,cited in 65). 
LA and ALA were suggested to possibly belong to different PUFA 
families and that LA and ALA were the parent PUFAs of these 
families. It was noted that LA and other PUFAs which cured skin 
lesions, as a result of fat deficiency, had their first double bond 
(counting from the methyl end) after the sixth carbon atom and that 
the other PUFAs had their first double bond after the t hird carbon 
atom (cited in 50, 62). 
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infants developed spasmodic bronchitis and eczema. Von 
Chwalibogowski in 1937 fed two new born babies on a diet consisting of 
skimmed milk, sugar and cereal. These babies were maintained on this 
diet for thirteen and fifteen months. Fruit and carrots were added 
later on to the diet, although this did not seem to make the diet any 
more palatable to the babies. They both became anaemic and had 
repeated infections (cited in 50). There are no follow up reports 
concerning the growth of any of these infants, but the ethics behind 
these studies still remain extremely dubious. 
A more ethical experiment was conducted in 1938 when Brown fed himself 
a low fat diet for six months. Brown seemed to benet it from this 
diet, as he stated he was less tired and had fewer headaches. If 
young rats were fed the same diet that Brown had they developed 
deficiency symptoms. Six months, however, was not considered a 
sufficient period of time for the experiment to be carried out if any 
comparison is to be drawn between human and rat reactions to a low fat 
diet. Six months in a human life is the equivalent of one week in 
the 1 ife of a rat, and this could indicate that deficiency symptoms 
could take a much longer time to occur in humans. This experiment 
also showed that it is eas ier to induce deficiency symptoms in younger 
animals than in adults. The EFAs in Brown's serum at the end of the 
six months had dropped by 50% indicating that the low fat diet was 
starting to have an effect (cited in 50,cited in 53). This evidence 
strongly suggests that EFAs are also essential for man. 
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In 1963 Hansen et £1 (53,cited in 68) published a paper concerning the 
role of LA in infant nutrition. This study was conducted over a 
period of four years and involved more than four hundred infants. 
The infants were maintained on diets which were fat free, or had 
different fatty acid compositions. The diets were fed in the form of 
milk mixtures. For many years attempts had been made to produce a 
milk mixture that emulated human milk. It is known that human milk 
has approximately five times more LA than cows milk, which seemed to 
suggest that LA is essential for infants. The infants who received 
the fat free diets or the diets low in LA developed dry scaly skin 
which tended to thicken. The infants on the fat free diets or low LA 
diets had high total fatty acids in the serum. Of specific interest 
were the diene fatty acid levels in the serum, as they directly 
reflected the LA content in the diet. Analysis of these levels 
indicated that the two kinds of diets were deficient in LA. It was 
noted that the deficiency symptoms were reversed when LA was given in 
the milk mixture . One deficiency symptom which was found and that 
had not been noted in rats was the susceptibility to bacterial skin 
infections. This study proved that LA was an essential nutrient for 
infants. Again it does not seem as though any follow up study was 
carried out or published concerning the future growth and welfare of 
these infants. 
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From these studies it can be seen that between the 1920 • s and the 
1960 1 s EFAs were a popular research topic and that their essentiality 
and metabolism was elucidated during this period. 
1.3.1.3 The Function of EFAs 
1.3.1.3.1 The Role of EFAs in Membranes 
Biological membranes consist of l ipid bilayers which are composed 
primarily of phospholipids and cholesterol. The membrane bilayers 
tend to exist at the transition point between gel and liquid crystal 
forms with the result that solid-like and fluid domains exist in the 
membrane. These domains have different fatty acid compositions with 
EFAs being an integral part of phospholipids. The ~-position of the 
phospholipids is preferentially esterified with EFAs with the result 
that they play a structural role in membranes. Between the domains 
of the bilayer there are interfacial areas which may contain enzyme 
binding sites or transport proteins . Hydrophobic forces are the main 
forces binding these proteins to the lipid bilayer. In the bilayer, 
the phospholipids and the proteins affect the physical properties of 
each other due to the lipid-protein interactions. If there are 
increased PUFAs in the membrane phospholipids, this results in 
increased membrane fluidity which results in increased activity of 
membrane bound enzymes. Membrane integrity thus plays a role in the 
activity of membrane bound enzymes (69-84). 
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Membrane phospholipids also influence transmembrane transport. Within 
a membrane there are various channels which allow the passage of 
molecules and transport proteins which will transport molecules across 
the membrane. Both these channels and transport proteins are 
influenced by EFAs in the membrane. Control is required to ensure 
that sufficient nutrients enter the cell and also to ensure that 
certai-n products and hormones are a 11 owed to 1 eave the ce 11 in a 
controlled manner (69,70,73,74,76-80). 
EFAs, as constituents of phospholipids, can affect membrane function 
in four ways ; they affect membrane fluidity, they can interact with 
membrane proteins, they can alter the membrane thickness and they can 
alter the composition of the membrane phase. All of these functions 
are vitally important to the normal functioning and integrity of the 
cells (60,70,73,74 ,76-80). 
The alteration of membrane function as a result of a deficiency of 
EFAs has resulted in various diseases, some of which are discussed 
later. A classic symptom of EFA deficiency is scaly skin. The 
scaly skin results in an increased permeabil i ty of the skin membranes 
to water. The problem is completely reversed and cured by either the 
topical application of LA, GLA or AA or by the increased intake of 
these EFAs (50,53,69,85). 
Both wound healing and burn healing have been shown to be greatly 
enhanced if EFA is added to the diet. In both cases it has been 
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shown that there is an EFA deficiency in the skin and surrounding 
tissues if the wounds or the burns are particularly severe. It is 
now possible to apply a LA cream to severe burns with very encouraging 
results. These results are thought to be due partially to the role 
of EFAs in the control of membrane integrity (86) . 
1.3.1 . 3.2 The Role of EFAs in the Immune System 
EFAs are suggested to influence the mitogenic response of the T-cells 
of the immune system and consequently affect the immune system. For 
this reason EFAs are thought to play a role in infection. EFAs are 
also considered to aid in the defence against foreign cells. An EFA 
deficient diet results in increased bacterial infections and when LA 
is supplemented in the diet it has been shown to help protect against 
this infection (86-89). 
1.3.1.3.3 Prostaglandin Synthesis 
LA is the precursor for the synthesis of the three different series of 
PGs which in turn have many varied roles. It has been found that PG 
synthesis can be modified by varying the EFA intake. PGs have a very 
limited biological half life and as such are usually only synthesised 
when required. PGs have many varied physiological funct ions, for 
ex amp 1 e PGE 1 has cytoprotect i ve, anti -aggregatory, vasod i 1 a tory and 
anti-inflammatory functions and PGE2 has aggregat ory and inflammatory 
functions. PGs are thought to be involved in various cancers as most 
-24-
human cancers have elevated amounts of the 2 series PGs. The 
significance of this will be discussed later . It is also thought that 
PG synthesis plays a role in membranes as the PG precursors are 
present in the membranes, mainly in the form of phospholipids (90-96) . 
PGs are present in a high concentration in seminal fluid and research 
has shown that PGs play an important role in sexual functioning . An 
EFA deficiency results in reproductive problems in both males and 
females and it is thought that these problems are a result of reduced 
PG synthesis. PGs are a 1 so known to mob i 1 i se or influence the 
mobilisation of free fatty acids. In this way PGs also play a role 
in the control of EFA synthesis (97,98). 
1.3.1.3.4 The Role of EFAs in Cell Proliferation 
As Fig. 1 shows, EFAs are thought to influence cell proliferation via 
PG and cAMP synthesis. There is generally an inverse relationship 
between cellular cAMP levels and cell proliferation. It has 
consequently been suggested that if there was reduced PGE1 synthesis, 
due t o an EFA deficiency, the synthesis of cAMP would be great 1 y 
reduced and thus cell proliferation wou ld increase. This is one of 
the ways in which EFAs are thought to play a role in cancer, i e by 
influencing the rate of cell proliferation. This may also be a reason 
why these compounds are also important in burn healing and wound 
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healing, i e by increasing cell proliferation. Cell division may 
also be affected by the membrane status and this is another way in 
which EFAs can influence cell proliferation (5,22-30). 
1.3 .1.4 EFAs and Various Diseases 
There are various reports that relate multiple sclerosis to a dietary 
deficiency of EFA. The one problem with these reports is that EFA 
deficiencies seem to be slightly inconsistent in that EFA quantities 
in the blood and tissues differ from case to case. It is thought 
that an EFA deficiency results in faulty myelination and as multiple 
sclerosis involves the loss of the myelin sheath around nerve cells, 
it is possible that this may be the result of a deficiency of EFAs 
(86,99-101). It is suggested that the w-3 EFAs also play a role in 
multiple sclerosis as the ALA content in the blood and tissues is very 
low (100). The initial reason that the lipid nutrition was focused 
upon in relation to this disease was that 60% of the solid matter of 
the brain and 70% of the myelin sheath consists of lipid, and as such, 
it plays a vital role in nerve function. It has been known for some 
time that EFA deficiency retards brain development and alters synaptic 
function . A shift in the proportion of saturated and unsaturated 
fatty acids has been recorded in the brains of multiple sclerosis 
patients. At this stage however more evidence is required concerning 
the interaction of EFAs and multiple sclerosis (86,99-101). 
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It has been found that babies that have died from sudden infant death 
syndrome (cot death) have a lower level of DGLA compared to babies of 
a similar age. At present, however, it is not known how DGLA or EFAs 
in general play a role in this syndrome although DGLA is the precursor 
for the 1 series PG's which may play a role in this disease (102). 
EFA metabolism appears to be abnormal in diabetics. Experimental data 
suggests that diabetes may result in partial EFA deficiency, although 
it is not known exactly how this plays a role in diabetes or whether 
it is just an effect of diabetes (86). 
LA concentrations have been found to be lower in cystic f i brosis 
patients while the total PUFAs do not seem to be abnormal. The 
patterns of fatty acids occurring in the serum are different, but it 
is not known if this is a direct result of EFA function (86,103). 
Acquired Immunodeficiency Syndrome (AIDS) has recently been 
hypothesised to be influenced by a dietary deficiency of certain EFAs, 
e g GLA. It is hypothesised that these fatty acids play a role in 
preventing the viral spread of AIDS. There is also a high incidence 
of sarcomas and other cancers in AIDS patients and it is · well 
documented that EFAs play a role in cancer prevention (104). 
EFAs have been implicated in numerous diseases, but as has been shown, 
it is not totally clear exactly what the relationship or the 
significance of EFAs are in these diseases. 
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1. 3.2 The Role of Zinc in Nutrition and Metabolism 
Zinc is an essential trace element and is the second most abundant of 
the transition and group II elements present in the body i e in a 
human adult of 70 kg there is 3g of zinc. Of the trace elements only 
iron is found more abundantly in humans (105). 
1.3.2.1 The History of Zinc 
In 1869 Raulin showed that zinc was 
Aspergillus niger (cited in 106,107). 
essent i a 1 for the growth of 
In the ensuing fifty years it 
was discovered that zinc played an essential role in all of the 
biological kingdoms i e monera, protists, fungi, plants and animals 
(105-108). It was only in 1961 that it was first hypothesised that 
zinc deficiency could occur in humans, and was subsequently confirmed 
in 1963. The first studies carried out showed that zinc deficiency 
resulted in dwarfism, severe anaemia, hypogonadism, 
hepatosplenomegaly, rough and dry skin and mental lethargy. It was 
later discovered that the anaemia was a result of iron deficiency. 
It has since been shown that iron deficiency is quite commonly found 
together with zinc deficiency. If zinc was supplemented in the diet 
the symptoms were alleviated and normal growth re-established (cited 
in 108). Zinc, therefore, plays an important role in the development, 
growth and differentiation of humans and other animals. It is known 
that certain dietary factors inhibit the absorption or uptake of zinc 
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e g phytic acid (found in fibre), a low protein diet, calcium and 
copper (108,109). 
Zinc deficiency in humans can be exhibited as a mild, moderate or 
severe form. Mild zinc deficiency is characterised by a decreased 
serum testosterone 1 eve 1 and o 1 i gospermi a in rna 1 es, decreased 1 ean 
body mass, hyperammonemia, neurosensory changes, anergy, decreased 
serum thymu 1 in activity and decreased inter 1 euk in activity. Growth 
retardation and male hypogonadism in puberty, rough skin, poor 
appetite, mental lethargy, delayed wound healing, cell-mediated immune 
dysfunctions and abnormal neurosensory changes are found in moderate 
zinc deficiency. Severe zinc deficiency is indicated by bullous 
pustular dermatitis, alopecia, diarrhoea, emotional disorder, weight 
loss, intercurrent infections due to cell-mediated immune 
dysfunctions, hypogonadism in males, neurosensory disorders, problems 
with ulcer healing, and death in certain cases (110-113). 
Zinc deficiency has been shown to occur all over the world and 
throughout entire populations (110,112,114) . The recommended daily 
allowance of zinc for humans is 3mg for infants up to six months, 10mg 
for children, 15mg for adults and 25mg for lactating females 
(109,113). 
The biochemical role of zinc was first demonstrated in 1940 when 
Keilin and Mann identified the first zinc metalloenzyme, carbonic 
anhydrase. This showed that zinc played an important role in the 
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catalytic functions and structural functions of organisms (cited in 
105). This area of research has greatly expanded since 1940 and zinc 
is now known to be involved with over 200 meta 11 oenzymes or zinc 
dependant enzymes and cofactors in many different species. These 
enzymes encompass a broad area of biological reactions and there are 
enzymes associ a ted with zinc in each of the six I UB categories of 
enzymes. This is in fact the only metal that is involved with 
enzymes in all of the six categories (105,109). (See Table 1 on page 
30). 
Due to the association of zinc with a large number of enzymes, it is 
involved in nearly all types of metabolic processes, including the 
synthesis and degradation of carbohydrates, proteins, lipids and 
nucleic acids, and it can influence many important biological 
functions. Some of these, particularly those of interest to this 
study, will be discussed below (113-115). 
1.3.2 .2 The Functions of Zinc 
1. 3.2.2.1 The Role of Zinc in Gene Expression 
Recently there has been much interest shown in the role that zinc 
plays in gene expression. This role involves both a structural and 
enzymatic ro 1 e. It has been hypothesi sed that zi nc promotes the 
transition of the 8-form of DNA (right-handed helix) to the Z-form of 
DNA (left-handed heli x). Z-ONA is thought to have regulatory 
functions related to gene expression (cited in 109). The 
involvement of zinc in this process requires further elucidation. 
TABLE 1: ZINC HETALLOENZYMES (105). 
Class I - Oxidoreductase& 
Alcohol dehydrogenase 
Alcohol dehydr~enase 
D-Lactate dehydrogenase 
D-Lactate cytochrome reductase 
Superoxide dismutaJe 
Class II - Transferase& 
Transcarboxylase 
Aspartate transcarbyamylase 
Phosphoglucomutase 
RNA polymerase 
Reverse transcriptase 
Nuclear poly(A) polymerase 
Terminal dNT transferase 
Mercapto~yruvate sulfur transferase 
Class III - Hydrolase& 
Alkaline phosphatase 
5' Nucleotidase 
Fructose-1 .6-biphosphatase 
Phosphodiesterase (exonuclease) 
Phospholipase C 
Cyclic nucleotide phosphodiesterase 
Nuclease 
-Amylase 
-0-Mannosidase 
Aminopeptidase 
Aminotripeptidase 
Dipeptidase 
Antigiotensin-converting enzyme 
Procarboxypeptidase A 
Procarboxypaptidase B 
Carboxypeptidase A 
Carbcxypeptidase e 
Carboxypeptidase (other) 
DO-Carboxypeptidase 
Elastase 
Neutral protease 
Collagenase 
Aminocyclase 
Dihydropyrimidine aminohydrolase 
Dihydrocrotase 
-Lactamase II 
Creatininase 
AMP deaminase 
Inorganic pyrophosphatase 
Nucleotide pyrophosphatase 
Class IV - Lyases 
Fructose-1 ,6-bisphosphate aldolase 
LRhamnulose-1-phosphate aldolase 
Carbonic anhydrase 
-Aminolsvulinic acid dehydratase 
Glyoxalase I 
Class v - Iaomeraaea 
Phosphomannose isomerase 
Class VI - Ligasea 
tRNA synthetase 
Pyruvate carboxylase 
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Source 
Yeast 
Vertebrates, plants 
Barnacle, bacteria 
Yeast 
Vertebrates, plants, fungi, bacteria 
Propionibacterium shermanii 
Escherichia coli 
Yeast 
Yeast, protists, wheat germ, bac teria 
Oncogenic viruses 
Rate liver, virus 
Calf thymus 
E.coli 
Mammals, bacteria 
eacteria, lymFhoblast plasma 
Mammals 
Snake venom 
Ba-cillus cereus 
Yeast 
Microbes 
Bacillus aubtilis 
Mammals, plants 
Mammals, fungi, bacteria 
Rabbit intestine 
Mammals, bacteria 
~lammals 
Pancreas 
Pancreas 
Vertebrates, crustacea 
Mammals, crustacea 
Mammals, crustacea, plants, bacteria 
Staphyloccua albus 
Pseudomonas aeruginosa 
Vertebrates, fungi, bacteria 
Mammals, bacteria 
Pig kidney, microbes 
Bovine liver 
Clostridiu& oroticum 
B.cereus 
Pseudomonas putida 
Rabbit muscle 
Yeast 
Yeast 
Yeast, bacteria 
E.coli 
Animbls, plants 
Mammalian liver, erthrocytes 
MamJroals, yeast 
Yeast 
E.coli, B.stearothermophilus 
Yeast, bacteria 
A 
A.D 
? 
? 
B 
? 
A 
A 
A 
A 
? 
A. (C)bO 
? 
c 
A 
A 
? 
7 
B 
? 
A.C 
A 
A 
A 
A 
A 
A 
A 
A 
A 
~(Blb 
A 
? 
7 
7 
A 
7 
7 
7 
A 
A 
A 
A 
A 
A 
? 
A 
? 
~ denotes a catalytic, B a structural, C a regulatory and 0 an undefined role, while ? indicates that 
availacle information is insufficient to make an assignment. 
Letters in parentheses refer to roles fulfilled ty metals other than zinc. 
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1.3.2.2.2 The Role of Zinc in Cell Proliferation 
Since zinc deficiency results in reduced growth in nearly all 
organisms, including man, it was thought that zinc may influence cell 
proliferation through an association with the enzymes involved in the 
proliferation process. It was found that zinc influenced certain DNA 
synthesis enzymes, for example, DNA polymerase and thymidine 
kinase . Zinc was suggested to be a vital component of DNA 
polymerase, although there is now contradictory evidence indicating 
that zinc does not play a role in the DNA polymerase of Escherichia 
co 1 i . If DNA polymerase is a zinc metalloenzyme, this could explain 
how zinc deficiency results in reduced growth. Zinc may also 
inf luence DNA synthesis via thymidine kinase (the regulatory enzyme in 
the DNA salvage pathway, previously discussed), but again no definite 
evidence that thymidine kinase is a zinc metalloenzyme or a zinc 
dependant enzyme is available (105,106,108,109,111,112,116-118'). It 
has now been shown that zinc is essential for certain stages of the 
DNA synthetic cycle, and zi nc definitely can influence these stages 
(119). 
Numerous workers have shown that there is reduced protein synthesis, 
as expected, with the reduced DNA synthesis resulting from zinc 
deficiency (112,120-123). 
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Zinc deficiency has been shown to have a teratogenic effect on the 
foetuses of hens, mice and rats. 
organ system in the foetuses . 
These abnormalities occur in every 
It is not known conclusively if zinc 
def iciency is teratogenic for humans, but there is much circumstantial 
evidence to support this hypothesis. Geographical areas that have 
the highest incidence of malformations of the nervous system have been 
shown to broadly include those areas in which it is known that 
children and adults suffer from zinc deficiency. Alcohol is known to 
enhance zinc deficiency and alcoholic human mothers often give birth 
to infants with malformations similar to those observed in studies on 
rats (105,108,111,112,114,116,123-127). 
1. 3.2.2.3 Zinc and Various Diseases 
Zinc deficiency in rats also resul ts in a troublesome pregnancy. 
There is excessive bleeding during parturition and the mothers seem to 
be unable to look after their young, as they do not clean them 
immediately after birth and they do not consume the afterbirth. Many 
mothers die at parturition and most of the young do not survive 
(105,108,111,112,114,116,123,124-127). 
Alcohol induces zinc deficiency. Livers which are cirrhotic are zinc 
deficient and patients show lympocytopenia and increased infections. 
These symptoms are alleviated by the addition of zinc. Infants born 
to alcoholic mothers show the same zinc deficiency symptoms as rat 
infants born to zinc deficient mothers. These infants show what is 
termed 11 foetal alcohol syndrome 11 • Most of the symptoms of this 
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syndrome are alleviated by the supplementation of zinc (108,114). 
As has been previously stated zinc deficiency results in 
lymphocytopaenia (a reduction in lymphocyte production) and an 
increased susceptibility to infections. This increased 
susceptibility to infection is expected as the immune system has a 
reduced function as a result of zinc deficiency . Zinc i s generally 
required for cell-mediated immune functions and as such plays a vital 
role in the immune response (108,110,112,114,123,128). 
Acrodermatitis enteropathica is a genetic disease whi ch resu lts in 
malabsorption of zinc, with zinc deficiency as a resu ltant symptom. 
When zinc is supplemented in the diet the disease is alleviated. 
Before it was discovered that this disease was due to a lack of zinc, 
it was usually terminal (cited in 110,112,129). 
If zinc is given to patients suffering from sickle cell anaemia there 
is a resultant increase in weight, growth of pubic ha ir, increased 
serum testosterone level, increased plasma zinc and increased 
neutrophils and a general alleviation of sympt oms of the disease 
( 108, 112). 
Zinc plays a protective role in maintaining integral cellular and 
organelle membranes via protection against PUFA and lipid peroxidation 
and by influencing enzymes associated with the membranes (some of 
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which control the structure and function of the membrane) e g 
ATPases. Zinc also influences membrane transport systems. This may 
also be one of the ways in which zinc influences cell proliferation 
(108,109,123,124,130,131). 
1.3.2.2.4 Zinc Toxicity 
Little is known about zinc toxicity and the effect it may have on 
ce lls. It is known that if zinc oxide fumes are inhaled the result 
is a mild to severe pulmonary inflammatory response with fever, chills 
and leukocytosis. Symptoms of zinc toxicity in humans include 
dehydration, electrolytic imbalance, abdominal pain, nausea, vomiting, 
lethargy, dizziness and muscular incoordination but these are with 
very high intakes of zinc. Zinc is also known to be non-accumulative. 
In general it would appear, therefore, that with the level of zinc 
supplementation normally used (two to ten times the recommended daily 
allowance (RDA)) there is unlikely to be any toxic effects 
(105,108,114) . 
1. 3.3 The Relationship between Zinc and EFAs 
The deficiencies of zinc and EFAs show very simi lar symptoms 
particularly with regard to skin lesions, alopecia, reproductive 
fa ilure and growth. This evidence suggested a possible interaction 
between zinc and EFAs which is supported by other findings such as: 
the characteristics of either zinc or EFA deficiency are exaggerated 
when the other factor is also deficient; when pregnant rats are tested 
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with drugs which block EFA conversion to PGs, the symptoms are similar 
to those of zinc deficiency in pregnant rats and treatment of zinc 
deficient rats and humans with EFAs alleviates some of the symptoms of 
zinc deficiency (cited in 132- 134). 
It was subsequently proposed that zinc deficiency may mimic many of 
the clinical features of EFA deficiency as it may be required in the 
linoleoyl-CoA desaturase step of EFA synthesis . It has been shown 
experimentally that zinc could be a cofactor of this enzyme (133,135) . 
Zinc deficiency has more recently been shown to reduce linoleoyl-CoA 
desaturase activity in many tissues except mammary tissue 
(132,133,136-143). 
Kramer has suggested that linoleoyl-CoA desaturase was not affected by 
zinc directly , but instead it was effected by a protein energy 
deficiency, which could result from a zinc deficiency. However, a 
definite effect of zinc on linoleoyl-CoA desaturase activity has been 
found by other researchers (136,144). 
Zinc effects the incorporation of EFAs into membrane phospholipids and 
zinc deficiency produces a number of abnormalities in lipid 
metabolism. For example, the capacity of the testes to synthesise 
PGs from EFAs is altered by zinc deficiency. In the parenchyma of 
the testes there is increased synthesis of PGE2 and 6-keto PGF1a and 
in the tunica of the testes there is reduced synthesis of PGE2 and 
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6-keto PGF1a (138,141,145). Zinc is also required for the 
mobilisation of DGLA from phospholipids and DGLA is the precursor for 
the synthesis of the 1 series PGs. Zinc may in addition be important 
in the conversion of DGLA to AA (146-149) and zinc may also be 
required for the release of EFA-containing free phospholipids from the 
membrane bound stores by phospholipase A2 (148). It can, therefore, 
be seen that there is much evidence to support the hypothesis of an 
interaction between zinc and EFAs . 
1.4 The Relationship between Cancer and Diet 
As has been indicated earlier diet has been implicated as an important 
factor in cancer. Most agents in the diet which play a role in 
cancer are considered to be promoters of tumour deve 1 opment rather 
than initiators (2,4). As the promotion step of cancer is 
reversible, this explains why the relationship between diet and cancer 
has become of such major interest in recent times. 
In 1809 William Lambe published a thesis on diet and cancer in wh ich 
he implied that foods originating from animals and water were the 
principle causes of cancer. Lambe's diet for the prevention of 
cancer was that of a strict vegetarian, and drinking only di stilled 
water (cited in 9). In 1954 McCormick advanced the hypothesi s that 
cancer was secondary to a degenerative change in the connect ive 
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tissue, and that this change could in turn be secondary to a 
deficiency of vitamin C (cited in 150) . In 1959 McCormick published 
another paper in support of this hypothesis (150). Although this has 
been contradicted by recent cancer research, it does show that diet 
may be important in cancer . A substantial part of cancer research 
undertaken recently, has involved the role of diet in the initiation 
and promotion of cancer. The influences of dietary lipid , fibre, 
vitamin, mineral and cholesterol intake have been the subject of 
intense investigation (cited in 2,cited in 3,4,5,cited in 6,cited in 
8,10,150-158). Factors in the diet are estimated to be significantly 
involved in 30-40% of cancers found in men and in approximately 60% of 
cancers found in women. Factors in the diet are , however, not only 
promoters of cancer since many have been found to play a curative ro le 
in cancer and it is these factors which have created a great amount of 
interest in recent years (2-8,11). 
Diet can influence the initiation and promotion of cancer in a number 
of ways. Carcinogens and procarcinogens may be ingested directly, 
and once ingested, the diet of the subject may affect the ways these 
agents are transported and/or metabolised. It is also possible that 
the diet may provide substrates for carcinogen formation, such as 
nitrates, which are used in the preservation of most tinned meats for 
ex amp 1 e and which upon contact with stomach acids and subsequent 
metabolism are converted to nitrosamines which are known carcinogens . 
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A diet may in addition alter cellular metabolism in such a way that it 
can increase the receptivity of agents for carcinogenic action. The 
bulk of the diet, in the form of calories or energy, may enhance the 
promotion or initiation of cancer . Dietary deficiencies, either as 
macro- or micro- deficiencies, may also result in the initiation or 
promotion of cancer (3,4,6,8,10,11,150-158). 
There are many dietary factors such as lipids, proteins, 
carbohydrates, fibre, vitamins, minerals, alcohol and mutagens which 
influence the development of cancer. Of interest to this study, as 
previously indicated, is the influence of lipids and minerals, and 
they will now be discussed in more detail. 
1.4.1 The Relationship between Lipids and Cancer. 
In 1941 Smedley-Maclean and co-workers (151,152) showed that total fat 
and PUFAs had an influence on tumour growth . If rats were fat- and 
PUFA-starved and Walker tumours were implanted into these animals, it 
was found that the tumours grew faster than implanted tumours in rats 
on a fat- and PUFA-sufficient diet (151,152). In 1942 Tannenbaum 
(153) tested the effect of a high-fat diet on the growth of various 
tumours. He showed that there was a definite increase in the 
incidence and decrease in the growth time of spontaneous breast 
tumours in humans on high fat diets. Induced epithelial tumours also 
showed an increased incidence of tumours when high-fat diets were fed, 
-39-
but the increase was not as great as with spontaneous breast tumours. 
High-fat diets had no significant effect on the growth of primary lung 
tumours or induced sarcomas in mice (153). 
high-fat diets were noted by Tannenbaum. 
Thus diverse effects of 
In 1945 Tannenbaum (154) showed that tumour growth was dependant on 
the composition of an experimental diet and the degree of caloric , 
restriction. Dunning et ill. (155) also found that restricting the 
caloric intake either reduced the formation of mammary tumours or 
increased the latency period of the tumours. They showed that high-
fat diets tended to result in reduced latency periods and greater 
tumour formation than low-fat diets. When the ca 1 ori c intake was 
restricted the high-fat diet showed reduced tumour formation as was 
also demonstrated by Tannenbaum (154,155). Silverstone and 
Tannenbaum in 1950 (156) and Engel and Copeland in 1951 (157) 
concurred with the results of Dunning et AI regarding high-fat diets 
and increased mammary carcinoma growth. These results clarified 
certain contradictory reports that had appeared up to this time. 
Engel and Copeland (156) showed that the effectiveness of a 
carc inogen, 2-acetylaminofluorene, at a particular site in the body, 
could be greatly influenced by the type of diet i e high- or low-fat 
diets and also by caloric restriction. For example, a low-fat diet 
and caloric restriction resulted in a reduced number of ear duct 
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tumours and a high-fat diet resulted in an increased number of mammary 
tumours. It was also shown that fibroadenomas exhibited increased 
growth with a high-fat diet (158). It has, therefore, been 
appreciated for some time that a relationship exists between dietary 
fat and cancer. 
More recently there have been numerous papers published concerning the 
relationship between fat and cancer. Mammary cancer has been shown 
to be one of the cancers that are directly correlated with dietary 
fat. Experiments have shown that as dietary fat is increased so the 
incidence of mammary tumours has concurrently increased (2,3,159, 
cited in 160, cited in 161,162,cited in 163-167,168,cited in 169,cited 
in 170,171,172). Initially this increase in tumour incidence was 
thought to be related to the increase of total fat intake, but 
recently it has been shown that the increase in the tumour incidence 
correlates better to the increase of PUFAs in the diet (3,cited in 
159-161,162,cited in 163,cited in 164,165,cited in 166,cited in 
167,168,cited in 169,cited in 170,171,172). The mammary tumours that 
have shown an increased incidence as a result of a high-fat diet 
include a wide range of tumours, viz spontaneous, carcinogen-
induced, X-irradiation- induced and transplantable mammary tumours. 
Apart from an increased incidence of these tumours there was also a 
reduced latency period (cited in 159,cited in 161,cited in 169,cited 
in 171). 
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An increased incidence of prostrate cancer has also been correlated 
with a high fat diet . Again, when the fat is in the form of PUFA, 
instead of saturated fat, there is a higher incidence of tumour 
formation (3,4,159,165,173). Cancer of the testes, the corpus uteri 
and the ovaries has also been shown to have an increased incidence 
with high-fat diets. In these cases the experimental evidence points 
to the total dietary fat present in the diet as being the important 
factor (3,4,165). 
There is not an abundance of evidence to indicate that stomach cancer 
is influenced by dietary fat, but the evidence that is available does 
point to some correlation between a high-fat diet and increased 
incidence of stomach cancer (3,166). There is an increased incidence 
of pancreatic cancer as a result of a high level of dietary PUFAs 
(3,163,165,166,172). Cancer of the colon also has a highest 
incidence in the presence of dietary PUFAs (3,159,163,165,172-174). 
On a high fat diet obesity acts as an extra promotor of certain 
cancers, such as cancers of the endometrium, gallbladder, cervix, 
colon, pancreas and breasts (3,4,10). 
In man the normal form of a dietary PUFA is the cis form. This is 
the form of PUFAs that most enzymes are capable of dealing with. One 
factor that has recently come to the fore is that during this century 
there has been an increase in the consumption of partially 
hydrogenated vegetable fats in the form of margerines, vegetable oils 
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and vegetable shortenings. In partially hydrogenating vegetable 
fats, significant quantities of the cis PUFAs are chemically altered 
to become trans PUFAs. These trans PUFAs are unnatura 1 and are 
believed to play a role in the promotion of various cancers. This is 
an area of research which at the present time is still controversial 
as Institutes such as the Institute of Shortening and Edible Oils, Inc 
are questioning the validity of these studies (159,169,175-182). 
1.4.1.1 The Relationship Between EFAs and Cancer 
In considering the role of specific PUFAs, viz EFAs in cancer, it 
should be noted that many of the studies on the relationship between 
EFAs and cancer have been cell cu 1 ture studies and wh i 1 e it is not 
always possible to directly extrapolate in vitro findings to in vivo 
s ituations, cell culture studies do provide valuable insight into the 
functioning of compounds such as EFAs in tumour cells (183-185). 
At present contradictory data has been published concerning the role 
that EFAs and PGs play in cancer, as some reports state that EFAs and 
PGs promote cancer and others state that the same EFAs and PGs inhibit 
cancer growth. One of the reasons for this may be that the ce 11 
lines or experimental animals utilised in the experiments invariably 
differ . In general, however , EFAs and PGs are known, to affect 
cancer cell s and their proliferation and it i s suggested that this 
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occurs through a number of mechanisms e g control of cAMP synthesis, 
membrane fluidity and structure, regulation of the immune system and 
possibly lipid peroxidation (5,22,23,25-30,86-88,186-189) . 
In contrast to the above finding, many cell lines have been shown not 
to require EFAs in their media for continued growth. This is thought 
to be a result of the loss of the activity of linoleoyl-CoA desaturase 
(as cancer cells either have reduced or no linoleoyl-CoA desaturase 
activity). It has also been suggested that individual cells may not 
require EFAs as they may play an integral role in maintaining tissue 
activities and signa 11 i ng between ce 11 s. A 1 though EFAs may not be 
essential for the continued growth of some cell lines, these cell 
lines are still influenced by EFA addition to the growth media (190-
193). 
LA has been shown to enhance chemically induced mammary tumours in 
rats when it is present at a level of 3% in the diet .(194). It has 
also been shown to result in an increased incidence of mammary 
adenocarcinomas in mice and rats (195-200). In cell culture, when LA 
was added to the media there was enhanced growth of a mammary tumour 
cell line (201,202). This seems to indicate that LA does play a role 
in the promotion of mammary cancer . A study carried out to determine 
the effect of a high LA diet on spontaneous tumours, showed that LA 
may play a role in the promotion of spontaneous tumours (196). 
-44-
It is hypothesised that EFA induced increased tumour growth is 
mediated through a process which in some way involves PGs. PGs are 
thought to influence cancer by immunosuppression, which could be a 
result of tumour cell membrane changes. It is possible that the 
mechanism by which LA promotes tumour growth could be multifactorial, 
and that PGs play only a partial role. The role of PGs in this 
process becomes more difficult to define if it is considered that 
cancer cells have a reduced activity of linoleoyl-CoA desaturase as 
has been proposed. It should then follow that there would be reduced 
synthesis of PGs and, therefore, the presence of low and not elevated 
PG 1 eve 1 s wou 1 d be corre 1 a ted with increased cancer growth 
(185,195,198,203-207). 
Of the w-6- EFAs, LA has been shown to be the EFA that is linked most 
often to cancer promotion (197-200,205-207). GLA on the other hand 
is suggested to inhibit cancer growth and not to influence the growth 
of normal cells. GLA is found in a large quantity in the evening 
primrose (Oenothera biennis) seed oil i e 9% of the oil (208-210). 
GLA and AA have been both shown to kill cancer cells (human lung and 
breast cancer cells) preferentially when normal and cancer cells are 
mixed in cell culture in the presence of these EFAs (211). Thi s was 
a very important study as normally cell culture studies are carried 
out using pure cultures of cancer or normal cells and in a host cancer 
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and normal cells are in contact and will compete for nutrients. GLA 
has also been shown to inhibit the in vitro growth of human prostatic 
adenocarcinoma, osteogenic sarcoma, laryngeal carcinoma, human 
neuroblastoma, murine melanomas, 
hepatomas, human lung carcinomas 
human mammary carcinomas, human 
and human oesophageal carcinomas 
(212-223). In addition, GLA has been shown to inhibit the in vivo 
growth of mammary tumours and murine leukemias (224-227). 
GLA has been found to completely prevent or reverse genetic damage due 
to the presence of a chemical carcinogen. This is unusual as most 
dietary factors are thought to promote or inhibit the promotion stage 
of cancer, but GLA was shown here to inhibit the initiation stage of 
cancer . This could have important therapeutic implications (225). 
AA has also been shown to be growth inhibitory to some tumour cells 
and LA has recently been found to be inhibitory to Ehrlich ascite 
cells . Further research is required with regard to this latter 
finding, as previously most of the data shows that LA had a promotory 
role in tumour growth (211,228). 
A possible mechanism by which EFAs may inhibit tumour growth is 
suggested to be lipid peroxidation. Lipid peroxidation plays a role 
in controlling cell proliferation and as such has a very important 
biological fun ction, although it can also cause cell injury. PUFAs 
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undergo lipid peroxidation both while in their free form and when 
esterified e g in phospholipids. When this occurs a primary 
reactive free rad i ca 1 interacts with a PUFA to initiate a camp 1 ex 
series of reactions, which results in numerous degradatory products. 
A reduction in PUFA intake will result in a reduction in lipid 
peroxidation, which in turn may result in reduced control of cell 
proliferation (186-189,229,230). 
Cancer cells and solid tumours display reduced amounts of lipid 
peroxidation in comparison to normal cells. This is hypothesised to 
be one of the reasons for loss of control of cell proliferation. The 
lipid peroxidation activity appears to be inversely related to tumour 
proliferation. Tumour membranes also seem to be less susceptible to 
lipi d peroxidation which could be a result of alterations in membrane 
composition. Novikoff tumours, which are rapidly proliferating 
tumours, have reduced PUFA levels and consequently reduced lipid 
peroxidation levels. A slow growing tumour viz Morris 9618A hepatoma 
showed reduced lipid peroxidation, but this reduction was not as large 
as that of the rapidly proliferating Novikoff tumour cell (186-
189,229-232). Therefore, increased EFA levels with resultant 
increased lip id peroxidation may bring about reduced cell 
proliferation. 
EFAs, thus, appear to play an important role in the metabolism of 
cancer cells. Their effects can result in either inhibition or 
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promotion of cancer growth which is probably the result of a 
difference in metabolic effects of EFAs in different cells as outlined 
above. 
1.4.2 The Relationship between Minerals and Cancer 
There have been numerous studies conducted on laboratory animals to 
determine the relationship between dietary minerals and cancer. 
Unfortunately, a large number of these experiments have been conducted 
using differing and sometimes inappropriate methodology, particularly 
the older studies. These problems were mainly related to a lack of 
adequate controls . Early studies by Schroeder and his associates 
(cited i n 3,cited in 233,cited in 234)were on the trace elements 
fluorine, titanium, vanadium, chromium, nickel, gallium, germanium, 
arsenic, seleni um, yttrium, zirconium, niobium, rhodium, palladium, 
cadmium, indium, tin, antimony, tellurium and lead. The number of 
experimental animals used were small which could have resulted in 
incorrect conclusions being drawn. Their results showed that only 
rhodium and palladium produced minimal signs pf carcinogenicity. 
Later studies on some of these trace elements and other elements will 
be discussed in greater detail in the ensuing paragraphs. 
Selenium was first considered to play a role in cancer therapy when 
Dalbert suggested its use in 1912 (cited in 235). Dietary selenium is 
suggested to reduce the risk of cancer and th is has been validated by 
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various animal experimental studies. There is some contradictory 
evidence concerning selenium in that two studies have shown that it 
was an inducer of hepatomas, but more recent studies have refuted this 
(cited in 4,cited in 160,cited in 161,cited in 234-236). Selenium 
has subsequently been found to significantly reduce the incidence of 
mammary carcinomas and high levels of dietary selenium suppressed both 
the initiation and promotion of chemically induced mammary carcinomas 
(cited in 161). In a recent review (3), it was stated that there 
have been no human or animal studies that have shown selenium to act 
as a carcinogen and that the conclusions drawn from the two earlier 
experiments which implicated selenium as an inducer of hepatomas has 
been invalidated. 
As at this present time, there is still insufficient evidence to draw 
a firm conclusion about the relationship between iron and cancer . 
The evidence that is available seems to show that an iron deficiency 
results in an increased incidence of cancers of the upper alimentary 
tract, including the oesophagus and stomach. There is some evidence 
which suggests that the inhalation of large quantities of iron results 
in an increased risk of cancer promotion. As of yet there is no data 
indicating that a high dietary level of iron increases the risk of 
cancer (3,4). 
As with iron, at this present time the evidence available concerning 
the relationship between dietary copper and cancer is insufficient to 
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permit any conclusions to be drawn . It has been found that there is 
a weak association with copper and increased incidences of cancers of 
the intestine, breast, 1 ung and thyra i d (cited in 3) . Copper is an 
essential nutrient that is widely distributed amongst the foods and 
this leads to the problem that the influences noted may not be solely 
due to copper but may be due to an interact ion between copper and 
some other compound. It has been shown in laboratory experiments 
that high levels of copper salts present in diets result in various 
degrees of protection against chemically induced liver tumours. On 
the other hand it has been suggested that the inhalation of copper, 
which can occur when certain fungicides are sprayed, can result in an 
increased risk of occurrence of cancers associated with the 
respiratory tract and lungs (4,6,236). 
In general while numerous studies have investigated the relationship 
between dietary essential elements and cancer, there is still a .great 
deal of research required to fully elucidate the importance of these 
nutrients to the disease. An element of particular interest to this 
study is zinc and will be discussed in greater detail. 
1.4.2.1 The Relationship between Zinc and Cancer 
Zinc is an essent i a 1 canst ituent of more than two hundred enzymes 
(105) and it is an essential trace element. Zinc is known not to be 
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mutagenic and it has been shown to only induce tumours upon local 
application (3,4,105,233,235,237). 
It has been found that certain cancers have lower than normal zinc 
1 eve 1 s in the tumour tissues, for ex amp 1 e, oesophagea 1 care i noma, 
primary hepatic carcinoma, renal cell carcinoma, prostrate carcinoma 
and leukaemic lymphocytes (cited in 238). 
Zinc deficiency, on the other hand, has been shown to reduce tumour 
growth in Ehrlich ascites tumours (239,240), Walker 256 
carcinosarcomas (6,241-243), Lewis lung sarcomas (243), Ll210 mouse 
leukaemias (244), 350 Hepatomas (245) and murine melanoma tumours 
(BL6) (246). In reducing the tumour growth, zinc deficiency has been 
shown not to harm the host. If zinc deficiency was induced in an 
experimental animal, it was shown to prevent the initiation of Walker 
256 carcinosarcomas (6,241-243), Lewis lung sarcomas (243) and Ll210 
mouse leukaemias (244). Mills et E.]_ (247) have established that 
mammary adenocarcinoma growth can be retarded solely by dietary zinc 
deficiency. Zinc deficiency has been shown to result in reduced 
growth of both normal and malignant cells (238). 
Dietary zinc deficiency is thought to reduce the growth of certain 
tumours by reducing DNA synthesis. This could be as the result of 
lower activities of DNA polymerase and thymidine kinase 
(109,112,116,118,122,248-250). Zinc deficiency may also result in 
increased lipid peroxidation, which in turn would lead to reduced cell 
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pro 1 iteration (251) . Of particular interest to this study is the 
possible interaction of zinc with linoleoyl-CoA desaturase which may 
result in reduced tumour growth and this will be discussed in the next 
section. 
One of the very few cancers that has been shown to have an increased 
growth when a zinc deficient diet is fed, is oesophageal cancer. 
This is true for both spontaneous and chemically induced oesophageal 
cancers(cited in 160,238,252). It has been shown that the countries 
(such as South Africa) which have very high oesophageal cancer levels 
tend to have a zinc deficiency in the soils and, thus, the foods 
produced. In South Africa, the Transkei region has an oesophageal 
cancer level approaching 50% in males(cited in 238,cited in 251). 
Thus cancer has been very well correlated with zinc deficiency. 
In contrast to the above studies a zinc supplemented (excess) diet has 
been shown to reduce the growth of a hamster cheek pouch care i noma 
(244). It has also been shown to reduce the growth of L1210 .mouse 
leukaemia cancers. This shows that both zinc deficiency and excess 
reduce the growth of L1210 mouse leukaemias (252). Excess zinc has 
been shown to reduce 816 melanoma growth in culture but when these 
melanoma cells were injected into mice and fed a zinc excess diet, the 
melanomas displayed increased growth (253,254). Two reports disagree 
with this finding and have suggested that excess zinc reduces the 
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growth of 816 melanoma cells, both in vitro and in vi vo (255,256). 
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Zinc excess may also result in reduced cell proliferation via reduced 
DNA synthesis as a result of lower activities of DNA polymerase and 
thymidine kinase (248-250). Zinc supplementation may also result in 
re-activation or increased activity of linoleoyl-CoA desaturase as it 
has been suggested that zinc is a possible cofactor of linoleoyl-CoA 
desaturase (133,135). So it can be seen that zinc could have an 
important ro le in cancer. 
1.4.3 The Relationship Between Zinc, EFAs and Cancer 
As has been outlined in the preceeding sections both zinc and EFAs 
play a role in the regulation of cell proliferation and hence in 
tumour growth. The possibility of an interaction between these two 
nutrients has also been discussed. It is therefore not unrealistic 
that zinc and EFAs may influence each other in the mechanism by which 
they inhibit cell and tumour proliferation. One possible mechanism 
could be through an association of zinc with the regulatory enzyme in 
EFA synthesis, linoleoyl-CoA desaturase. The possibility of such an 
involvement by zinc in EFA synthesis has already been eluded to in 
section 1.3.6 and as Fig . 2 outlines, this could lead to an effect on 
cellular cAMP levels in the cells and a subsequent effect on the rate 
of ce 11 pro 1 iferation. A zinc deficiency could consequently result 
in a reduction in the activity of linoleoyl-CoA desaturase and a 
resultant decrease in cAMP synthesis which in turn could lead to an 
increased rate of cell proliferation (5,22-30,138,140,143). Skeef 
and Duncan (245,246) have shown that zinc does influence cAMP levels 
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i e added zinc results in an increased synthesis of cAMP and a 
reduction in the rate of cell proliferation, which may be the result 
of increased activity of linoleoyl-CoA desaturase. 
The aim of this thesis was to study the effects of zinc, and the EFA, 
GLA on tumour growth and the effects of zinc and GLA supplementation 
on the enzyme complex linoleoyl-CoA desaturase activity in normal and 
malignant cells in vitro. The normal cell line used was a monkey 
kidney cell line (LLCMK) and the malignant cell line used was a murine 
melanoma cell line (BL6). The effect of GLA supp 1 ementat ion was 
studied as it is the product of one of the reactions that linoleoyl-
CoA desaturase catalyses (35) and the effect of zinc supplementation 
on linoleoyl-CoA desaturase was studied as it has been suggested that 
zinc was a cofactor of linoleoyl-CoA desaturase (133,135). The 
isolation of the terminal enzyme in the linoleoyl-CoA desaturase 
complex, ~6-desaturase was one of the primary aims of this study and 
it was decided that this would be approached by isolating the enzmye 
complex and then enzymatically removing the other two components of 
the complex i e cytochrome bs and cytochrome bs reductase with a pure 
~6-desaturase resulting. In order to enzymatically remove the two 
components from the linoleoyl-CoA desaturase complex it was decided 
initially to attempt to isolate and purify these components using 
enzymati c solubilisation from microsomes in order to determine if this 
was possible. Once this had been achieved then the isolation of ~6-
desaturase would be attempted. 
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CHAPTER 2 
ISOLATION AND PURIFICATION OF CYTOCHROME bs 
2.1 Introduction 
Linoleoyl -CoA desaturase is an enzyme complex which consists of 
cytochrome b5, cytochrome b5 reductase and t.fi-desaturase (cited in 
44). As can been seen in Fig. 4 NADH passes electrons to cytochrome 
b5 reductase which in turn passes the electrons onto two cytochrome b5 
molecules and they are then passed onto two t.fi-desaturase molecules . 
The passage of electrons results in the conversion of cis-LA into GLA. 
NADH CYTOCHROME bs 
REDUrASE 
CYTOCHROME bs 
AJDESATURASE 
LINOLEOYL-CoA 
+ 
,-LINOLEllYL-CoA 
DIHOMOGAMMA-LINOLENIC ACID 
Figure 4. The electron flow through the linoleoyl-CoA desaturase (44) 
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One of the aims of this thesis was to isolate and purify each 
component of linoleoyl-CoA desaturase in an attempt to understand the 
functioning of the enzyme complex better. The first component 
isolated was cytochrome b5 as most was known about this component. 
Cytochrome b5 was first isolated from rabbit liver microsomes by 
lipase action and classified as a haeme protein in 1956 by 
Strittmatter and Vel ick (257). Up to this time cytochrome bs had 
a 1 so been ref erred to as cytochrome b1 and cytochrome m (cited in 
257) . Strittmatter and Velick noted that two very simi lar forms of 
cytochrome bs were isol ated with molecular weights (MW) of 
approximately 17 000. Experimental results indicated that there was 
one haeme molecule and no non-haeme iron in cytochrome b5 (257). By 
1966 cytochrome b5 was the generally accepted name for this haeme 
protein . Strittmatter and Ozo ls (258) showed that the two ·major 
forms of cytochrome b5 that had been isolated differed in that the one 
form contained an extra peptide sequence but both forms were 
ca ta 1 yt i ca 11 y active. This sequence was shown to be the carboxy 1 
terminal sequence. Tryptic digestion of the larger form resulted in 
the formation of the second and smaller form. The smaller, or core, 
form of cytochrome b5 was shown to consist of 81 amino acids. In 
1968 cytochrome b5 was first solubilised from rabbit liver microsomes 
using the detergents Triton-X 100 and sodium deoxycholate. The 
detergent solubilised cytochrome b5 had a MW of approximately 25 000 
and whereas the lipase or protease solubilised cytochrome b5 molecules 
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were present in solution as monomers, the detergent solubilised 
cytochrome bs was present in solution as an oligomer (259). 
Ito and Sato (259) put forward the proposal that the catalytic 
activity of cytochrome b5 was to be found in the haeme portion of the 
molecule and that the carboxyl terminal sequence was hydrophobic and 
could possibly have the role of anchoring cytochrome bs to membranes. 
In 1968 Kajihara and Hagihara (260) crystallised cytochrome bs after 
solubilising it from rabbit liver microsomes 
trypsin. Th is cytochrome bs had a MW of 11 500. 
using crystalline 
As with the lipase 
action trypsin solubilisation resulted in two very similar forms of 
cytochrome bs being isolated. In 1969 several workers showed that 
cytochrome bs was susceptible to proteolytic action as a result of its 
positioning on the outside surface of membranes (261,262) . Fig. 5 
shows the present proposed structure of cytochrome bs and the two 
proposed sites of tryptic proteolysis (263). 
Cytochrome b5 i s now known to be an amphipathic molecule which 
consists of a hydrophilic catalytic domain which is linked via a short 
flexible sequence to a hydrophobic domain (see Fig. 5). This 
hydrophobic domain anchors the molecule within membranes 
(264,265,cited in 266). Cytochrome bs is an integral protein viz. 
it is strongly bound to a membrane and interacts with the lipids of 
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the membrane. Cytochrome b5 1 once synthesised I is spontaneously 
inserted into the intracellular membranes of cells (267-272). 
HYDROPHOBIC 
DOMAIN 
HYDROPHOBIC 
FRAGMENT 
HYDROPHILIC 
HAEME-CONTAINING 
DOMAIN 
Head Groups 
_ _.......,.._.~ 
Hydrocarbon 
Core BILAYER 
----............ -----Head Groups 
-----------
FigureS. Schematic representation of cytochrome bs in u phospholipid 
bilayer, based on data derived from limited proteolysis and from dimensionul 
studies in detergent solutions. The COOH-terminus of the protein must lie 
outside the-hydrocarbon core of the bilayer, but there is no direct evidence 
that it emerges from the same side us the inter-domain link as shown in the 
figure (263). 
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Further research has shown that the cytochrome bs found in rabbit 
liver consists of 141 amino acids and that the catalytically active 
domain consists of 97 amino acids . This would mean that the 
detergent solubilised cytochrome b5 would be 141 amino acids in length 
and the trypsin solubilised cytochrome b5 would be 97 amino acids in 
length. The molecular weight of the intact cytochrome b5 was shown 
to be approximately 16 700 (259,264,269) . 
Cytochrome b5 is normally a 6-coordinate low sp in haeme protein with 
histidine-39 and histidine-53 as the axial ligands (273,274). 
Mathews (cited in 275) used X-ray diffraction techniques at a 
resolution of 2A to indicate that the haeme portion of cytochrome b5 
was inserted into a tight non-polar crevice within the compact 
globular molecule of cytochrome b5. Most of the polar residues 
within the mo lecule were found to be on the outer surface of 
cytochrome b5. 
Studies of eight different species , i e man, monkey, pig , chicken , 
bovine, rabbit, murine and rat have shown that cytochrome b5 from all 
of these eight species demonstrates sequence homology among amino 
acids 42-72. These include the two axial ligands. Sequence 
variability is located in the amino acids of the hydrophobic membrane 
binding region of cytochrome b5 (276,277). 
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Cytochrome bs is found in membranes as a monomer which is consistent 
with its function as an electron carrier (275,278) . Microsomal 
e 1 ectron transport chain components are known to undergo movement 
within the membrane and integral proteins are thought to undergo rapid 
rotational and translational movement within the membrane bilayer 
(279 ,280). Cytochrome bs is known to be randomly distributed on the 
surface of membranes and for it to receive and pass on electrons it 
must be able to diffuse throughout the membrane (263,268,281). It 
has been shown that the rate of electron transfer from cytochrome bs 
reductase to cytochrome bs is determined by the lateral diffusion 
within the membrane of cytochrome b5. So cytochrome bs is a mobile 
electron transport protein (275,cited in 263,278) . 
As cytochrome bs has been proven to be a component of linoleolyl-CoA 
desaturase via enzymatic and immunological methods it was decided to 
attempt to isolate and purify cytochrome bs from rat liver using a 
simplified methodology with a hopefully increased yield 
(282,283). 
Cytochrome bs has been shown to be present in high quantities in the 
endoplasmic reticulum of mammalian liver cells and for this reason 
cytochrome bs was isolated and purified from rat liver microsomes 
(260,268,269,276,281). 
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2.2 Materials and Methods 
2.2.1 Reagents 
Unless stipulated, all buffer and other dilutions, in this thesis, 
were made with deionised water. 
Homogenisation buffer. The homogenisation buffer consisted of 0.25 M 
sucrose, 0. 15 M potassium chloride, 0.005 M magnesium chloride, 0.001M 
ethylenediamine tetra-acetic acid (EDTA) in 0.1 M Tris-HCl pH 7.4. 
Protein solution A. Protein solution A consisted of 2.0 g of 
potassium sodium tartrate and 100 g of sodium carbonate (Na2C03) 
dissolved in 500 cm3 of 1.0 N sodium hydroxide (NaOH). The volume was 
then made up to 1000 cm3 with deion i sed water in a volumetric flask. 
Protein solution B. Protein solution B consisted of 2.0 g of 
potass i urn sod i urn tartrate and 1. 0 g copper su 1 phate hydrate 
(CuS04.5H20) dissolved in 90 cm3 of deionised water and the solution 
was then made up to 100 cm3 with 1.0 N NaOH in a volumetric flask. 
Protein solution C. Protein solution C consisted of Folin and 
Ciocalteu's reagent (2.0 N) (Saarchem, RSA) diluted 1:10. 
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Protein Standard solution. The protein standard solution consisted 
of bovine serum albumin (BSA) at 150 ~g/cm3 and the concentration of 
the standards were 25; 50; 100 and 150 ~g/cm3. The standards 
contained the same volume of buffer as the samples and each time a 
different buffer was utilised a different standard curve was prepared. 
Carboxymethyl-cellulose (CM-cellulose). CM-cellulose (Bio-Rad 
Laboratories, USA) was activated as specified in Clark and Switzer 
( 284) . 
Diethylaminoethyl-cellulose (DEAE-cellulose). DEAE-cellulose was 
purchased as the chemical Cellex-0 (Bio-Rad Laboratories, USA) and was 
activated as specified in Clark and Switzer (284). 
Diethylaminoethyl-Sephadex (DEAE-Sephadex). DEAE-Sephadex A-50 
(Pharmacia Fine Chemicals, Sweden) was swollen for 24 hrs in the 
appropriate buffer (1 g swelled to a final volume of 12-15 cm3) and 
the "dead" beads were removed from the surface . 
2.2.2 Animals 
The rats utilised were Long-Evans female rats obtained from the 
University of Port Elizabeth animal unit, RSA. They were fed normal 
chow pellets. 
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2.2.3 Methods 
Unless stipulated all procedures were conducted at room temperature. 
Microsome Preparation. The procedure for the preparation of rat liver 
microsomes was a modification of the methods of Larsson and Brimmer, 
Mahfouz and De Schriver and Privett (285-287). Ten rats were 
anaethesised and the livers were rapidly removed and immediately 
washed in homogenisation buffer and placed on ice. 
The livers were then homogenised with a dounce homogeniser (20 x and 
20 x with the loose and the tight plungers respectively) in 3 volumes 
(v/w) (100 g/420 cm3) of homogensation buffer. The homogenate was 
centrifuged (Beckman J2-21 centrifuge and a JA 21 rotor) at 10 000 g 
for 20 min at 4°C (to pellet the cellular debris and mitochrondial 
fractions). The supernatant was centrifuged (Beckman LS 3801 
ultracentrifuge and a 70.1 Ti rotor) at 110 000 g for 90 min at 4°C. 
The pellet was resuspended in homogenisation buffer at 4°C for 30 min 
to provide microsomes equivalent to 1 g of original tissue per cm3 of 
homogenisation buffer. The volume of the microsome solution was 150 
cm3. The protein concentration was determined utilising the Hartree 
modification of the Lowry method (288,289). The preparations were 
diluted appropriately (see Appendix 1 for the protein standard curve). 
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The assay for the presence of cytochrome b5 utili sed an increase in 
the major Soret peak of cytochrome b5 at 423 nm in the presence of 0.2 
mM reduced nicotinamide adenine dinucleotide (NADH). The assay 
utilised the wavelengths 419-430 nm. A NADH reduced minus oxidised 
cytochrome b5 difference spectrum (between 400-610 nm) was run to 
ensure that cytochrome b5 was present, as this is a spectrum 
charactristic of cytochrome b5 . This spectrum also gave an 
indication that the major Soret peak of cytochrome b5 was present and 
this peak is utilised in the cytochrome b5 assay (290 ,291). The 
assays and spectrum were run on a Bausch and Lomb Spectroni c 1001 
using a multiwavelength programme. Cytochrome b5 was assayed for at 
each step in the iso lation and purification procedure . 
Solubi1isation of Cytochrome b~ From this stage the general 
methodology followed was that of Kajihara and Hagihara (260) and any 
modifications made to their methodology will be discussed later in 
this chapter. Crystalline trypsin (Sigma Chemical Company, USA) was 
added at 0.005 mg per mg of microsomal protein (total microsomal 
protein was 1050 mg) and consequently 5. 25 mg of trypsin was added. 
The solution was stirred for 5 hours at 37°C to solubilise the 
catalytic domain of cytochrome b5. Streptomycin and Penicillin (100 
international units (IU)/cm3 and 100 ~g/cm3 respectively) were added 
at 1.0 cm3 per 100 cm3 of microsomal solution, which had a final 
volume of 151.5 cm3 . 
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Ammonium Sulphate Fractionation of Cytochrome b~ Ammonium sulphate 
was added to the microsomal solution until 50% saturation was reached 
(291 mg of ammonium sulphate/cm3). The solution was left at 4°C for 
1 hour and was then filtered through 4 sheets of Whatman No 1 filter 
paper and Celite 545 on a Buchner funnel. 100 cm3 of 50% ammonium 
sulphate solution, pH 7.4, was then washed through the residue on the 
filter paper. The washing and filtrate were combined and brought to 
75% saturation by the further addition of ammonium sulphate. The 
cytochrome b5 solution was filtered through 4 sheets of Whatman No 1 
filter paper and Celite 545 again and it was then dialysed against 
0.02 M potassium phosphate buffer pH 6.5 for 24 hours ·with frequent 
changing of the buffer. The final volume was 545 cm3. 
eM-cellulose and DEAE-cellulose chromatography. The dialysate was 
passed through a CM-cellulose column (1.5 x 30 em) at a rate of 
approximately 12 cm3/hr. The column had previously been equilibrated 
with 0. 02 M potass i urn phosphate buffer pH 6. 5. The e 1 uent was 
collected and then placed directly onto a DEAE-cellulose column (2 . 5 x 
38 em) with a flow rate of approximately 60 cm3/hr. Haemoglobin and 
other proteins were bound to the CM-cellulose column but not the 
cytochrome bs. When passed through the DEAE-ce ll u lose column the 
cytochrome bs was absorbed onto the top of the column. This ~olumn 
was washed with 1 1 of 0.03 M potassium phosphate buffer pH 7.4 to 
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move the reddish-brown cytochrome bs band into the column . The 
cytochrome bs was eluted from the DEAE-cellulose column using a 0.25 M 
potassium phosphate buffer pH 7.4. One hundred fractions of 
approximately 3 cm3 were collected. These fractions were assayed 
for the presence of cytochrome b5 and protein. Fractions 49-60 (the 
combined volume was 46 cm3) were kept as they were found to contain 
the cytochrome bs. These fractions had a reddish-brown colouration. 
The combined fractions were diluted 8.33 times so that the solution 
had the same molarity as the column and the solution was then passed 
through a second DEAE-cellulose column (2.5 x 25 cm3) at a flow rate 
of approximately 66 cm3/hr. The column had previously been 
equilibrated with 0.03 M potassium phosphate buffer pH 7. 4. The 
cytochrome b5 was absorbed onto the top of the co 1 umn as a reddish-
brown band. The cytochrome b5 was eluted from the column with 0.25 M 
potassium phosphate buffer pH 7.4. Fractions {approximately 7 cm3) 
were co 11 ected from this co 1 umn. Fractions 19-28 were found to 
contain cytochrome b5 and these fractions were slightly coloured . 
The combined volume of the fractions was 59 cm3. 
DEAE-Sephadex A-50 chromatography. The so 1 uti on was d i 1 uted 1. 92 
times to adjust the buffer concentration to 0.13 M and the solution 
passed through a DEAE-Sephadex A-50 column (2.5 x 35 cm3) at a flow 
rate of approximately 20 cm3/hr. The column had previously been 
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equilibrated with 0.13 M potassium phosphate buffer pH 7.4. The 
cytochrome b5 was eluted from the column using 0.3 M potassium 
phosphate buffer pH 7. 4 and fractions of approximately 6 cm3 were 
collected. Fractions 76-89 were found to contain the cytochrome b5. 
The combined volume of the fractions was 72 cm3. 
Freeze Dryi nq. The cytochrome b5 solution was then freeze dried 
(V irt i s Freezemobile 6) and the resulting powder was assayed for 
protein and cytochrome b5 content and stored frozen. 
Disc gel electrophoresis. Disc gel electrophoresis was performed on 
the freeze dried cytochrome b5 , at room temperature and according to 
the methodology of Clark and Switzer (284). After electrophoresis 
the gels were fixed in methanol-acetic acid (1:1) for 1 hr. The gels 
were then stained in 0.25% Coomassie Brilliant Blue R-250 (Merck, West 
Germany) in methanol -acetic acid-water (5 :1:5) for 1 hr. 
were destained with 5% trichloroacetic acid. 
2. 3 Results 
The ge 1 s 
The NADH reduced minus oxidised cytochrome b5 difference spectrum (as 
shown in Fig. 6) correlated well with a previous report (291) in that 
the major Soret was shown to exist at 425 nm and the l iterature 
re sults showed the peak to exist at 423 or 424 nm. 
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Fig. 7 shows the elution profile of the cytochrome b5 solution from 
the first DEAE-cellulose column. The cytochrome b5 was found to be 
eluted in a relatively broad peak. 
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Figure 6. Tite NADH-reduced minus oxldised difference spectrum of the 
microsome solution in the isolation and purltication of cytochrome bs. 
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Fig. 8 shows the elution profile of cytochrome bs from the second 
DEAE-cellulose column. It was expected that the cytochrome bs band 
would separate into two bands. This was not shown to occur although 
a small protein peak was located in fraction 39. 
was identified in this peak. 
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Fig. 9 shows the elution profile of cytochrome bs from the DEAE-
Sephadex A-50 co 1 umn. As with the previous column i t was expect ed 
that the cytochrome bs band would separate into two distinct bands. 
Again this was not found. 
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Table 2 is the purification table of cytochrome b5. The table shows 
that 11 mg of cytochrome b5 was isolated from 100 g of starting rat 
liver. This is a three to four times increase in yield of that cited 
in literature (260,264) . Previous studies have also tended to use, 
as the enzyme source, kgs of liver instead of the gram quantities used 
in this study. The ammonium sulphate fractionation step showed a 
great increase in specific activity indicating that other 
contaminating proteins had been precipitated out. A 11 the 
chromatography steps utilised showed increased specific activ ity and 
were thus of value in the isolation procedure. 
TABLE 2: PURIFICATION OF CYTOCHROME b5 
Step Total Total activity Specific activity Yield 
Protein (unit) 
units/mg ratio (\) (mq) 
Microsome Solution 1050 2917 2.78 1 .00 100 
Trypsin Solubilisation 1098 2183 1 .99 0 . 72 75 
Ammonium £ulphate 242 , 847 • 7.63 2 .74 63 Fractionation 
Dialysis 123 1384 1, .25 4.05 47 
1st DEAf-Cellulose 22 260 11 . 82 4.25 Column 9 
2nd DEAE-Cellulose 16 200 12.50 4.50 7 Column 
DEAE Sephadex A~O 
, 3 244 18.77 6.75 8 Column 
Freeze Drying 11 236 21 . 45 7 . 72 8 
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Disc gel electrophoresis showed one discrete band in the gels 
indicating that cytochrome bs had been isolated in one pure form. No 
photographs have been included in this thesis of the gels from this 
and ensuing chapters as a result of the bands not being visible in the 
photographs. Both colour and monochrome photographs were attempted 
with various filters and lenses. The bands were clearly visible to 
the naked eye within the gels and photographs of the gels have been 
included in a previous publication (292) even though the bands were 
not visible in the photographic plates. The cytochrome bs band had a 
Rf value of approximately 0.90 - 0.95. Carlsen et £1. util ised 
immunoblotting to enable a photograph with a visual cytochrome bs band 
to be published (293). This article was published after this ·study 
had been concluded and, thus, immunoblotting was not attempted. 
2.4 Discussion 
There are several points worthy of noting in the isolation and 
purification procedure used in this study. As indicated previously 
smaller starting quantities of rat liver were used i e only ten rats 
were used in contrast to at least one hundred cited in literature. 
Thi s smal ler quantity did not in any way affect the efficiency of the 
procedure. Also, working with a smaller number of rats and 
consequently a smaller volume of cytochrome bs solution greatly 
simplified the procedure. As stated previously the aim was to achieve 
a simplified but successful methodology for the isolation and 
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purification of catalytically active cytochrome b5 and consequently 
all the stages in the isolation and purification procedures cited in 
literature were scrutinised in an attempt to simplify the methodology. 
When trypsin had previously been used to solubilise chytochrome b5 
from microsomes this had been conducted at 0°C for approximately 
fifteen hours (260). Trypsin [EC 3.4 .21.4] is classif ied as a 
peptidyl peptide hydrolase and it hydrolyses peptides, amides and 
esters at lysine and arginine carboxyl bonds. Trypsin is found to be 
most active at 37°C and as such it seemed slightly illogical from the 
enzyme action point of view for the microsome solution to be incubated 
at 0°C (12,294,295) . Incubation with trypsin was consequently 
conducted at 37°C in this study. 
In order to prevent any microbrial or bacterial contamination 
antibiotics were added to the microsome solution with the trypsin. 
The solution was constantly stirred in an attempt to maximise the 
cytochrome b5 solubilisation from the microsomes. As Fig. 5 shows, 
trypsin has two points at which it can hydrolyse cytochrome b5. 
Another reason for incubating the solution at 37°C was an attempt to 
prevent two forms of cytochrome b5 from being solubilised as had been 
cited in literature (260 ,264). It was hoped that the increased 
enzymatic activity of trypsin would result in the smallest fo.rm of 
cytochrome b5 being solubilised i e the trypsin would hydrolyse the 
solubilised cytochrome b5 at both the possible hydrolysis points. 
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The results showed that this modified methodology achieved the 
increased solubilisation of only one form of cytochrome b5 as 
hypothesised. 
Literature reports had indicated that all the stages of the isolation 
and purification procedure had to be conducted at approximately 4°C 
(260,264). This can be problematic as it would mean that the entire 
procedure would have to be conducted within a cold room and it was 
decided to attempt the isolation and purification procedures at room 
temperature, except for a few critical stages, which were indicated in 
the methodology section. It was shown that the use of room 
temperature did not result in loss of cytochrome b5. The isolation 
and purification procedure was thus greatly simplified by being able 
to work mainly at room temperature. 
In general, the flow rates utilised by Kajihara and Hagihara (260) 
seemed to be excessively fast and all the flow rates utilised in this 
study were greatly reduced. The reduced flow rates were expected to 
result in greater binding of the cytochrome b5 to the ion exchange 
columns. 
The CM-cellulose step was efficient in binding the haemog lob in and 
other protein impurities and allowing the elution of the cytochrome bs 
through the column without binding to it. Kajihara and Hagihara 
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(260) found that the cytochrome bs band separated into two distinct 
bands on both the second DEAE-cellulose and the DEAE-sephadex A-50 
columns. As stated in the results, in this study the cytochrome bs 
band was not found to separate into two distinct bands using the 
modified methodology. As there was no second cytochrome bs band it 
it was unnecessary to utilise the additional chromatography steps that 
Kajihara and Hagihara had used. This also resulted in a simplified 
procedure. 
As Kajihara and Hagihara (260) utilised 2 kgs of liver, their 
resu 1 t i ng vo 1 umes of cytochrome bs so 1 uti on were consequently much 
larger than obtained in this study, and as such it was unnecessary to 
carry out the concentration stage that Kajihara and Hagihara had 
conducted. It has been noted in literature that cytochrome bs can be 
unusually difficult to crystallise (260,264). Initially it was 
attempted to crystallise the cytochrome bs, but when the methodologies 
cited by Kajihara and Hagihara and normal organic methods for 
crysta 11 i sat ion were unsuccessfu 1, it was decided to attempt freeze 
drying as a viable alternative. It was found that freeze drying in 
no way altered the catalytic activity of cytochrome bs, and this 
provided a quick and convenient method of producing a storable form of 
cytochrome bs. The freeze dried powder was found to be very 
hygroscopic and thus, had to be stored in a tightly sealed container. 
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The cytochrome b5 could be stored in a freezer in this form for in 
excess of two years without appreciable loss of its ability to 
transfer electrons. 
The fold purification, 7.72, achieved using this modified methodology 
showed a large increase compared to that achieved in a previous 
literature report of 1.36 (260). The overall yield achieved in this 
study was greater than that in a previous literature report (260). 
In this study there was increased purification at each step except 
that of trypsin solubilisation but this was compensated for with the 
ammonium sulphate fractionation step. There was a small increase in 
fold purification with the first DEAE-cellulose chromatography step 
but this step did result in the removal of some of the contaminating 
protein and as such was extrememly useful. The second DEAE-cel1ulose 
chromatography step resulted in further purification of the cytochrome 
b5. Both the DEAE-Sephadex A-50 and freeze drying resulted in 
greater fold purification and as such were important steps in the 
isolation and purification of cytochrome b5. 
From these results it can be seen that a catalytically active and pure 
form of cytochrome b5 could be easily and reproducably isolated using 
a simplified procedure requiring less starting material and less 
rigorous conditions. This methodology was repeated several times in 
order to ensure that it was easily reproducible and could thus be 
readily utilised for the isolation of ~6-desaturase from the 
linoleoyl-CoA desaturase complex. 
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CHAPTER 3 
ISOLATION AND PURIFICATION OF CYTOCHROME b5 REDUCTASE 
3. 1 Introduction 
Cytochrome b5 reductase [EC 1.6.2.2] is the first component in the 
linoleoyl-CoA desaturase complex and transfers electrons to cytochrome 
bs (see Fig. 4) (290,296). Cytochrome b5 reductase was first 
isolated by Strittmatter and Velick in 1956 and 1957 (297,298) by 
solubilising the enzyme from microsomes using cobra venom. Takesue 
and Omura (cited in 299,300) reported that this solubilisation of 
cytochrome bs reductase was not due to the cobra venom but in fact was 
due to lysosomal contamination of the microsomes . This work was 
confirmed by StLouis et .9.1 (299) and they identified the active 
component of the lysosomes as an acid proteinase. Lysosomal 
solubilisation resulted in the isolation of a catalytically active 
cytochrome b5 reductase with a MW of approximately 33 000 
(299 ,301,302). 
Cytochrome b5 reductase has also been isolated when solubilised 
utilising detergents, 
Detergent solubilised 
approximately 45 000 
i e Triton-X 100 and sodium deoxycholate. 
cytochrome b5 reductase had a MW of 
(265,302-304). As with cytochrome bs, 
cytochrome bs reductase can therefore be isolated in two forms and the 
smaller form is still catalically active. 
-78-
Cytochrome b5 reductase is a NADH: ferricytochrome b5 oxidoreductase 
(305). It was discovered that the structure of cytochrome b5 
reductase was similar to that of cytochrome b5 in that it is an 
amphipathic integral protein which is anchored to membranes via a 
short hydrophobic section with a large catalytic domain attached to 
the membrane binding section via a short flexible neck (cited in 269). 
Detergent solubilisation resulted in the isolation of the intact form 
of cytochrome b5 reductase and lysosomal solubilisation resulted in 
the isolation of a smaller form of cytochrome b5 reductase that still 
contained the flavin prosthetic group and was catalytically active 
(304). Cytochrome b5 reductase was found to contain one molecule of 
flavine adenine dinucleotide (FAD) per enzyme molecule (303) . 
Cytochrome b5 reductase has been isolated from various species i e 
human, pig, bovine, rat and rabbit (44,265,302,306-318). In humans 
cytochrome b5 reductase has been isolated from erythrocytes in which 
both soluble and membrane bound enzymes have been found (306,312,315); 
and from placenta, leucocytes, muscle, liver, fibroblasts (313,cited 
in 313) . All of these human cytochrome b5 reductases were found to 
exhibit great immunological similarities (cited in 313). Yubisui et 
~ (315) determined that cytochrome b5 reductase isolated from human 
erythrocytes consisted of 275 amino acids. Tamura et ~ (308) compared 
the structures of bovine erythrocyte, brain and liver cytochrome b5 
reductases and found that the enzymes have identical structures 
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except for the ami no-termi na 1 end of the enzymes. They determined 
that the cytochrome bs reductases isolated from both erythrocytes and 
the brain consisted of 273 amino acids whereas those i solated from the 
liver consisted of 274 amino acids (308). 
As with cytochrome bs, cytochrome b5 reductase is not fixed within 
the membrane structure and it is able to undergo rapid rotational 
and translational movement within the lipid bilayer (279,281,319). 
Cytochrome b5 reductase has been shown to be present rna in ly in the 
endoplasmic reticulum of cells. It has also been shown that 
cytochrome bs reductase is randomly distributed within the endoplasmic 
reticulum (281,320,321). 
It was discovered by Ozols et £} (322) that the amino-terminal end of 
cytochrome b5 reductase, isolated from bovine livers, was blocked with 
n-tetradecanoyl acid (myristic acid) and it was proposed that th i s 
could selectively stabilise the structure and membrane orientation of 
the enzyme so that there is maximal electron transfer between it and 
cytochrome b5. Cytochrome bs reductase accepts two electrons from 
NADH resulting in the formation of a NAD+-reduced flavoprotein charge-
transfer complex. This complex will then transfer a single electron 
to a molecule of cytochrome b5. It has been suggested that one 
molecule of cytochrome bs reductase concomittantly transfers two 
electrons onto two molecules of cytochrome bs (one electron per 
cytochrome bs) (323,324,cited in 324). Dailey and Strittmatter (325) 
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have shown that the interaction between cytochrome b5 reductase and 
cytochrome b5 occurs via complementary charge pair interactions 
involving carboxyl groups of cytochrome b5. So it can be seen that 
the interactions between cytochrome b5 reductase and cytochrome bs are 
vitally important for the functioning of the linoleoyl-CoA complex. 
As with cytochrome b5 it was decided in this study to attempt to 
isolate and purify cytochrome b5 reductase using a simplified method 
with a hopefully increased yield and which could be utilised in the 
final isolation of ~6-desaturase. 
3.2 Materials and Methods 
3.2.1 Reagents 
Protein solution A. As in section 2.2.1. 
Protein solution B. As in section 2.2.1. 
Protein solution C. As in section 2.2.1. 
Protein Standard solution. As in section 2.2.1. 
Sephadex G-100. Sephadex G-100 (Pharmacia Fine Chemicals, Sweden) 
was swo 11 en for 24 hrs in the appropriate buffer and the 11 dead 11 beads 
were removed from the surface. 
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DEAE-cellulose. As in section 2.2.1. 
CM-Sephadex C-50. CM-Sephadex C-50 (Pharmacia Fine Chemicals, 
Sweden) was activated as specified in Clark and Switzer (284). 
3.2.2 Animals 
As in section 2.2.2. 
3.2.3 Methods 
Unless stipulated all procedures were conducted at room temperature. 
Lysosome-Microsome Fraction Preparation. The methodo 1 ogy fo 11 owed 
was a modification of that of Takesue and Omura (311). Rat livers 
(100 g), from freshly killed rats, were blended in a Moulinex Type 
241 liquidiser, with four volumes of 0.25 M sucrose containing 1 mM 
EDTA pH 7 .5. The homogenate was then centrifuged at 7000 g for 10 
min (Beckman J2-21 centrifuge and a JA 21 rotor). The pellet and 
11 fluffy 11 layer were discarded. The supernatant was centrifuged at 78 
000 g for 90 min at 4°C (Beckman LS 3801 ultracentrifuge and a 70.1 Ti 
rotor) . This sed i men ted the 1 ysosomes and m i crosomes. The pe 11 et 
was washed by resuspending it in half of the original volume of 0.15 M 
potassium chloride containing 1 mM EDTA pH 7. 5. To resuspend the 
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pellet it was constantly stirred at 4°C for 30 min. The resuspended 
pellet was then centrifuged at 78 000 g for 60 min at 4°C and the 
resulting pellet was again resuspended with constant stirring at 4°C 
for 30 min in 100 cm3 of 0.1 M Tris-HCl buffer pH 5.7 containing 1 mM 
EDTA. This solution represented the lysosoma 1-mi crosome fraction 
and the final volume was 206 cm3. The protein concentration was 
determined throughout utilising the Hartree modification of the Lowry 
method (288,289). 
The assay for the presence of cytochrome bs reductase was as described 
by Mihara and Sato (303) with the exception that a Bausch and Lomb 
Spectronic 1001 was used in its kinetic mode . This assay utilised 
the increased reduction of 1 mM of potassium ferricyanide in the 
presence of 0.1 mM of NADH and cytochrome b5 reductase. 1 unit of 
enzyme activity (cytochrome bs reductase activity) is defined as the 
reduction of 1 mol of potassium ferricyanide per min at 420 nm . At 
each stage in the isolation and purification cytochrome b5 activity 
was assayed for. 
Solubilisation of Cytochrome bs Reductase. Penicillin and 
Streptomycin were added to the lysosome-microsome fraction at 100 
IU/cm3 and 100 ~g/cm3 respectively. This solution was incubated in a 
37°C water bath with occasional stirring. 
centrifuged at 78 000 g for 90 min at 4°C. 
The solution was then 
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The solubilised cytochrome bs reductase was located in the supernatant 
and this solution was neutralised (to pH 7.0) with 1.0 M sodium 
hydroxide. If necessary the solution can be frozen at this stage for 
several weeks without significant loss of enzyme activity. The final 
volume of this solution was 92 cm3. 
Ammonium Sulphate Fractionation of Cytochrome b5 Reductase. Ammonium 
sulphate was added to the solution until 50% saturation was achieved 
(291 mg of ammonium sulphate/cm3). The solution was left to stand at 
4°C for 1 hr to allow for some protein preciptation to occur. The 
solution was centrifuged at 8000 g for 15 min to remove any 
precipitate that may have formed. The supernatant was then brought 
to 75% saturation and was again left to stand at 4°C for 1 hr. The 
solution was centrifuged at 8000 g for 15 min. The pellet was 
dissolved in 20 cm3 of 20 mM Tris-HCl buffer pH 8.5. 
Sephadex G-100 chromatography. The so 1 ut ion was passed through a 
Sephadex G-100 column (3 x 70 em) at a rate of approximately 30 
cm3/hr. The column had been previously packed and equilibrated with 
20 mM Tris-HCl buffer pH 8.5. The enzyme solution was eluted from 
the co 1 umn uti 1 ising the same buffer. Fractions of 10 cm3 were 
collected and fractions 21-29 were found to contain high cytochrome bs 
reductase activity and were combined giving a final volume of 90 cm3. 
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DEAE-cellulose chromatography. The eluent was passed through a 
DEAE-cellulose column (2.5 x 16 em) which had previously been 
equilibrated with 20 mM Tris-HCl buffer pH 8. 5. The flow rate of the 
column was approximately 60 cm3/hr. Once the eluent had been applied 
to the column, it was washed with 20 cm3 of 50 mM Tris- HCl buffer pH 
8.5 and then eluted with an increasing linear concentration gradient 
of potassium chloride. The grad ient consisted of 150 cm3 of 50 mM 
Tris-HCl buffer pH 8.5 and 150 cm3 of 50 mM Tris-HCl pH 8.5 with 0.1 M 
potassium chloride. The eluent was collected in 10 cm3 fractions and 
fractions 15-21 were combined as they were found to contain the 
cytochrome b5 reductase and had a final volume of 80 cm3. 
CM-Sephadex C-50 chromatography. Mihara and Sato (303) suggested 
that after the DEAE-cellulose column a CM-Sephadex C-50 column should 
be utilised, as they had shown that this resulted in greater 
purification . A CM-Sephadex C-50 column (1 x 15 em) was prepared and 
equilibrated with 10 mM potassium phosphate buffer pH 6.5. The 
cytochrome b5 reductase solution was diluted 10-fold with deionised 
water and was then applied to the column. The column was eluted at a 
flow rate of approximately 60 cm3/hr and 10 cm3 fractions were 
collected. An increasing linear concentration gradient of phosphate 
was set up using 100 cm3 of 10 mM potassium phosphate buffer pH 6.5 
and 100 cm3 of 100 mM potassium phosphate pH 6.5 . The cytochrome b5 
reductase did not bind to the column and thus the eluent (the 
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volume eluted through the column before the fractions were collected) 
and fractions 1-6 were combined as they contained the cytochrome bs 
reductase activity. 
Dialysis and Freeze Drying. The cytochrome bs reductase solution was 
dialysed against 50 mM potassium phosphate buffer pH 7.5 with 1 mM 
EDTA at 4°C for 20 hrs. The dialysate had a final volume of 112 cm3. 
It was necessary to store the enzyme for a long period of time and it 
had been reported (303,311) that the dialysate lost activity after 
several months. Thus, in contrast to the other studies, the 
dialysate was freeze dried. The resulting powder was redissolved in 
5 cm3 of 50 mM potassium phosphate buffer pH 7.5 with 1 mM ED~A and 
was freeze dried once more to yield a crystalline form of cytochrome 
bs reductase. 
Disc gel electrophoresis. Disc gel electrophoresis was performed on 
the freeze dried cytochrome bs reductase, at room temperature and 
according to the methodology of Clark and Switzer (284) . The fixing, 
staining and destaining were carried out as in section 2.2.3. 
3.3 Results 
Fig. 10 shows the elution profile of cytochrome bs reductase from the 
Sephadex G-100 gel filtration column. The cytochrome bs reductase 
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was eluted in a relatively narrow peak. Relatively large amounts of 
protein, were also eluted from the column in other fractions. 
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Fig . 11 shows the elution profile of cytochrome b5 reductase from the 
DEAE-cellulose column. The enzyme was eluted at 0.061 M potassium 
chloride. Again the cytochrome bs reductase was eluted in a 
relatively narrow peak . 
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Fig. 12 shows the elution profile of cytochrome bs reductase from the 
CM-Sephadex C-50 co 1 umn. It was expected that the cytochrome bs 
reductase would bind to the column, but instead the enzyme activity 
was located in the eluent (fractions were only collected once the 
entire enzyme solution had been applied to the column) and the first 
six fractions. 
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Table 3 is the purification table of cytochrome bs reductase. This 
table shows that 9.8 mg of cytochrome bs reductase was isolated from 
100 g of starting rat liver. This is a 9-fold increase in yield of 
that cited in literature (303). Literature reports have also cited, 
as with cytochrome bs, that starting quantities of rat liver were 
usually in the kgs and not grams (303,311). Unlike the cytochrome bs 
isolation and purification, the largest increase in specific activity 
came from the utilisation of the gel filtration step i e most of the 
contaminating proteins were removed at this stage. Of the co 1 umn 
chromatography steps only the CM-Sephadex C-50 did not seem to be 
really necessary to this isolation and purification procedure. 
TABLE 3: PURIFICATION OF CYTOCHROME b5 REDUCTASE 
Step Total Total activity Specific activity Yield 
protein (units x 101 ) 
units/mg ratio (\) 
(mg) 
Lysosome-microsome 1747 851 487 1 .00 100 
Digested supernatant 226 133 588 1 .21 16 
Ammonium sulphate 1 71 1 1 1 649 1 .33 13 fraction 
Sephadex G-100 gel 37.8 95.2 2519 5 . 17 11 filtration 
!DEAE-cellulose 25.6 69.2 2703 5.55 8 
chromatography 
~M-Sephadex C-50 24.6 92.3 3752 7.70 1 1 
chromatography 
!Dialysis 10.3 48 .5 4708 9.67 6 
Freeze drying 9.8 47.2 4816 9.89 6 
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Disc gel electrophoresis showed one discrete band in the gels 
indicating that cytochrome b5 reductase had been isolated in a pure 
form. As explained in Chapter 2, no photographs have been included 
in this thesis although they have been included in a previous 
publication (292) even though the bands were only visible to the ·naked 
eye . The Rf value of the cytochrome b5 reductase band was 
approximately 0.80 - 0.85. The disc gel electrophoresis was 
conducted several times with very similar Rf being shown. 
3.4 Discussion 
The potass i urn ferri cyanide assay had been chosen to assay for the 
presence of cytochrome b5 reductase in preference to the cytochrome b5 
assay. The difference between the two assays is that in the 
cytochrome b5 assay, cytochrome b5 reductase transfers its electrons 
to cytochrome b5 and the reduction of cytochrome b5 is followed at 423 
nm in the presence of NADH to assay for the activity of cytochrome b5 
reductase whereas in the potassium ferricyanide assay, cytochrome b5 
reductase transfers its electrons to potassium ferricyanide, and the 
reduction of the potassium ferricyanide, in the presence of NADH, is 
followed at 420 nm to indicate the activity of cytochrome b5 
reductase. The potassium ferricyanide assay was chosen in preference 
to the cytochrome b5 assay as this latter assay is known to vary 
according to the amount of free and bound cytochrome b5 reductase 
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present in a solution and also it assumes that at no time is 
cytochrome bs rate controlling and this may not always be true 
(317,318). 
There are several points worthy of noting in this isolation and 
purification procedure. As mentioned previously smaller starting 
quantities of rat liver were used i e only 100 g in contrast to at 
least 1 kg cited in literature (~03,311). This involved the killing 
of only 10 rats in comparison to at least 100 rats in the experiments 
cited in literature. The smaller quantity did not in any way affect 
the procedure. Instead it actually simp 1 ifi ed and shortened the 
procedure. As with the cytochrome b5 isolation, the aim was to 
achieve a simplified but successful methodology for the isolation and 
purification of a catalytically active cytochrome b5 reductase. 
During the preparation of the lysosome-microsome fraction, the pellets 
were resuspended at 4°C for 30 min to ensure that they were completely 
resuspended. It was found that if the majority of the lysosomes and 
microsomes were not in solution, the resulting yield of cytochrome bs 
reductase was very low. Although previous studies have indicated 
that the entire isolation and purification procedure should be 
conducted at 4 °C, this was found to be unnecessary and only the 
ultracentrifugation spins , the two resuspension stages and the 
dialysis stage were conducted at 4°C. This greatly simplified the 
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methodology and the isolated cytochrome b5 reductase retained a high 
level of activity even when the chromatography was conducted at room 
temperature. 
Takesue and Omura (311) found that the cytochrome b5 reductase was 
eluted from the DEAE-cellulose column at approximately 0.05 M 
potassium chloride, but in this study it was found that the enzyme 
eluted at 0.061 M potassium chloride. As stated in the results, 
although Mihara and Sato (303) found that a CM-Sephadex C-50 column 
resulted in much greater purification, in this study it was found that 
there was very little or no binding of cytochrome b5 reductase to the 
column. 
omitted. 
Thus, it is suggested that in future isolations this step be 
Due to the problems experienced in this study with the attempted 
crystallisation of cytochrome b5 and the lack of reports of attempts 
to crysta 11 i se cytochrome b5 reductase, it was decided to freeze dry 
the cytochrome b5 reductase so 1 uti on. There were no contaminating 
proteins present (as shown by disc gel electrophoresis) and thus 
freeze drying would not result in any contamination of the powder by 
other proteins . This also allowed for the enzyme to be stored for a 
long period without appreciable loss of activity. As noted in the 
results, in the dialysate solution loss of the enzyme activity was 
found if it was stored for more than a few months. 
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The disc gel electrophoresis of the freeze dried cytochrome bs 
reductase indicated the presence of one band and thus that the enzyme 
had been isolated in a pure form. This procedure was repeated 
several times and no contaminating compounds were found. Takesue and 
Omura ( 311) had found that two bands were produced in the ge 1 s of 
cytochrome b5 reductase they had isolated. They discovered that this 
second band was a modified cytochrome b5 reductase which .still 
retained the characteristics of the original enzyme. As they had 
incubated microsomes with continual shaking for 6 hrs, it was decided 
in this study, in an attempt to isolate one form of cytochrome bs 
reductase, to only incubate the lysosome-microsome fraction for 30 min 
with constant shaking. This did result in the isolation of one pure 
form of cytochrome bs reductase. 
In general the fold purification achieved by Takesue and Omura (311) 
was generally much greater than that achieved in this study but this 
could be a result of the very low activities noted by Takesue and 
Omura (311) in the first step i e the lysosome-microsome step. In 
this study there was more activity found in the first step than in a 
previous report (311) . The greatest fold purification achieved by 
Takesue and Omura (311) was that from the lysosome-microsome to the 
digested supernatant step i e from 1.0 to 7.9 fold purification 
whereas this study showed only a 1.0 to 1.21 fold pur if ication at this 
stage and the greatest fold purification found in this study was from 
the ammonium fractionation step to the Sephadex G-100 step where the 
fold purification increased from 1.33 to 5.17 . The final fold 
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purification achieved by Takesue and Omura (311) was 723.0 and in this 
study it was 9.89. The percentage yield in the study by Takesue and 
Omura (311) was 41% and in this study it was 6%. The purification 
table in this study shows an anomaly as the percentage yield decreases 
from 11% to 8% in going from Sephadex G-100 to the DEAE-cellulose 
chromatography and then it increases back to 11% after the CM-Sephadex 
C-50 step. This procedure was repeated several times and each time 
the same result was found . There seems to be no clear explanation 
for this occurence. Although the fold purifications and the final 
percentage yeild were lower than those achieved in the study of 
Takesue and Omura (311) the final enzyme yield achieved in this study 
was approximately 9 times greater than that achieved previously. 
From these results 1 it can be seen that a catalyt ica lly active and 
pure form of cytochrome b5 reductase could be easily isolated. 
Although the yield of enzyme was less than that reported previously, 
the total enzyme recovery relative to the quantity of starting 
material utilised was far greater. This methodology was conducted 
several times with very similar results being obtained and thus this 
methodology can be utilised in the isolation of A6-desaturase from the 
linoleoyl-CoA desaturase complex. 
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CHAPTER 4 
THE ISOLATION AND PURIFICATION OF LINOLEOYL-CoA DESATURASE 
4.1 Introduction 
Linoleoyl-CoA desaturase [EC 1.14.99.25] is a multicomponent enzyme 
system which consists of cytochrome bs reductase, cytochrome b5, and 
the terminal enzyme A6-desaturase (see Fig. 13). L inoleolyl-CoA 
desaturase is classified as a mixed function oxidase and the reaction 
of interest in which it plays a role is the conversion of cis-LA into 
GLA (when they are in the CoA form). This is the rate limiting step 
in the metabolism of the w-6-EFAs (45,326-329) . 
Linoleoyl-CoA 
Figure 13. The hypotheticnl structure of the components of the 
Linoleoyi-CoA Dcsnturase complex bound to the microsomnllipid bilnyer 
(modified from 326)· 
bilayer 
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In contrast to cytochrome b5 and cytochrome b5 reductase 1 ittle is 
known about this enzyme complex. Linoleoyl-CoA desaturase was first 
solubilised in 1979 by Okayasu et ~ (330) when they utilised various 
detergents i e Triton X-100, sodium cholate and sodium deoxycholate to 
solubilise the enzyme complex from microsomes. They took this work 
further in 1981 when they isolated linoleoyl-CoA desaturase. They 
reported that linoleoyl-CoA desaturase is a nonpolar single 
polypeptide with a MW of appromimately 66 000 (328). Unti 1 the 
present no further work on the isolation and purification of 
linoleoyl-CoA desaturase has been reported. 
It has been reported ( 326, 329, 331) that 1 i no 1 eoy 1-CoA desaturase is 
bound to the endoplasmic reticulum on the cytoplasmic surface and that 
this enzyme complex is not present in a latent state in the 
endoplasmic reticulum but is constantly in an active form . This 
report verifies what was expected as cytochrome bs reductase and 
cytochrome b5 transfer their electrons to .116-desaturase via their 
catalytic segments and it is known that both cytochrome bs reductase 
and cytochrome bs have their catalytic segments orientated on the 
cytoplasmic surface of the endoplasmic reticulum (326,328-331) . 
It has been suggested that since linoleoyl-CoA desaturase is unable to 
desaturate LA unless it is in the CoA form, that CoA plays a role in 
the bi nding of the substrate to the enzyme complex (cited in 331,332). 
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Brenner (333) also suggested that when the substrate is bound to the 
enzyme the 6-7 carbons of the substrate are located in front of the 
active centre of the enzyme, so that the double bond can be inserted. 
This hypothesis has been supported by Castuma et £1 (331). 
Detergents were utilised to solubilise linoleoyl-CoA desaturase 
because detergents are typical amphipathic compounds like 
phospholipids and as such are extremely useful in solubilising enzymes 
from membranes and maintaining them within a simulated membrane 
environment i e a narrow band of hydrocarbon bounded by water soluble 
polar groups that allows them to remain catalytically active 
(263,267,334). The structure and localisation of linoleoyl-CoA 
desaturase (discussed previously} show the necessity for maintaining 
t he entire enzyme complex in as natural an environment as possible and 
enzymatic sol ubil isation would in all probability only result in 
partial solubilisation of the enzyme complex. 
It was decided to attempt to isolate and purify the enzyme complex, 
linoleoyl-CoA desaturase in order to utilise the complex for the 
isolation of ~6-des aturase via the enzymatic remova l of cytochrome b5 
and cytochrome b5 reductase from the complex. Detergent 
so lubil isation of the complex from microsomes was to be attempted and 
hopefully a simplified methodology and increased yield of linoleoyl-
CoA desaturase would result. 
-98-
4.2 Materials and Methods 
4.2.1 Reagents 
Homogenisation buffer. As in section 2.2.1. 
Protein solution A. As in section 2.2.1. 
Protein solution B. As in section 2.2.1. 
~rotein solution C. As in section 2.2.1. 
Protein standard solution. As in section 2.2.1. 
DEAE-cellulose. OEAE-cellulose was purchased as the chemical Cellex-
D (Bio-Rad Laboratories, USA) and was activated as specified in Clark 
and Switzer (284). 
CM-Sephadex C-50 . CM-Sephadex C-50 (Pharmacia Fine Chemicals, 
Sweden) was activated as specified in Clark and Switzer (284). 
4.2.2 Animals 
As in section 2.2.2. 
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4.2.3 Methods 
Unless stipulated all procedures were conducted at room temperature. 
Microsome preparation. The procedure for the preparation of 
microsomes was the same as in section 2.2 .3. Three rats were killed 
and the starting mass of rat li ver used was 25 g. 
of microsome solution was 45 cm3. 
The final volume 
The assay for linoleoyl-CoA desaturase activity was a cytochrome b5 
reoxidation assay. The difference between the time for NADH (3 ~M 
per assay) oxidation in the presence and absence of linoleoyl-CoA 
desaturase, indicated by the onset of cytochrome b5 reoxidation, was 
used to calculate linoleoyl-CoA desaturase activity . This assay was 
followed utilising a Bausch and Lomb spectronic 1001, using the dual 
wave length programme at 423nm (the Soret peak of reduced cytochrome 
bs) and 410nm. Rotenone (2 ~ per assay) was added to the assay 
mixtures to prevent any mitochondria 1 contamination i e any extra 
reduction of NADH. Assays were conducted as pairs , with the one 
assay mixture (containing sample , Rotenone and buffer -0.1 M Tris-HCl 
pH 7. 4) being incubated for 4 min at room temperature and then the 
NADH was added but no substrate i e linoleoyl-CoA and the second assay 
mixture was also incubated at room temperature and then both NADH and 
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substrtate (20 11M per assay) were added. The assays were followed 
for 5 min with readings being taken every 6 seconds. The difference 
in the rates of cytochrome bs reoxidation was utilised to calculate 
the linoleoyl-CoA desturase activity which had the units of 1-Lmol of 
product formed/min (275,290,335). 
At each stage in the isolation and purification procedure protein 
assays were conducted utilising the Hartree modification of the Lowry 
method of protein estimation (288,289) and cytochrome bs reoxidation 
assays were conducted utilising the above assay procedure. 
Solubilisation of linoleoyl-CoA desaturase. From this stage the 
isolation and purification of linoleoyl-CoA desaturase is a 
modification of the methodology utilised by Okayasu et £1 (328) . Ten 
percent (w/v) Triton X-100 was added to the microsome solution until a 
final concentration of 2% Triton X-100 was achieved. This solution 
was then stirred on ice for 30 min to solubilise linoleoyl-CoA 
desaturase. The volume of this mixture was 56 cm3. The microsome-
2% Triton X-100 solution was then diluted with 20 mM Tris -HCl buffer 
pH 7.5 to lower the Triton X-100 concentration to 0. 5%. This 
solution was then centrifuged at 77 000 g for 90 min at 4°C. The 
volume of the supernatant after the centrifugation was 196 cm3 . All 
buffers used in further steps in this procedure, unless specified, 
contained 0.5% Triton X-100 and 10% glycerol as stabilisers. 
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DEAE-cellu lose chromatography. The supernatant was passed through a 
DEAE-cellulose column (2.5 x 30 em) at a rate of approximately 30 
cm3/hr. The column had previously been equilibrated with 20 mM Tris-
HCl buffer pH 7.5. The linoleoyl-CoA desaturase did not bind to the 
co lumn and it was eluted from the column utilising the same buffer 
with which the column had been equilibrated. Fractions of 
approximately 4.5 cm3 were collected and fractions 31-37 were found to 
contain the linoleoyl-CoA desaturase and were combined to yield a 
final volume of 31.8 cm3. 
CM-Sephadex C-50 chromatography. The linoleoyl-CoA desaturase 
solution was adjusted to pH 7.3 with 0.3 N HCl. This solution was 
then passed through a CM-Sephadex C-50 column (2.5 x 25 em) which had 
been equilibrated with 20 mM Tris-HCl buffer pH 7.2 . The flow rate 
of the column was approximately 30 cm3/hr and fractions of 
approximately 3.5 cm3 were collected (except fraction 7 which was 11.2 
cm3). The column was eluted with the same buffer that it had been 
equilibrated with and the linoleoyl-CoA desaturase was eluted in the 
void volume of the column in fractions 6 and 7 with a final combined 
volume of 14.7 cm3. 
Dialysis and Freeze Drying. As the buffers up to this stage had 
contained glycerol it was necessary to dialyse the glycerol out of the 
linoleoyl-CoA solution as it reduces the efficiency of freeze drying. 
The linoleoyl-CoA desaturase solution was dialysed at 4°C for 
-102-
three days with frequent changes of the buffer (0.1 M Tris-HCl buffer 
pH 7.5). The resulting dialysate was then freeze dried to yield a 
crystalline form linoleoyl-CoA desaturase. 
Disc gel electrophoresis. Disc gel electrophoresis was performed on 
the linoleoyl-CoA solution after its elution from the CM-Sephadex C-50 
column and on the freeze dried linoleoyl-CoA desaturase. The 
electrophoresis was carried out at room temperature and according to 
the methodology of Clark and Switzer (284). The fixing, staining and 
destaining were conducted as in section 2.2.3. 
4.3. Results 
Fig. 14 shows the elution profile of linoleoyl-CoA desaturase from the 
DEAE-cellulose column. The linoleoyl-CoA desaturase was eluted from 
the column in a fairly narrow peak. 
Fig . 15 shows the elution profile of linoleoyl-CoA desaturase from the 
CM-Sephadex C-50 column. As with the previous column the linoleoyl-
CoA desaturase was eluted from the column in a fairly narrow peak. 
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Table 4 is the purification table of linoleoyl-CoA desaturase. The 
final yield of linoleoyl-CoA desaturase was 3.05 mg from 25 g of 
starting rat liver. This is a three- to four-fold increase in yield 
of that cited in literature (328). The largest increase in specific 
activity came from the combined Triton X-100 steps as the result of 
pe 11 et i ng of extraneous prate in. The linoleoyl-CoA desaturase did 
not bind to either of the columns but contaminating proteins did, as 
after both column steps great reductions in the total protein were 
found, especially after the CM-Sephadex C-50 column. It was found 
that a percentage yield of greater than 100% was achieved in certain 
steps. 
chapter. 
The possible reasons for this will be discussed later in the 
TABLE 4: PURIFICATION TABLE OF LINOLEOYL-CoA DESATURASE 
Step Total Total Activity Specific Activity Yield 
Protein ~mol/min) v..mol/min / mql (\) 
(ratio) 
Microsome a 1817.1 643 0.35 ( 1. 00) 100 
Triton X-100 (2") 1271 • 3 1688 l. 33 (3.80) 263 
Triton X-1 00 (0 .5") 9 74.1 6533 6. 71 (19 .17) 1016 
DEAE-Celluloae 263 .9 3150 12.05 (34.43) 185 
CM-Sephadex C-50 3.47 480 138 . 3 CB5.10l 75 
Freeze-dried 3.05 455 1 <a . 2 (426.30) 71 
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Disc gel electrophoresis of both the combined fractions after the CM-
Sephadex C-50 column and the freeze dried powder of the linoleoyl-CoA 
desaturase isolation showed three discrete bands in the gels. Two of 
the bands were found to be characteristic, i e had the characteristic 
Rf values, of cytochrome b5 and cytochrome b5 reductase and the third 
band was assumed to be that of A6-desaturase. The third band had a 
Rf value of approximately 7.0 - 7.5. This seemed to indicate that 
the enzyme complex, linoleoyl-CoA desaturase separated into its 
components upon electrophoresis. If this was true then l inoleoyl-CoA 
desaturase had been isola ted in a pure form although it was not 
possible to confirm this because of the apparent instability of the 
complex during electrophoresis. As stated in Chapter 2 no 
photographs of the gels are included in this thesis. Photographs 
were inc luded in a previous report (336) even though the bands were 
not clearly visible in the photographs. The bands in the gels were 
again, however , clearly visible to the naked eye. 
4.4 Discussion 
There are several points worthy of noting in the isolation and 
purification procedure utilised in this study. In order to prevent 
sacrificing an excess number of rats a smaller starting quantity of 
rat liver was used in this study as it was anticipated that the enzyme 
complex would be very quickly disrupted at room temperature conditions 
which were utilised at certain steps in the procedure. This was 
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expected due to previous literature reports (328,330) which had cited 
linoleoyl-CoA desaturase as being extremely labile and difficult to 
work with. It was decided to attempt to use room temperature at 
certain steps in the procedure, instead of 4 oc as previously used 
(328,330), as room temperature had been used very successfully in 
this study in the isolation and purification procedures of cytochrome 
b5 and cytochrome b5 reductase despite the fact that in all previous 
studies the isolation of these enzymes was conducted at 4°C. As the 
results showed the enzyme complex was not in fact labile when left at 
room temperature and the complex in general was found to be as stable 
at room temperature as was found with the cytochrome b5 and cytochrome 
b5 reductase. As stated in Chapter 2, it was preferable to work at 
room temperature where possible in order to simplify the procedure . 
Although a smaller starting quantity of liver was utilised it in no 
way hindered the isolation and purification procedure. 
This was the first study to utilise the cytochrome b5 reoxidation 
assay as an indication of the activity of linoleoyl-CoA desaturase . 
Previously reported (328,330) assays were time comsuming since they 
involved thin layer chromatography of saponified and methylated EFAs 
in order to assay the quantity of radioactive GLA formed. As this 
procedure involved attempting to isolate and purify a supposedly 
labile enzyme complex it was deemed necessary to utilise an assay 
which was quicker and thus a procedure which could be concluded in a 
shorter time period. Cytochrome b5 reoxidation has been used to 
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assay the activity of both stearyl-CoA desaturase and malonyl-CoA 
desaturase (275,290,335). In a literature report a comparison was 
made between the thin layer assay and the cytochrome b5 reoxidation 
assay for stearyl-CoA desaturase and it was noted that both assays 
gave very similar results (275). The cytochrome b5 reoxidation assay 
is very specific for 1 inoleoyl-CoA desaturase as the substrate for 
this enzyme complex is added to the assay, i e linoleoyl-CoA, and only 
when it has been converted into 1 -linolenoyl-CoA will the cytochrome 
b5 molecules become reoxidised . If linoleoyl-CoA desaturase is 
inactive then the cytochrome bs molecules are unable to pass their 
electrons to ~6-desaturase and thus are unable to become reoxidised. 
The possibility of any external NADH or cytochrome b5 reoxidation 
involvement is removed by the addition of rotenone , which blocks any 
mitochondrial oxidation of NADH. Thus this assay is quick, easily 
reproducable and utilises less equipment and chemicals. 
Triton X-100 was utilised as the detergent to solubilse lino leoyl -CoA 
desaturase as it is a non-ionic detergent and some literature resu l ts 
have stated that ionic detergents can denature proteins (263,334) . 
Sodium deoxycholate was utilised as the solubilising detergent in one 
attempted isolation procedure but this resulted in total loss of 
linoleoyl-CoA desaturase activity and it was presumed that this was 
either the result of total protein denaturation or of the breakage of 
ionic bonds which could possibly be involved within the enzyme 
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complex. A previous report (330) has stated that sodium deoxycholate 
can be utilised to solubilise linoleoyl-CoA desaturase but results 
from this study did not agree with this finding . Triton X-100 is 
known to interfere with protein assays and an attempt to overcome this 
was made by assaying small volumes of samples to reduce the Triton X-
100 concentration and by ensuring that the protein standards 
contained the same quantity of Triton X-100 (263). However, some 
interference from Triton X-100 was in fact found. The presence of 
Triton X-100 is probably the reason why certain percentage yields were 
greater than 100% i e it interfered with the protein assays despite 
attempts made to reduce the interference . It is possible to remove 
Triton X-100 from samples but the methodologies involved are time 
comsuming and expensive and tend to only be useful for large sample 
volumes. It would only be necessary in this study to remove the 
Triton X-100 from those samples being assayed for protein and enzyme 
activity and thus the volumes would be very small and the number of 
samples assayed was large. It would also not be advantageous to 
remove the Triton X-100 from the entire samples obtained as the main 
function of this detergent is to act a stabiliser of the enzyme 
complex. The methods available for the removal of Triton X-100 
utilise activated charcoal (337), dialysis, density gradient 
centrifugation, gel filtration (cited in 337) and Bio-Beads (338). 
None of these methods lend themselves easily to use in this study. 
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The Triton X-100 solubilisation of linoleoyl-CoA desaturase resulted 
in an increase in fold purification of 3.80. When the solution was 
diluted (to reduce the percentage of detergent) and centrifuged (to 
remove extraneous proteins) there was a larger increase in fold 
purification of 19.17. Okayasu et ~ (328) also noted that Triton X-
100 solubilisation resulted in an increase in purification but they 
noted a smaller increase, 1.47, than was found in this study. Tr iton 
X-100 thus had the dual role of solubilising linoleoyl-CoA desaturase 
and precipitating some extraneous protein. 
The DEAE-cellulose chromatography resulted in an 80% increase in fold 
purification i e from 19.17 to 34.43 as a result of binding 
contaminating proteins and eluting the linoleoyl-CoA desturase through 
the column without any binding. A similar increase was also noted by 
Okayasu et ~ i e from 1.47 to 4.07 (328). 
In this study the greatest increase in fold purification was ach ieved 
with the CM-Sephadex C-50 step as the fold purification increased to 
395 .1. This step also resulted in the largest reduction in total 
protein i e from 263.9 mg to 3.47 mg. Okayasu et ~ (328) accounted 
for this by suggesting that although the linoleoy l-CoA desaturase did 
not bind to the column all the contaminating cytochrome P-450 did . 
Okayasu et ~ (328) did not find as great a reduction in total protein 
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i e from 321 mg to 116 mg or as great an increase in the fold 
purification i e from 4.07 to 8.0 as was noted by this study. From 
these results it can be seen that both the columns utilised in this 
study were very effective in further purifing linoleoyl-CoA 
desaturase. 
The final yield in this study was 3.05 mg of linoleoyl-CoA desaturase 
from 25 g of starting rat liver, this was three to four times greater 
than that achieved by Okayasu et _li (328). This was a percentage 
yield of 71% in comparison to the 12% achieved by Okayasu et _li (328). 
They also utilised affinity chromatography in their study (328) i e 
cytochrome bs-sepharose. It was at this stage that Okayasu et _li 
(328) found the greatest fold purification (from 8.0 to 229.33). In 
this study the linoleoyl-CoA solution was freeze dried once it had 
eluted from the CM-Sephadex C-50 column and had been dialysed. 
Disc gel electrophoresis was performed on fractions of both the eluent 
from the CM-Sephadex C-50 column and the freeze dried powder. Both 
fractions showed the same three bands in the gels and as two of the 
bands were characteristic of those of cytochrome bs and cytochrome bs 
reductase (showed characteristic Rf values) it was presumed that the 
third band was probably that of a6-desaturase . It was decided that 
it was unnecessary to conduct the cytochrome bs-sepharose 
chromatography as in this study greater purification had already 
been achieved without this step than Okayasu et £1 (328) had 
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achieved with the inclusion of this step. The freeze dried 
linoleoyl-CoA desaturase had a final fold purication of 426.3. 
Okayasu et .£1 (328) did not freeze dry their final linoleoyl-CoA 
solution but instead froze it under nitrogen at -70°C. The freeze 
dried powder was more stable than a frozen solution as Okayasu et .£1 
(328) had reported an instability of the enzyme complex and the loss 
of 80% of the enzyme complex activity with repeated freezing and 
thawing. The freeze dried powder retained most of the linoleoyl-CoA 
desaturase activity for the duration of this study. As this enzyme 
complex was to be utilised in the attempted isolation and purification 
of a6-desaturase it was necessary for the enzyme complex to be in as 
stable a form as possible . 
From these results it can be seen that a catalytically active and pure 
form of linoleoyl-CoA desaturase had been isolated using a simplified 
methodology and with a greater yield and percentage purification to 
that cited in the only other report on the isolation of this enzyme 
complex (328) . 
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CHAPTER 5 
THE ATTEMPTED ISOLATION AND PURIFICATION OF ~6-DESATURASE 
5.1 Introduction 
~6-desaturase is the terminal enzyme in the linoleoyl-CoA desaturase 
enzyme complex and it is the enzyme ultimately responsible for the 
enzymatic conversion of cis-LA into GLA (328,331) . Of all the 
components of l inoleoyl-CoA desaturase the least is known about ~6-
desaturase. There is some confusion concerning the isolation and 
purification of this enzyme as most reports that cite work with ~6-
desaturase are really referring to the entire enzyme complex of 
linoleoyl-CoA desaturase, e g Okayasu et ~ (328) refer to the 
isolation and purification of linoleoyl-CoA desaturase in their report 
but in the discussion of the results they cite facts concerning ~6-
desaturase when these really re 1 ate to the enzyme comp 1 ex. Others 
such as Fujiwara et ~ (329) have made the same error . 
It is known that ~6-desaturase is membrane bound, as are the other 
components of linoleoyl - CoA desaturase (329,331). Due to the 
positioning of cytochrome bs and cytochrome b5 reductase within the 
endoplasmic reticulum, exposing their catalytic sites at the 
cytoplasmic side of the endoplasmic reticulum, it was assumed that 
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a6-desaturase had similar positioning. This assumption was made as 
it is essential for the activity of linoleoyl-CoA desaturase that the 
cytochrome b5 molecules can pass their electrons to a6-desaturase to 
initiate the conversion of cis-LA into GLA (328,329). 
It was decided that as so little was known about a6-desaturase the 
best method to utilise in the isolation of this enzyme would involve 
initially the isolation and purification of linoleoyl-CoA desaturase 
and then an attempt would be made to enzymatically remove the 
cytochrome b5 and cytochrome b5 reductase molcules from the linoleoyl-
CoA desaturase complexes in the hope that a pure a6-desaturase would 
be the end result. As trypsin had already been utilised in the 
isolation and purification of cytochrome b5, it was decided that in 
this study it would again be utilised to attempt to remove the 
cytochrome b5 from the linoleoyl-CoA desaturase complex. It is known 
that trypsin will only solubilise cytochrome b5 and not cytochrome b5 
reductase ( 260,261). When cytochrome b5 reductase was so 1 ub il i sed 
using lysosomes, one of the active enzymes within the lysosomes was 
cathepsin 0 [EC 3.4.4.23]. Cathepsin 0 only solubilises cytochrome 
b5 reductase and not cytochrome b5 (298,317). It was consequently 
decided to utilise this enzyme to solubilise cytochrome b5 reductase 
from the linoleoyl-CoA desaturase complex. It was hoped that this 
methodology would result in the isolation of a6-desaturase. 
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5.2 Materials and Methods 
5.2.1 Reagents 
Protein solution A. As in section 2.2.1 . 
Protein solution B. As in section 2.2.1 . 
Protein solution C. As in section 2.2.1. 
Protein standard solution. As in section 2.2.1. 
Sephadex G-75. Sephadex G-75 (Pharmacia Fine Chemicals, Sweden) was 
swollen for 24 hrs in the appropriate buffer and the 11 dead 11 beads were 
removed from the buffer surface. 
5.2.2 Methods 
Unless stipulated all procedures were conducted at room temperat~re. 
Isolation and Purification of Linoleoyl-CoA desaturase. 
Chapter 4. 
As in 
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Cathepsin D solubilisation of Cytochrome bs Reductase. The 
methodology utilised for the solubilisation of cytochrome bs reductase 
via cathepsin D (Sigma Chemical Company, USA) enzymatic action was a 
modification of the methodology of Ito (279). The cathepsin D 
solution (50 ~g of crystalline cathepsin D was dissolved in 200 ~1 of 
0.1 M Tris-HCl buffer pH 7.5) was added to the linoleoyl-CoA 
desaturase solution (0.5 mg of purified linoleoyl-CoA desaturase 
freeze dried powder was dissolved in 0.5 cm3 of 0.1 M Tris-HCl buffer 
pH 7. 5). The enzyme solution was incubated at 37°C for 4 hrs with 
occasional shaking. 
Sephadex G-75 chromatography . The enzyme solution was then passed 
through a Sephadex G-75 column (1.5 x 23 em) at a rate of 
approximately 10 cm3/hr. The column had previously been equilibrated 
with 0.1 M Tris-HCl buffer pH 7.5 and it was also eluted with this 
buffer. Fractions of approximately 5.2 cm3 were collected. 
Each fraction was assayed for the presence of protein, cytochrome b5 
reductase, cytochrome b5 (as an indication of the location of !:l6-
desaturase, as there is no assay for !:l6-desaturase that does not 
involve the entire linoleoyl-CoA desaturase complex) and cathepsin D. 
The protein assays were conducted utilising the Hartree modification 
of the Lowry method of protein estimation (288,289). The assay for 
the presence of cytochrome b5 reductase was the same as that described 
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in section 3.2.3. The assay for the presence of cytochrome b5 was 
the same as that described in section 2.2.3. The assay for the 
presence of cathepsin 0 was a modification of the method used by 
Boethling (339) in which 1 cm3 of diluted sample, 1 cm3 of haemoglobin 
(10 mg/cm3 dissolved in 0.5 M Tris-HCl buffer pH 4.5) and 1 cm3 of 
deionised water were incubated at 37°C for 5 min separately and were 
then mixed and incubated for a further 15 min at 37°C . After 15 min 
2cm3 of 10% trichloroacetic acid (TCA) was added and the sample was 
placed on ice for an hour for precipitation to occur. The solution 
was then filtered through Whatman Number 1 filter paper and the 
filtrate was assayed for the presence of peptides as previously 
described . The presence of increased pept ides in fractions is an 
indication of the presence of cathepsin 0 in those fractions. 
Cytochrome b5 reductase was located in fractions 11-15 and 27. 
Cytochrome b5 was located in fractions 11-15 and 19-20. Cathepsin 0 
was located in fractions 4-6, 14-15 and 20 . Fractions 11-15 were 
combined, with a final volume of 25.8 cm3, and were fre eze dried for 
uti 1 i sat ion in the the next stage of a6-desaturase i so 1 at ion. The 
freeze dried powder retained the enzyme activities that were present 
in the fractions. 
Trypsin solubilisation of Cytochrome b5. The methodology utili sed 
for the solubi lisation of cytochrome b5 was the same as that utilised 
in Chapter 2, i e a modification of that used by Kajihara and 
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Hagihara (260). The freeze dried powder of fractions 11-15 was 
dissolved in 3 cm3 of 0.1 M Tris-HCl buffer pH 7.5. Crystalline 
trypsin was added at 0.5% (v/v) . The solution was then incubated at 
37°C for approximately 4 hrs with occasional shaking. 
Sephadex G-75 chromatography. The enzyme solution was passed through 
a Sephadex G-75 column (1.5 x 23 em) at a flow rate of approximately 6 
cm3/hr. The column had previously been equilibrated with 0.1 M Tris-
HCl buffer pH 7.5. Fractions of approximately 3 cm3 were collected 
and they were assayed for the presence of prate in, cytochrome bs 
reductase, cytochrome bs and trypsin. The assays for protein, 
cytochrome b5 reductase and cytochrome bs were conducted as previously 
described . The assay for the presence of trypsin was the same as 
that for cathepsin D with the exceptions that as trypsin is an 
alkaline protease, unlike cathepsin D which is an acid protease, the 
substrate in the assay was casein (10 mg/cm3 dissolved in 0.5 M Tris-
HCl buffer pH 7.5) and the assay was conducted under alkaline 
conditions . 
Cytochrome b5 was located in fractions 4-5, 8-9 and 41-42 . 
Cytochrome b5 reductase was located in fractions 7-9 and 39-41. 
Trypsin was located in fractions 4-7. From these results it was not 
known exactly where the a6-desaturase was located and fractions 8-9 
were combined and freeze dried as were fractions 39-42. 
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5. 3 Results 
Fig. 16 shows the elution profile of the Sephadex G-75 column after 
cathepsin D solubilisation of the linoleoyl-CoA desaturase solution. 
The cathepsin D was eluted mainly in fractions 4-6 with small 
quantities being eluted in fractions 14-15 and 20. Cytochrome b5 
reductase was eluted mainly in fraction 27 and a much smaller quantity 
was eluted in fractions 11-15. Cathepsin D also solubilised some 
cytochrome b5 and this was eluted in fractions 19-20. The major 
portion of cytochrome b5 was eluted in fractions 11-15. In the 
fractions 11-15 it was found that there was still some cytochrome b5 
reductase present with the majority of the cytochrome b5 present. 
This indicates that the solubilisation of cytochrome b5 reductase was 
not totally successfu 1. There was a relatively large quantity of 
protein present in these fractions as we 11 as a sma 11 quantity of 
cathepsin D. It was assumed that ~6-desaturase was present in these 
fractions because of the high concentration of cytochrome b5 and these 
fractions were combined and freeze dried. 
Fig. 17 shows the elution profile of the Sephadex G-75 co lumn after 
trypsin sol ubi 1 isation of the freeze dried fractions 11-15 from the 
previous stage. The trypsin was eluted in fractions 4-7. 
Cytochrome b5 was eluted in fraction s 4-5 on its own, in fractions 8-9 
with cytochrome b5 reductase and trypsin and in fractions 41-42 only 
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with cytochrome b5 reductase. Cytochrome b5 reductase was eluted in 
fractions 7-9 with cytochrome bs and trypsin and in fractions 39-41 
where it was only found with cytochrome b5. This indicates that the 
trypsin solubilisation of cytochrome b5 was also not totally 
successful . 
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Fractions 8-9 and 39-42 were freeze dried and second cathepsin D and 
trypsin solubilisations were conducted on both the freeze dried 
powders. The second solubilisations resulted in greatly reduced 
quanitites of both cytochrome b5 and cytochrome b5 reductase after the 
chromatography steps with the result that cytochrome b5 reductase was 
shown not to be present in combination with cytochrome b5 and after 
the second cytochrome b5 solubilisation with trypsin, cytochrome b5 
reductase was not found to be present at all which was partially one 
of the aims of this study. Cytochrome b5 was found to be present in 
more than one peak even after the second solubilisation of cytochrome 
b5. This is shown in Fig. 18. 
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5.4 Discussion 
These results have shown that although ~6-desaturase was not isolated 
in a pure form it is possible to utilise enzymatic solubilisation of 
the components of linoleoyl-CoA desaturase to attempt to isolate a 
purified form of ~6-desaturase. Cytochrome b5 reductase seems to be 
relatively easily removed from the linoleoyl-CoA desaturase complex 
after a second cathepsin D solubilisation. This is not totally 
unexpected as it is the first component of the linoleoyl-CoA 
desaturase complex and as such should be the most accessible of all 
the components. In the l ino leoyl-CoA desaturase complex it is 
assumed that for every molecule of cytochrome b5 reductase (which 
carries two electrons) there are two molecules of cytochrome b5 (each 
of which carries one electron) and as such there is less cytochrome b5 
reductase to sol ubi lise from the complex (see Fig. 13) . Cytochrome 
b5 seems to be relatively more diffficult to totally remove from the 
linoleoyl-CoA desaturase complex and this could be due to the extra 
cytochrome b5 (in comparison to cytochrome b5 reductase) present in 
the linoleoyl-CoA desaturase complex. 
The major problem with this isolation is the small quantities of 
enzyme wh ich are present and which could result in relatively large 
errors in enzyme activity and protein assays. Future studies could 
perhaps utilise increased quantities of starting material. Disc gel 
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electrophoresis was run on the freeze dried powders and no bands were 
detected. This was repeated several times. This is probably the 
result of the very low concentration of the enzyme used. 
The aim of this section (Chapters 2 - 5) of the thesis was to isolate 
the linoleoyl-CoA desaturase complex and from the complex to isolate 
the terminal enzyme, A6-desaturase by enzymatically solubilising the 
other two components of linoleoyl-CoA desaturase i e cytochrome bs and 
cytochrome b5 reductase. Interest was shown in this enzyme and the 
complex, as has previously been discussed, as it is believed to play a 
role in the control of cell proliferation and because it appears to 
have reduced activity in some cancer cells and it has been suggested 
that this could be one of the reasons for the loss of control of cell 
proliferation in cancer cells (5,22-24). 
In order to enzymatically solubilise cytochrome b5 and cytochrome bs 
reductase from the linoleoyl-CoA desaturase complex it was first 
necessary to isolate and purify these two components individually from 
rat liver microsomes. Both of these components were isolated in a 
purified form utilising simplified and easily reproducible 
methodologies and with increased yields in comparison to those 
reported in earlier studies. Once this had been achieved it was then 
possible to attempt to isolate and purify the linoleoyl-CoA desaturase 
comp 1 ex . The comp 1 ex was a 1 so 
methodology and an increased yield. 
isolated utilising a simplified 
Unfortunately the purification 
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of the ~6-desaturase enzyme was not entirely successful for the 
reasons previously discussed. 
The isolation and purification procedures were mainly conducted at 
room temperature with no detrimenta 1 effects. Disc gel 
electrophoresis showed the purity of the isolated compounds. 
The final stage of this section was the attempted iso l ation of A6-
desaturase from the linoleoyl -CoA desaturase complex. This was not 
totally achieved in that the presence of some cytochrome b5 was still 
detected with the t:..6-desaturase. It was realised that the enzymatic 
solubilisation of cytochrome b5 and cytochrome b5 reductase would 
result in a portion of both components remaining in the membrane 
bilayer with the ~6-desaturase but if they had been solubilised 
utilising detergents it was fe lt that this would probably result in 
the total disruption of the membrane bilayer and thus the complex with 
the resultant loss of all enzymatic activity, as the membrane bilayer 
is essential for enzyme activity. 
This section of the thesis shows that it is possible to uti l ise 
enzymatic solubilisation of cytochrome b5 and cytochrome b5 reductase 
for the isolation of A6-desaturase. 
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CHAPTER 6 
THE EFFECT OF GLA AND ZINC SUPPLEMENTATION ON THE GROWTH OF 
NORMAL AND TUMOUR CELLS IN VITRO 
6.1 Introduction 
One of the aims of this thesis was to study the effect of GLA, zinc 
and a GLA/zinc combination on the growth of normal and tumour cells in 
culture to determine whether the linoleoyl-CoA desaturase enzyme 
complex was a site of action of zinc inhibited tumour growth as it had 
been suggested in other studies (133,135). Cell culture was used for 
this purpose as it allows the utilisation of a homogeneous cell 
population (with a virtually conserved genetic complement) which grows 
in an easily manipulated environment (340). The manipulation of the 
environment allows for the study of the different effects nutrient 
supplementations have on the cell population. It is this 
characteristic of ce ll culture that is utilised in this study. Cell 
culture also has the advantage of allowing numerous experiments to be 
conducted without the ethical problems that working with live animals 
involve (340), although it is not always possible to directly 
extrapolate results achieved in in vitro experiments to those that 
will be achieved in in vivo situations. 
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GLA was utilised in this study as it is the product from the reaction 
when LA is converted into GLA by linoleoyl-CoA desaturase and this 
enzyme complex is of primary interest to this study as it has been 
found to have reduced activity in certain tumour cell lines (5,22-24). 
If there is reduced activity of the linoleoyl-CoA desaturase complex 
then correspondingly there will be reduced GLA produced in the tumour 
cells and it is hypothesised that with the supplementation of GLA, 
tumour growth may be inhibited (5). GLA has in fact been found to 
inhibit the growth of human mammary carcinomas, prostatic 
adenocarcinomas, lung care i nomas, neurob 1 a stomas, hepatomas, 
oesophageal carcinomas and murine melanomas (211-223). GLA has also 
been shown to preferentially inhibit the growth of mammary carcinoma 
cells when placed together with normal lung cells and as such is not 
toxic to normal cells (211). 
Zinc deficiency is well known for its inhibitory effect on the growth 
of tumour cells while not effecting the growth of normal cells. It 
has been shown to inhibit the growth of Ehrlich ascites tumours, 
Walker 256 carcinosarcomas, Lewis lung sarcomas, L1210 murine 
leukaemias, 350 hepatomas and murine melanomas (BL6) (6,239-246). 
Zinc supplementation (excess) has also been shown to inhibit the 
growth of tumour cells e g it inhibits the growth of hamster cheek 
pouch carcinoma, L1210 murine leukaemias, BL6 murine melanomas 
(244,252,253,256). Zinc is thought to be a cofactor of the 
linoleoyl-CoA desaturase enzyme complex (133,135) and it is possible 
that zinc supplementation results in the inhibition of tumour cell 
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growth as a result of the reactivation of linoleoyl-CoA desaturase. 
In this study it was decided to utilise zinc supplementation and not 
zinc deficiency as this is more easily controlled in culture and is of 
more relevance with regard to the possible therapeutic value of zinc 
in cancer treatment. 
As stated in Chapter 1, it is possible that GLA and zinc may influence 
each other in the mechanism/s by which they inhibit the growth of 
tumour cells in culture. It has been hypothesised that a zinc 
deficiency could result in a reduction in the activity of linoleoyl-
CoA desaturase and that this could in turn result in a lowering in the 
synthesis of GLA and consequently a lowering in the synthesis of cAMP 
which could result in an increased rate of cell proliferation (5,22-
30,138,140,143). Although several reports have indicated that there 
is a possible relationship between zinc and EFAs, specifically GLA 
(133,134,137,139,141-143,146-149) there are no published reports 
elucidating the relationship between GLA and zinc in cell culture. 
This study attempted to determine if any relationship was apparent in 
cell culture experiments between GLA and zinc, when both were 
concurrently supp 1 emented to ce 11 s and subsequently (in Chapter 7) 
whether this may be through an association with the linoleoyl -CoA 
desaturase enzyme complex. 
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6.2 Materials and Methods 
6.2.1 Reagents 
Antibiotic Solution. The antibiotic solution was prepared by 
dissolving one vial of sodium benzylpenicillin (106 IU) (Novo 
Industries, RSA) and one vial of streptomycin sulphate (106 ~g) (Novo 
Industries, RSA) in 100 cm3 of deionised water. 
Cell Culture Media. The cell culture medium utilised was Eagle's 
Basal Medium (Modified) (Flow Laboratories, Scotland) . Medium was 
prepared in batches of 10 l by dissolving the powdered medium in 
Milli-Q water and adding ascorbic acid (0.5g), serine (0.1g), glycine 
(0.06g), NaHC03 (7,5g) and antibiotic solution (50 cm3). The pH was 
checked to ensure that it was 7.2-7.4 and if neceesary 1M HCl or NaOH 
was added to yield the desired pH and the volume was made up to 10 l 
with Mi 11 i -Q water. The medium was filtered through a millipore 
filtration unit (Millipore Corporation, USA) utilising a Sartorius 
prefilter, a filter with pore size of 0.45 ~m and finally a filter 
with pore size of 0.22 ~m into autoclaved media bottles of volumes 100 
cm3, 250 cm3 and 500cm3. This ensured that the med i urn should be 
sterile. The media bottles were then incubated for one week at 37°C 
to ensure no contamination had occurred and they were consequently 
stored at 4°C until used. 
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Growth medium (GM) was prepared by sterile filtering, through a 0.45 
~m Millipore filter using a Swinnex-25 holder (Millipore Corporation, 
USA), foetal calf serum (FCS) (State Vaccine Institue,RSA) into the 
Eagle's Basal Medium until it contained 10% (v/v) FCS. The GM was 
incubated at 37°C for approximately 48 hrs before use to ensure that 
no contamination of the medium had occurred. Maintenance medium 
(MM) was prepared by sterile filtering FCS into Eagle's Basal Medium 
until it contained 5 % (v/v) FCS. The MM was incubated under the 
same conditions as the GM. Shelf Culture medium (SCM) was prepared 
by sterile filtering FCS into Eagle's Basal Medium until it contained 
2 % (v/v) FCS. The SCM was incubated under the same conditions as 
the GM. Freezing medium (FM) was prepared by adding 10 % (v/v) 
dimethyl sulphoxide (DMSO) and the medium was frozen unti 1 required 
and then it was sterile filtered in the same method as the FCS. 
The GLA-supplemented media was prepared by sterile filtering the 
appropriate volume of a GLA solution (10 mg/cm3 diluted in 0.1 M 
NaC03) (Sigma Chemical Corporation, USA) into 100 cm3 bottles of GM to 
yield solutions containing 0 (control), 0.5, 2, 4, 6, 8 and 10 ~g/cm3 
of GLA. 
The zinc-supplemented media was prepared by sterile filtering the 
appropriated volume of a zinc standard atomic absorption (AA) 
spectroscopy standard solution (SMM Chemicals, USA) of 1000 ~g/cm3 
into 100 cm3 bottles of GM to yield solutions containing 0 (control), 
1, 2, 3, 4, 5 and 10 ~g/cm3 of zinc. 
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The GLA- plus zinc-supplemented media was prepared as above to yield 
solutions that had the following concentrations of GLA (~g/cm3) : zinc 
(~g/cm3), 0:0, 4:2, 4:3, 4:4, 6:2, 6:3, 6:4, 8:2, 8:3, and 8:4. 
These concentrations were chosen as they had been shown from previous 
experiments to be the most probable concentrations that could be used 
therapeutically in the treatment of cancer. 
Trypsin Subculturing Solution. The trypsin subculturing solution 
contained NaCl (8.0 g), KCl (0.4 g), D-glucose (1.0 g), NaHco3 (0.58 
g), EDTA (0.2 g), phenol red (0.02 g), trypsin (5 x 105 units) (Sigma 
Chemical Company, USA) and antibiotic solution (10 cm3) in 1 l. 
Dulbecco's Phosphate Buffered Saline without calcium or 
maqnes i urn. (Phosphate buffered saline - PBS) The PBS contained KC l 
(0.2 g), NaCl (8.0 g), Na2HP04.2H20 (1.15 g) and KH2P04 (0.2 g) in 1 
l. 
AA Zinc Standard solution. The zinc standard solution was purchased 
(SMM Chemicals, USA) at 1000 parts per million (ppm) (1 ppm = 1 
~g/cm3) and the standards were 0.1, 0.2, 0.5 and 1.0 ~g/cm3. 
Pheno l-Cresol mixture. The phenol-cresol mixture was prepared by 
dissolving 500 g of detached phenol crysta ls and 0.5 g of 8-hydroxy-
quinolone in 70 cm3 of meta-cresol (no ortho-cresol must be present 
and 55 cm3 of deionised water. 
stored in an amber bottle. 
The phenol-cresol mixture must be 
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DNA Standard solution. The DNA standard solution consisted of 
crystalline DNA (Sigma Chemical Company, USA) at 300 f.Lg/cm3 and the 
standards contained 50, 100, 150, 200, 250 and 300 f.Lg/cm3 of DNA. 
Diphenylamine solution. The diphenylamine solution was prepared by 
dissolving 1.5 g of ananlytical grade di phenylamine in 100 cm3 of 
glacial acetic acid and 1.5 cm3 of concentrated sulphuric acid. This 
solution is stored in an amber bottle and in the dark and immediately 
prior to use 0.1 cm3 of aqueous acetaldehyde (1.6 %) was added to 
every 20 cm3 of diphenylamine solution used. 
6.2 .2 Cell Lines 
The two continuous cell lines utilised in this study were the 
B16FlOBL6 mouse melanoma cell line (BL-6) and the Lilly Laboratory 
Continuous Monkey Kidney cell line (LLCMK). The ce 11 1 i nes were 
obtained from the Department of Physiology, Medunsa, RSA. 
6.2.3 Methods 
Routine Cell Culture Procedures. As sterility was vital for 
successful cell culture experiments all work was conducted on a 
laminar flow bench which had previously been sterilised by ultra-
violet (UV) light, all equipment was purchased sterile or was 
autoclaved, solutions were sterile filtered and incubated at 37°C for 
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a minimum of 48 hrs, prior to use, to ensure no contamination had 
occurred and all equipment was swabbed with 95% alcohol prior to use. 
Cells not being utilised for experiments were grown in Cell-Cult 
large cell culture flasks (75cm2) (Sterilin, UK) with MM. The medium 
was changed frequently and the cell lines were trypsinised and 
passaged just before they reached confluency within a flask. The 
flasks were incubated at 37°C. To maintain the cell line, some cells 
were frozen in FM using liquid air, and several flasks of cells were 
maintained at room temperature utilising SCM for 4 weeks at a time. 
This ensured that if any mass contamination was to occur the cell 
lines could easily be regrown. 
Experimental Cell Culture Procedure. When experiments were set up 
five duplicates of each point were prepared and the flasks utilised 
were 25 cm2 Cell-Cult flasks. Large cell culture flasks with nearly 
confluent cell populations were trypsinised with 10 cm3 of trypsin 
subculturing solution and were incubated at 37°C until the cells 
lifted from the flask surfaces where upon the solutions were 
transferred to sterile centrifuge tubes (Sterilin, UK) and centrifuged 
to pellet the cells. The trypsin solution was then decanted and 2 
cm3 of GM was added to the centfifuge tubes and the cells were 
dispersed with a sterile pasteur pipette. A drop of the cell 
solution was then placed on a haemocytometer (Neabauer counting 
chamber) and covered with a glass cover slip. The cells were counted 
and the total number of cells in the entire suspension was calculated 
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in order to pipette a set volume of the cell suspension into each 
flask, so that each flask had 350 000 cells at the start of an 
experiment. The experimental media i e the GLA-, zinc- and GLA- plus 
zinc-supplemented media was then added to the flasks (10 cm3 per 
flask) and controls were always set-up (i e had no supplementations 
added). 
The flasks were incubated at 37°C and the media was changed if 
necessary during the experiment. Twelve hours before the cells were 
to be harvested a radio-active label was added to the cells. Methyl-
3H thymidine (Amersham International, UK)was the radio-active label 
and 5 ~Curries (~Ci) was added per flask. The label was in PBS. The 
cells were harvested (trypsinised) under non-sterile conditions and 
once the cells had been spun and pelleted they were suspended in 10 
cm3 of PBS and the cells were counted on a haemocytometer. 
DNA Isolation and 3H-Thymidine Uptake. The methodology utilised was 
that of Baker (341). Once the cells had been counted, the cell 
suspensions were once again centrifuged to ·pellet the cells. The PBS 
was decanted and 2cm3 of 6 % sodium-4-amino salicylate, 2 cm3 of 1 % 
NaCl and 2 cm3 of the phenol-cresol mixture was added to each sample. 
The cells were homogenised in a dounce homogeniser (10 strokes with 
the loose plunger and 10 strokes with the tight plunger). The 
homogenate was shaken for 20 mins at room temperature and then 
centrifuged at 500 g for 30 min. The aqueous phase was removed and 
to this mixture was added 3.0 g of NaCl per 100 cm3 of sample and 0.5 
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volume of phenol-cresol mixture. The resulting solution was allowed 
to stand for 10 mins at room temperature and was then centrifuged at 
7000 g for 20 mins. The aqueous phase was removed and mixed with 2 
volumes of an ethanol-meta-cresol mixture (9:1 v/v). The solution 
was left to stand at 4°C for 30-60 mins. 
overnight if necessary . 
The solution could be left 
The solution was then centrifuged at 18 000 g for 15 mins and the 
precipitate was extracted twice with with 6 cm3 of cold 3.0 M sodium 
acetate (pH 6.0) and then centrifuged at 4000 g for 10 mins to remove 
the remaining precipitate. The washings were combined and mixed with 
10 cm3 of 2-ethoxy-ethanol. If no precipitation occurred, then 2-
ethoxy-ethano 1 was added until prec i pit at ion occurred. The solution 
was centrifuged at 18 000 g for 15 mins to pellet the precipitate and 
this precipitate was suspended in 5.0 cm3 of 0.5 M NaCl and 3.0 M 
sodium acetate (1:1 v/v). 
The samples were analysed for 3H-thymidine in a scintillation counter 
(Beckman LS 3801 scintillation counter) by adding 10.0 cm3 of 
scintillation cocktail (Ready-Solv EP, Beckman, Ireland) to 1.0 cm3 of 
sample. Duplicates were prepared as were vials containing 
scintillation cocktail only for background reading . 
The samp 1 es were a 1 so ana lysed for DNA content. The methode 1 gy 
utilised for this was that of Burton (342). Duplicates of 1.0 cm3 of 
the samples were added to 4.0 cm3 of diphenylamine solution and were 
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thoroughly mixed. The samples were heated in a boiling water bath 
for 10 mins and then cooled, where upon the absorbances of the samples 
at 600 nm were read on a Spectronic 1001 (Bausch and Lomb) . The DNA 
content was determined from a DNA standard curve (see Appendix 2). 
Atomic Absorption Spectroscopy. All the glassware utilised for AA 
assays was acid washed . AA spectroscopy was utili sed in order to 
determine the zinc content of grath medium. A Varian Techtron Model 
1000 AA Spectrophotometer with an air/acetylene flame, a slit width of 
0.5 nm, a wavelength of 213.9 nm and a lamp current of 5 rnA was 
utilised. A zinc standard curve was determined (see Appendix 3). 
The GM was diluted with deionised water to obtain readings that were 
on the standard curve . 
Statistical Analysis. The statistical significance of differences 
between curves was tested utilising two-way analysis of variance and 
the Student Newman Keuls test. The means and standard errors of the 
mean (SEM) five replicates are present and were checked by hand 
calculations. 
6.3 Results 
AA spectroscopy showed that the GM contained 0.3 ~g/cm3 of zinc. The 
effect of added zinc on the growth of BL-6 and LLCMK cells is shown in 
Figures 19 and 20, utilising cell counts (Figure 19) and 3H-thymidine 
incorporation into DNA (cpm/mg of DNA) (Figure 20) as indications of 
growth. 
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Figure 19. The effects of added zinc on the growth (cell counts) of 
LLCMK and BL-6 cells. 
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Figure 20. The effects of added zinc on the growth (cpm/mg or DNA values) of 
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Table 5 shows that statistically there was a significant decrease in 
the cell count of the BL-6 cells upon the addition of zinc as compared 
· to the control (when no zinc was added). When 4 ~g/cm3 of zinc was 
added to the BL-6 cells there was a small increase in the cell count 
of the BL-6 cells. The cell counts of the LLCMK cells were 
significantly decreased upon the addition of 1, 2, 5 and 10 ~g/cm3 of 
zinc, with the latter two additions showing a greater statistically 
significant decrease than the former two additions. When 3 ~g/cm3 of 
zinc was added to the LLCMK cells there was a significant increase in 
the cell count. 
TABLE 5: THE EFFECT OF ADDED ZINC ON THE GROWTH OF BL-6 AND LLCMK CELLS WHEN 
EXPRESSED AS CELL COUNTS 
[Zn] BL-6 ( ce l1 counts) LLCMK (cell counts) 
(ll-g/cm3) X± SEM x 10-6 "X ± SEM x 10-6 
0 3. 29 ± 0.30 1.65 ± 0.21 
1 2.19 ± 0 .17** 1.13 ± o.os* 
2 1.09 ± 0.07** 1.14 ± 0.18* 
3 1.13 ± 0.07** 2.46 ± 0.10** 
4 1.51 ± 0.11 ** 1. 73 ± 0.07 
5 0.78 ± o.os** 0.72 ± o.o8** 
10 0.26 ± o.os**· 0. 40 ± 0.07** 
~ p > 0.01 
** p > 0.001 
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Table 6 shows that when zinc was added there was a significant 
decrease in the 3H-thymidine incorporation into the DNA of the BL-6 
cells except when 1 and 4 ~g/cm3 of zinc was added when compared to 
the control. Only when 10 ~g/cm3 of zinc was added, was there a 
statistically significant decrease in the 3H-thymidine incorporation 
into the DNA of the LLCMK cells. 
TABLE 6: THE EFFECT OF ADDED ZINC ON THE GROWTH OF BL-6 AND LLCMK CELLS 
WHEN EXPRESSED AS 3H-THYMIDINE INCORPORATION INTO DNA 
[Zn] 
(p.g/cm3) 
0 
1 
2 
3 
4 
5 
10 
BL-6 (cpm/mg DNA) 
X' ± SEM x lQ-3 
310.52 ± 48 .60 
243.62 ± 11 . 90 
147.24 ± 12.92** 
120.70 ± 35.34*** 
195 . 78 ± 37.06 
127.94 ± 21.31 *** 
32.78 ± 7.07**** 
* p > 0.05 
** p > 0.025 
*** p > 0.01 
**** p > 0.001 
LLCMK (cpm/mg DNA) 
"X ± SEM x lQ-3 
138.98 ± 52.28 
62.68 ± 15.99 
62.96 ± 15.22 
264 .82 ± 130.00 
196.98 ± 74.90 
46.36 ± 7.36 
5.37 ± 0.69* 
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The effect of added GLA on the growth of BL-6 and LLCMK cells is shown 
in Figures 21 and 22, utilising cell counts (Figure 21) and 3H-
thymidine incorporation into DNA (Figure 22) as indications of growth. 
Figure 21 shows that the addition of GLA tended to result in a general 
decrease in both cell count and 3H-thymidine incorporation into DNA in 
the BL-6 cells while in general not really affecting the growth of the 
LLCMK ce 11 s. 
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Table 7 shows that statistically the difference in cell counts in the 
BL-6 cells was significantly higher than the control when 0.5 - 4.0 
J.Lg/cm3 of GLA was added, while there was a significant decrease in 
cell counts when 10 J.Lg/cm3 of GLA was added. The only affect of GLA 
on the LLCMK cell counts was a significant decrease when 8.0 and 10.0 
J.Lg/cm3 of GLA was added. In general, the addition of GLA had little 
effect on the cell counts of the LLCMK cells. 
TABLE 7: THE EFFECT OF ADDED GLA ON THE GROWTH OF BL-6 AND LLCMK CELLS WHEN 
EXPRESSED AS CELL COUNTS 
(GLA] 
(JJ.g/cm3) 
0 
0.5 
2.0 
4.0 
6.0 
8.0 
10.0 
BL-6 (cell counts) 
X ± SEM x 10-6 
4.17 ± 0.25 
5.84 ± 0.29** 
4.98 ± 0.16* 
4.90 ± 0.21* 
4.22 ± 0.17 
3.80 ± 0.25 
2.29 ± 0.15** 
* p > 0.005 
** p > 0.001 
LLCMK (cell counts) 
X ± SEM x 10-6 
2.11 ± 0.16 
1.94 ± 0.09 
1.87 ± 0.13 
2.22 ± 0. 12 
1. 70 ± 0.08 
1.25 ± 0.09** 
1. 21 ± 0.09** 
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The effect of GLA addition on the 3H-thymidine incorporation into DNA 
in the BL-6 and LLCMK cells is shown in Table 8. The addition of GLA 
resulted in a significant decrease in the 3H-thymidine incorporation 
into DNA at all concentrations of added GLA, with the most significant 
decrease being with the addition of 2.0 ~g/cm3 or greater. The LLCMK 
cells 3H-thymidine incorporation into DNA only showed a ~tatistically 
significant decrease when 6.0 ~g/cm3 of GLA was added. The addition 
of GLA at other concentration had very little effect on the 3H-
thymidine incorporation into DNA in the LLCMK cells. 
TABLE 8: THE EFFECT OF ADDED GLA ON THE GROWTH OF BL-6 AND LLCMK CELLS 
WHEN EXPRESSED AS 3H-THYMIDINE INCORPORATION INTO DNA 
[GLA] BL-6 {cpm/mg DNA) LLCMK {cpm/mg DNA) 
(fJ.g/cm3) X ± SEM x lQ-3 X ± SEM x lQ-3 
0 85.16 ± 14.74 25.91 ± 3.29 
0.5 66.25 ± 7.53* 25.35 ± 5.59 
2.0 37.22 ± 4.69*** 22.43 ± 2.95 
4.0 20.59 ± 0.86*** 33.85 ± 2.70 
6.0 20.95 ± 1.oo*** 2.25 ± 0.28** 
8.0 30.34 ± 3.75*** 14.79 ± 2.05 
10.0 10.69 ± 1.so*** 28.86 ± 3.37 
* p > 0.025 
** p > 0.005 
*** p > 0.001 
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Figures 23-26 and Tables 9 and 10 are data obtained from studies on 
the effects of added zinc together with added GLA on tumour and normal 
growth in the BL-6 and LLCMK cells. In these tables and figures the 
effect of added GLA at different levels of added zinc are considered. 
Contra 1 s were cultures with no added GLA at the different 
concentrations of added zinc. Figure 23 and Table 9 show the 
combined effect of added zinc and added GLA on the cell counts of the 
BL-6 cells. The addition of zinc and GLA together resulted in the 
general decrease in cell counts of the BL-6 cells. When no zinc was 
added, the addition of 4 1Lg/cm3 of GLA resulted in a significant 
increase in the cell count and the addition of 8 1Lg/cm3 resulted in a 
significant decrease in the cell count compared to the control with no 
added GLA in th ~ s group. When 2 IL9/ cm3 of zinc was a.dded , the 
addition of 6 and 8 1Lg/cm3 of GLA resulted in a significant decrease 
in the cell count of the BL-6 cells. In the 3 or 4 1Lg/cm3 of added 
zinc group, the further addition of 4, 6 and 8 1Lg/cm3 of GLA resulted 
in statistically significant decreases in the cell count. In Figures 
23-26 where necessary at the start of the curves, numbers have been 
placed next to the curve such that 0 represents 0 1Lg/cm3 of added 
zinc. In Figures 27-31 where necessary at the start of the curves, 
numbers have been placed next to the curve such that 0 represents 0 
1Lg/cm3 of added GLA. 
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Figure 24 and Table 9 show the combined effect of added zinc and added 
GLA on 3H-thymidine incorporation into DNA in the BL-6 cells. There 
was a general decrease in the 3H-thymidine incorporation into DNA upon 
the addition of zinc and GLA. Using cultures with no added GLA, when 
no zinc was added, the addition of 4, 6 and 8 JJ.g/ cm3 of GLA to the 
BL-6 cells resulted in significant decreases in the 3H-thymidine 
incorporation into DNA . When 2 and 4 JJ.9/cm3 of zinc were added, the 
addition of 4, 6 and 8 JJ.g/cm3 of GLA significantly decreased the 3H-
thymidine incorporation into DNA in the BL-6 cells. In the 3 JJ.g/cm3 
of added zinc group, only when 4 and 6 JJ.g/cm3 of GLA were added, was 
there a statistically significant decrease in the 3H-thymidine 
incorporation into DNA. 
<C 
:z: 
c 
0 
+' 
-~ ;::;-- 30 
s::' 0 0 
. ,.... rl 
-:;; X 
~<C 
0 :z: 
e- Q 20 o.._ g 0 
..... Cl 
cu E -~ g 
-c c.. i .3 10 
~ 
I-
I 
:I: 
M 
1Lg/cm3 zinc 
~J:Y-----~0 1Lg/cm3 zinc 
2 1Lg/cm3 zinc 
4 1Lg/cm3 · zinc 
0 2 4 6 8 
Added GLA (1Lg/cm3) . 
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TABLE 9: THE EFFECT OF ADDED ZINC AND GLA (ZINC KEPT CONSTANT) ON THE GROWTH 
OF BL-6 CELLS 
[Zn : GLA] 
(IJ.g/cm3) 
0 : 0 
0 : 4 
0 : 6 
0 : 8 
2 : 0 
2 : 4 
2 : 6 
2 : 8 
3 : 0 
3 : 4 
3 . 6 . 
3 . 8 . 
4 : 0 
4 : 4 
4 : 6 
4 : 8 
Cell Counts 
"X" ± SEM x 10-6 
7.02 ± 0.29 
8.31 ± 0.42*** 
7.08 ± 0.28 
6.39 ± 0.45*** 
2.34 ± 0.14 
2.50 ± 0.11 
1.69 ± 0.11 *** 
1.72 ± 0.07*** 
2.41 ± 0.10 
1.61 ± 0.18*** 
0.58 ± 0.06*** 
0 . 73 ± 0.17*** 
3.21 ± 0.21 
1. 51 ± 0.11 *** 
1. 28 ± 0.15*** 
1.84 ± o. so*** 
* p > 0.025 
** p > 0.005 
*** p > 0.001 
cpm/mg DNA 
"X" ± SEM x 10-3 
39.70 ± 9.01 
9.75 ± o.5o*** 
13.50 ± 0.49*** 
13.75 ± 2.51*** 
19.45 ± 1. 64 
13.91 ± 2.36* 
6.64 ± 2.09*** 
11.79 ± 1.46** 
16.01 ± 1.10 
9.95 ± 2.04* 
2.80 ± 0.48*** 
13.89 ± 2.35 
25.75 ± 3.30 
16.18 ± 1.65*** 
13.35 ± 2.03*** 
4.15 ± 0.68*** 
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Figure 25 and Table 10 show the combined effect of added zinc and 
added GLA on the cell counts of LLCMK cells. There is generally less 
effect of added zinc and GLA on the cell counts of the LLCMK cells 
than that found in the BL-6 cells. When no zinc and 6 and 8 ~g/cm3 
of GLA were added there were statistically significant decreases in 
the cell counts when compared to cultures with no added GLA. When 3 
~g/cm3 of zinc was added, the addition of 4, 6 and 8 ~g/cm3 of GLA 
significantly decreased the cell counts. Statistcally significant 
increases in the LLCMK cell counts were however found in the group to 
which 4 ~g/cm3 of zinc was added, when 4, 6 and 8 ~g/cm3 of GLA were 
added. 
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Figure 26 and Table 10 show the combined effect of zinc and GLA 
addition on 3H-thymidine incorporation into DNA of LLCMK cells. In 
general, there is also less effect than that found in the BL-6 cells . 
When no zinc was added, 6 ~g/cm3 of added GLA resulted in a 
significant decrease. When 2 ~g/cm3 of zinc was added, the addition 
of 4, and 8 ~g/cm3 of GLA resulted in significant increases in the 3H-
thymidine incorporation into DNA of LLCMK cells, while 6 ~g/cm3 of 
added GLA caused a significant decrease in the 3H-thymidine 
incorporation into DNA of LLCMK cells. When 3 and 4 ~g/cm3 of zinc 
were added, 4, 6 and 8 ~g/cm3 of added GLA resulted in significantly 
decreased 3H-thymidine incorporation into DNA. 
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TABLE 10: THE EFFECT OF ADDED ZINC AND GLA (ZINC KEPT CONSTANT) ON THE GROWTH 
OF LLCMK CELLS 
[Zn : GLA] Cell Counts cpm/mg DNA 
(IJ.g/cm3) "X ± SEM x 10-6 "X ± SEM x Io-3 
0 : 0 2.57 ± 0.15 10.64 ± 1.30 
0 : 4 2. 70 ± 0. 13 13 .65 ± 2. 10 
0 : 6 2.10 ± 0.10*** 0.85 ± 0.01*** 
0 : 8 1. 51 ± 0.1 1*** 6.80 ± 1. 22 
2 : 0 2.68 ± 0.12 4.30 ± 1.30 
2 : 4 2.58 ± 0.18 9.87 ± 1.09* 
2 : 6 2.92 ± 0.18 0.23 ± 0.10*** 
2 : 8 2.45 ± 0.15 12. 29 ± 1.34** 
3 : 0 3.82 ± 0.18 20.10 ± 9.78 
3 : 4 1.85 ± 0.18*** 5.65 ± o. n*** 
3 : 6 2.56 ± 0.17*** 5.98 ± 0.75*** 
3 : 8 2.45 ± 0.17*** 8.10 ± 1.38*** 
4 : 0 1. 78 ± 0.05 14.45 ± 5.64 
4 : 4 2.54 ± 0.19*** 4. 14 ± 0.45*** 
4 : 6 3.08 ± 0.12*** 1. 90 ± 0.37*** 
4 . 8 2.82 ± 0. 12*** 1. 51 ± 0.28*** . 
* p > 0.05 
** p > 0.005 
*** p > 0.001 
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In Figures 27-30 and Tables 11 and 12 the same data as shown in 
Figures 23-26 and Tables 9 and 10 were used but in this case the 
effect of added zinc on ce ll growth is considered at different levels 
of added GLA. Controls were the cultures with no added zinc at the 
different levels of added GLA. Figure 27 and Table 11 show the 
combined effects of GLA and zinc on the cell counts of the BL-6 cells. 
The general trend is a decrease in the cell counts of the BL6-cells. 
Table 11 shows that when no GLA was added and 2, 3 and 4 J.Lg/cm3 of 
zinc were added, there was statistically significant decreases in the 
cell counts compared to the counts with no added zinc. The same 
trend occurred at all levels of added GLA. 
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Figure 28 and Table 11 show the combined effect of added GLA and zinc 
on 3H-thymidine incorporation into DNA in the BL-6 cells. With the 
addition of zinc and GLA there is again a general trend of decreased 
3H- thymidine incorporation into DNA. When no GLA was added, the 
addition of 2, 3 and 4 ).Lg/cm3 of zinc resulted in a significant 
decrease in the 3H-thymidine incorporation into DNA in the BL-6 cells. 
When 4 ~g/cm3 of GLA was added there were no statistical significance 
differences noted when zinc was added. When 6 ).Lg/cm3 of GLA was 
added, at 2 and 3 ~g/cm3 of added zinc significant decreases occurred. 
The only statistically significant decrease in 3H-thymidine 
incorporation that occurred when 8 ~g/cm3 of GLA was added, was when 4 
).Lg/cm3 of zinc was added compared to the control with no added zinc. 
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TABLE 11: THE EFFECT OF ADDED GLA AND ZINC (GLA KEPT CONSTANT) ON THE GROWTH 
OF BL-6 CELLS 
[GLA : Zn] 
(ll-g/cm3) 
0 : 0 
0 : 2 
0 : 3 
0 : 4 
4 : 0 
4 : 2 
4 : 3 
4 : 4 
6 : 0 
6 : 2 
6 : 3 
6 : 4 
8 : 0 
8 : 2 
8 : 3 
8 : 4 
Cell Counts 
X" ± SEM x 10-6 
7.02 ± 0.23 
2.37 ± 0.14*** 
2.40 ± 0. 13*** 
3.22 ± 0.24*** 
8.35 ± 0.44 
2.50 ± 0.11 *** 
1.61 ± 0.18*** 
1.51 ± 0.07*** 
7.08 ± 0.28 
1.69 ± 0. 11 *** 
0 58 ± 0.06*** 
1.28 ± o.15*** 
6.38 ± 0.45 
1.72 ± 0.07*** 
0.73 ± 0.17*** 
1.84 ± 0.51*** 
* p > 0.025 
** p > 0.005 
*** p > 0.001 
cpm/mg DNA 
X" ± SEM x 1o-3 
39.88 ± 10.63 
19.30 ± 2.61*** 
15.95 ± 4.70*** 
25.75 ± 5.10*** 
9.55 ± 0.58 
13. 91 ± 2.36 
9.95 ± 2.04 
16.18 ± 1.65 
13.50 ± 0.65 
6.64 ± 2.09* 
2.80 ± 0.48*** 
13.35 ± 2.03 
13.51 ± 1.80 
11.79 ± 1.46 
13.89 ± 2.35 
4.15 ± 0.68** 
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Figure 29 and Table 12 show the combined effects of added GLA and zinc 
on the cell counts of LLCMK cells. In general there is little effect 
on the distinct trend in the cell counts of the LLCMK cells upon these 
additions. When no GLA was added and 2 11g/cm3 of zinc was added 
there was a significant decrease in the cell count, but when no GLA 
and 3 IJ..g/cm3 of zinc were added there was a significant increase in 
the cell count. The only statistically significant difference in the 
group with 4 11g/cm3 of added GLA was found when 3 11g/cm3 of zinc was 
added and this resulted in a decrease in the cell count. When 6 
IJ..g/cm3 of GLA was added, the addition of 2, 3 and 4 11g/cm3 of zinc 
resulted in a significantly increased cell count. This significantly 
increased cell count was also found in the 8 11g/cm3 of added GLA 
group, when 2, 3 and 4 11g/cm3 of zinc were added. 
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Figure 30 and Table 12 show the combined effects of added GLA and zinc 
on 3H-thymidine incorporation into DNA in the LLCMK cells. Generally 
there was less effect than that found when using cell counts as an 
indication of cell growth. When no or 6 ~g/cm3 of GLA were added, 
the addition of 2 ~g/cm3 of zinc resulted in a significant decrease 
in the 3H-thymidine incorporation into DNA, while the addition of 3 
~g/cm3 of zinc caused a significant increase. When 4 ~g/cm3 of GLA 
was added and 3 and 4 ~g/cm3 of zinc were added there was a 
significant decrease in the 3H-thymidine incorporation into DNA in the 
LLCMK cells. In the 8 ~g/cm3 of added GLA group, 2 ~g/cm3 of added 
zinc caused a significant increase while 4 ~g/cm3 of added zinc, 
resulted in a significant decrease in the 3H-thymidine incorporation 
into DNA in the LLCMK cells. 
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TABLE 12: THE EFFECT OF ADDEO GLA AND ZINC (GLA KEPT CONSTANT) ON THE GROWTH 
OF LLCMK CELLS 
[GLA : Zn] 
L.~.g/cm3) 
0 : 0 
0 : 2 
0 : 3 
0 : 4 
4 : 0 
4 : 2 
4 : 3 
4 : 4 
6 : 0 
6 : 2 
6 : 3 
6 : 4 
8 : 0 
8 : 2 
8 : 3 
8 : 4 
Cell Counts 
"X" ± SEM x 10-6 
2.58 ± 0.16 
1.78 ± 0.28**** 
3.82 ± 0.16**** 
2.68 ± 0.10 
2.68 ± 0.14 
2.58 ± 0.18 
1.85 ± 0.18**** 
2.54 ± 0.19 
2.12 ± 0.11 
2.92 ± 0.18**** 
2.56 ± 0.17*** 
3.08 ± 0.12**** 
1.55 ± 0.08 
2.45 ± 0.15**** 
2.45 ± 0.17**** 
2.82 ± 0 .12**** 
* p > 0.05 
** p > 0.025 
*** p > 0.005 
**** p > 0.001 
cpm/mg DNA 
X" ± SEM x 10-3 
10.71 ± 0.72 
4.35 ± 1.31** 
20.55 ± 9.38**** 
14.41 ± 5.73 
13.62 ± 3.09 
9.87 ± 1.09 
5.65 ± 0.77*** 
4.14 ± 0.45**** 
0.85 ± 0.05 
0.23 ± 0 .10** 
5.98 ± 0.75**** 
1.90 ± 0.37 
6.58 ± 1.07 
12.29 ± 1.34* 
8.09 ± 1.38 
1.51 ± 0.28* 
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6.4 Discussion 
This study showed that the general trend upon zinc addition BL-6 
cells was a overall reduction in cell counts and 3H-thymidine 
incorporation into the DNA of these cells. This general inhibition 
of tumour ce 11 growth was found to be simi 1 ar to that found in 
previous reports (244,252,253,256) . This effect was not as apparent 
in the LLCMK cells in which the addition of zinc at 3 f.Lg/cm3, in 
fact, caused an increase in the cell count in these cells. Although 
this trend seems unusual and cannot be explained, this experiment was 
conducted several times and concurred with results previously achieved 
within this laboratory . The addition of zinc at all other 
concentrations resulted in decreased cell counts in the LLCMK 
cultures, although these decreases were not as marked as those in the 
BL-6 cells. The addition of zinc also resulted in the general decrease 
in the 3H-thymidine incorporation into DNA in the LLCMK cel l s , except 
when 3 and 4 f.Lg/cm3 of zinc was added but none of these groups with 
the exception of that to which 10 f.Lg/cm3 of zinc had been added, were 
significantly different to the control group. 
When GLA was added to the GM there was a general increase in the cell 
counts of the BL-6 cells at low concentrations of added GLA and a 
decrease at higher concentrations. There was little effect on the 
LLCMK cells except at high concentrations of added GLA, when a 
decrease in the cell count was noted. When the 3H-thymi dine 
incorporation into DNA was measured upon the addition of GLA there was 
a general and significant decrease in the BL-6 cells and little effect 
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in the LLCMK cells, except for a significant decrease in the 3H-
thymidine incorporation when 6.0 f.i..g/cm3 of GLA was added. These 
results concur with those of previous literature reports (6,239-246). 
It was subsequently decided to investigate the combined effects of 
zinc and GLA addition on the BL-6 and LLCMK cell growth. Initially 
the effect of varied added GLA concentrations was examined in groups 
to which different amounts of zinc had been added. In general, in 
the BL-6 cells , when zinc was added to the medium, the further 
addition of GLA resulted in a significant decrease in the ce ll growth 
when measured as cell counts or 3H-thymidine incorporation. While 
the effect of added GLA was enhanced by the addition of zinc to the 
medium as well, the addition of more than 2 f.i..g/cm3 of zin~ did not 
increase this effect. 
In the LLCMK cells, the cell counts and 3H-thmidine incorporation was 
less effected by the combined addition of GLA and zinc than that found 
in the BL-6 ce lls . There was also no general trend to this effect 
with cell growth being found in certain cases and decreased growth in 
others. 
The data on the combined effect of added zinc and GLA on the cell 
growth was also examined in a slightly different manner, by 
determin ing the effect of different concentrations of added zinc to 
groups of cell cultures which had been supplemented with increasing 
concentrations of GLA. In this case, in the BL-6 cells, this 
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resulted in increased inhibition of cell growth, as determined by cell 
counts, at all concentrations of added zinc in all the groups 
supplemented with GLA (including those to which no GLA was added). 
When cell growth was expressed as 3H-thymidine incorporation into DNA 
this effect was not as apparent, although the same general trend was 
found. As found when examining this data by looking at the effect of 
increasing zinc in the different groups, the effect of added zinc on 
ce 11 growth inhibition was enhanced by the presence of GLA in the 
medium, but GLA at concentrations above 4 f.Lg/cm3 had no additional 
effect to that found at lower concentrations. 
Examining this data in a similar manner in the LLCMK cells again 
showed that there was generally less effect of zinc and GLA in these 
cells and that the effect was variable. 
One of the aims of this study was to investigate if it was possible to 
inhibit the growth of the cancer cell line i e the BL-6 cells, by the 
addit ion of zinc, GLA or a combination of the two while maintaining 
normal growth of the LLCMK cell line (the normal cells). This study 
showed that it was possible to manipulate the cell growth of both the 
LLCMK and BL-6 cell lines by varying the concentrations of added zinc 
and GLA but that there indeed appeared to be a greater effect on the 
BL-6 cells with an inhibition of growth of these cells being the most 
common result.The results of the combined effect of supplementary zinc 
and GLA clearly showed this inhibitory effect on the BL-6 cell growth, 
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while a less and variable effect on the LLCMK cells was found. It 
was also demonstrated that the presence of both zinc and GLA in the 
medium produced an enhanced effect than when only the one nutrient was 
supplemented in the medium. The effect was most evident when 
re lat ively high concentrations of the one nutrient was present 
together with a low concentration of t he other. High concentrations 
of both nutrients did not further enhance the inhibition of cell 
growth. 
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CHAPTER 7 
THE EFFECT OF GLA AND ZINC SUPPLEMENTATIN ON 
LINOLEOYL-CoA DESATURASE ACTIVITY IN NORMAL AND 
TUMOUR CELLS IN VITRO 
7.1 Introduction 
Results from the previous chapter illustrated that both GLA and zinc 
supplementation resulted in a more significant inhibition of tumour 
cell growth than normal cell growth and at low concentrations the 
additions did not adversely affect the growth of normal cells while 
still significantly inhibiting that of the tumour cells. It was, 
therefore, decided to see if there was any correlation with the growth 
inhibition and the activity of linoleoyl-CoA desaturase. Several 
reports (147-149) suggest that zinc possibly plays a role in the 
desaturation of LA into GLA through an influence on the enzyme 
complex linoleoyl-CoA desaturase. Only two reports i e those of 
Cunnane and Wahle (139) and Ayala and Brenner (143) have attempted to 
correlate the influence of zinc with activity of linoleoyl-CoA 
desaturase . Cunnane and Wahle (139) demonstrated that zinc 
deficiency resulted in increased desaturation of LA but Ayala and 
Brenner (143) demonstrated that zinc deficiency resulted in a decrease 
in LA desaturation. This indicated that the mechanism by which zinc 
influences the activity of linoleoyl-CoA desaturase is unclear, if in 
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fact it influences the enzyme complex at all. This study attempts to 
more clearly define the relationship between zinc and this enzyme 
complex by examining the effect of zinc addition on the activity of 
the linoleoyl-CoA desaturase complex itself. 
7.2 Materials and Methods 
7.2 . 1 Reagents 
Antibiotic solution. As in section 6.2.1. 
Ce l l Culture Media. The GM, GLA-supplemented media, the zinc-
supplemented media and the GLA- and zinc-supplemented media was 
prepared as in section 6.2.1. 
Trypsin Subculturing solution. As in section 6.2.1 . 
7.2.2 Cell Lines 
As in section 6.2.2 . 
7.2 .3 Methods 
Routine Cell Culture Procedures. As in section 6.2.3. 
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Experimental Cell Culture Procedures. As in section 6.2.3 except 
t hat no radio-active label was added and the harvested and pelleted 
cells were suspended in 2.0 cm3 of 0.1 M Tris-HCl buffer pH 7.4 and 
the ce 11 s were then counted. Once the ce 11 s had been counted then 
the cell suspensions were homogenised in a dounce homogeniser (20 
strokes with the loose plunger and 20 strokes with the tight plunger). 
Cytochrome bs Reoxidation Assay. The cytochrome bs reoxidation assay 
was conducted on each of the sample homogenates as described in 
section 4. 2. 3. The units of enzyme activity were ~mol of 
product/min/106 cells. 
Statistical Analysis. As in section 6.2.3. 
7.3 Results 
The ce 11 counts were not included as they were almost i dent i cal to 
those in Chapter 6. Figure 31 and Table 13 shows the effect of zinc 
addition on the activity of linoleoyl-CoA desaturase in the BL-6 and 
LLCMK ce ll s . 
The BL-6 cells generally showed lower linoleoyl-CoA desaturase 
activity than the LLCMK ce 11 s . The only statistically sign ificant 
increase in the linoleoyl-CoA desaturase activity when zinc was added 
to the BL-6 cells, occurred when 10 ~g/cm3 of zinc was added. The 
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addition of 1, 3 and 10 f.Lg/cm3 of zinc resulted in a small increase 
in the enzyme comp lex activity in the cells while the addition of 3, 4 
and 5 f.Lg/cm3 of zinc led to decreases in the linoleoyl-CoA desaturase 
activity. The trend of the ce 11 count of the BL-6 cells did not 
correlate with the linoleoyl-CoA desaturase activity since the 
addition of zinc resulted in a decrease in the cell counts (see Figure 
19 and Table 5 in Chapter 6). These results show that the linoleoyl-
CoA activity of the BL-6 cells showed a tendency to increase as the 
ce 11 count decreased. This increase in activity was however only 
significant when the cell count was at its lowest i e when 10 f.Lg/cm3 
of zinc was added . 
In the LLCMK ce 11 s the trend shown was one of increasing enzyme 
activity upon the addition of zinc when compared to the control. 
These increases were statistically significant on all additions of 
zinc except when 2 f.Lg/cm3 of zinc was added. The greatest increase 
in enzyme activity occurred when 5 f.Lg/cm3 of zinc was added. The 
cell counts of the LLCMK cells showed increases when 3 and 4 f.Lg/cm3 of 
zinc were added (see Figure 19 and Table 5 in Chapter 6), and unlike 
the BL-6 cells, these cell count increases did not correlate with a 
decrease in linoleoyl-CoA desaturase activ ity. As with the BL-6 
cells, the lowest LLCMK cell counts tended to have the higher enzyme 
complex activities. These trends, with both the BL-6 and LLCMK 
cells, seem to intimate that as the cell growth is inhibi ted with the 
addition of zinc, the linoleoyl-CoA desaturase enzyme complex is 
activated to higher levels. 
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activity of BL-6 and LLCMK cells. 
o--o = BL-6 cells 
~ = LLCMK cells 
TABLE 13: THE EFFECT OF ZINC ADDITION ON LINOLEOYL-CoA DESATURASE ACTIVITY 
IN BL-6 AND LLCMK CELLS 
BL-6 LLCMK 
[Zinc] Total Enzyme Activity Total Enzyme Activity 
(fl.g/cm3) (fl.mol/min/106 cells) (fl.mol/min/106 cells) 
X ± SEM X ± SEM 
0 278.1 ± 57.8 170.0 ± 20.6 
1 410.0 ± 93.0 515.8 ± 117.3* 
2 247 . 7 ± 27.5 399.5 ± 65.7 
3 478.6 ± 48 .9 705.9 ± 118. 7** 
4 153.0 ± 12.8 1040.5 ± 197.7*** 
5 239.0 ± 60.0 2833.3 ± 204.1 *** 
10 776.1 ± 183.4** 1037 .0 ± 291.4*** 
* p > 0.05 
** p > 0.005 
*** p > 0.001 
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Figure 32 and Table 14 show the effects of added GLA on the linoleoyl-
CoA desaturase enzyme complex activity of BL-6 and LLCMK cells. GLA 
addition has no statistically , significant effect on the activity of 
the enzyme complex in the BL-6 cells when compared to the control. 
The effect of GLA addition on the cell counts of BL-6 cells was also 
not noticeable except when 10 ~g/cm3 of GLA was added and this 
resulted in a decrease in the cell count (see Figure 21 and Table 7 in 
Chapter 6) . As with the addition of zinc, the highest concentration 
of GLA addition did result in the lowest cell count and the most 
linoleoyl-CoA desaturase enzyme complex activity although this was not 
statistically significant. This again suggests that the inhibition 
of cell growth may be correlated with the activation of the enzyme 
complex. 
The addition of GLA resulted in a general increase in linoleoyl-CoA 
desaturase activity in the LLCMK cells. Statistically significant 
increases in the enzyme activity occurred when 6 and 8 ~g/cm3 of GLA 
were added to the BL-6 ce 11 s. As with the addition of zinc, the 
general trend emerging seemed to again suggest that as the cell growth 
was inhibited the activity of the linoleoyl-CoA desaturase enzyme 
complex was increased (see Figure 21 and Table 7 in Chapter 6). 
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Figure 32. The eiTect of ndded GLA on the Linoleoyl-CoA Desnturuse 
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TABLE 14: THE EFFECT OF GLA ADDITION ON LINOLEOYL-CoA DESATURASE ACTIVITY 
IN BL-6 AND LLCMK CELLS 
BL-6 LLCMK 
[GLA] Total Enzyme Activity Total Enzyme Activity 
(ll-g/cm3) (ll-mol/min/106 cells) (ll-mol/min/106 cells) 
X ± SEM X ± SEM 
0 86.3 ± 24.4 302.4 ± 44.2 
0.5 75.4 ± 11.2 482.5 ± 86.7 
2.0 66.0 ± 3.1 500.5 ± 90.0 
4.0 98.0 ± 17.9 416.2 ± 34.8 
6.0 66.1 ± 3.5 1161.3 ± 186.6* 
8.0 59.7 ± 11.6 846.9 ± 136.3* 
10.0 116.3 ± 20.4 434.0 ± 87.8 
* p > 0.001 
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The effects of the combined addition of zinc and GLA on the linoleoyl-
CoA desaturase enzyme complex activity of the BL-6 cells, is shown in 
Figure 33 and Table 15. Controls in this case were cell cultures to 
which different concentrations of zinc but no GLA had been added. 
When no zinc but GLA was added to the BL-6 cells there was a general 
decrease in the linoleoyl-CoA desaturase enzyme activity as compared 
to the centro 1 . The ce 11 counts showed 1 itt 1 e effect upon GLA 
addition (see Figure 23 and Table 9 in Chapter 6). When either 2, 3 
or 4 11g/cm3 of zinc were added and at all points of GLA addition 
there was a significant increase in enzyme activity in the BL-6 cells. 
The combined effects of zinc and GLA tended to show a greater increase 
in the enzyme complex activity than when zinc or GLA was supplemented 
on their own. The cell counts of the BL-6 cells upon the combined 
addition tended to reflect a greater inhibition of cell growth. Once 
again it was noted that as the ce 11 counts decreased there was a 
general trend to increased enzyme activity . 
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TABLE 15: THE EFFECTS OF ZINC AND GLA ADDITION (ZINC KEPT CONSTANT) ON THE 
LINOLEOYL-CoA DESATURASE ACTIVITY OF BL-6 AND LLCMK CELLS 
BL-6 LLCMK 
(Zn : GLA] Total Enzyme Activity Total Enzyme Activity 
(JJ.g/cm3) (JJ.mol/min/106 cells) ( JJ.mo 1/mi n/106 ce 11 s) 
'X ± SEM 'X ± SEM 
0 : 0 138.2 ± 34.7 243.3 ± 20.0 
0 : 4 57.5 ± 2.1 343 .7 ± 6.5 
0 : 6 39.0 ± 2.1 940.3 ± 48.1***** 
0 : 8 35.4 ± 2.3 690 .6 ± 24.9***** 
2 : 0 116.4 ± 7.5 166. 1 ± 8.8 
2 : 4 462 .8 ± 77. 2*** 465.1 ± o.o** 
2 : 6 754.1 ± 82.1 ***** 220. 2 ± 66.1 
2 : 8 772.5 ± 51.9***** 239.0 ± 75.8 
3 : 0 227.1 ± 8.0 452.6 ± 11.4 
3 : 4 838.9 ± 62.9***** 711.7 ± 9.0* 
3 : 6 2112.2 ± 114.0***** 410.2 ± 58.6 
3 : 8 1563.9 ± 19a.o***** 326 .5 ± 40.9 
4 : 0 72 . 3 ± 1.4 1022 . 7 ± 295 . 2 
4 : 4 635.8 ± 121.4***** 547.2 ± 99.8"'**** 
4 : 6 834.9 ± 137.6***** 357.0 ± 30.3***** 
4 : 8 411.4 ± 47.2**** 266.0 ± 30.7***** 
* p > 0.05 
** p > 0.025 
*** p > 0.01 
**** p > 0.005 
***** p > 0.001 
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Figure 34 and Table 15 are data on the combined effects of zinc and 
GLA addition on the linoleoyl-CoA desaturase enzyme complex activity 
of the LLCMK cells. When no zinc was added and 4, 6 and 8 ~g/cm3 of 
GLA were added, increases were noted in the enzyme complex activity 
compared to controls in which no GLA was supplemented. These 
increases were statistically significant when 6 and 8 ~g/cm3 of GLA 
were supplemented. Unlike the BL-6 cells, the lowest cell count did 
not corre 1 ate to the greatest enzyme activity, a 1 though the genera 1 
trend of a decreasing cell count correlating with an increasing enzyme 
complex activity was maintained (see Figure 25 and Table 10 in Chapter 
6). In the group to which 2 ~g/cm3 of zinc was added, addition of 
GLA only resulted in a significant increase in enzyme activity when 4 
~g/cm3 of GLA was added, although the addition of GLA at higher 
concentrations resulted in increased enzyme activity. The cell count 
curve correlated with the trend of decreased cell counts with 
increased enzyme complex activities. When 3 ~g/cm3 of zinc was added 
and as with the addition of 2 ~g/cm3 of zinc, the only statistically 
significant increase in enzyme activity was noted when 4 ~g/cm3 of GLA 
was added to the LLCMK cel ls. Upon the addition of 8 ~g/cm3 of GLA 
it was noted for the first time that there was a decrease in the 
linoleoyl-CoA desaturase enzyme complex activity as compared to the 
control. The lowest cell count was again shown to correlate with the 
highest enzyme activity. The addition of 4 ~g/cm3 of zinc and 4, 6 
and 8 ~g/cm3 of GLA resulted in statistica lly significant decreases i n 
the enzyme complex act ivity upon all additions of GLA compared to the 
control group to which no GLA was added. The cell counts showed 
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increases at all levels of GLA addition compared to the control. 
The smallest decrease in the enzyme complex activity correlated 
with the smallest increase in the cell counts. Thus, as previously 
noted increases in ce 11 counts corresponded with decreases in the 
activity of the linoleoyl-CoA desaturase enzyme complex. 
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In Figures 35 and 36 and Table 16 the same data to that obtained above 
is shown but in this case the results are grouped into those with 
different concentrations of GLA addition and controls being those ce l l 
cultures in each group to which no zinc had been added. 
As shown in Figure 35 and Table 16 in the group to which no GLA had 
been added there was no statistically significant effect of added zinc 
on the enzyme activity in the BL-6 cells. An increase in the ce 11 
count with the addition of IJ.g/cm3 of zinc did correl ate with the 
largest decrease in enzyme activity found with this treatment (see 
Figure 27 and Table 11 in Chapter 6). To the group to which 4, 6, or 
8 IJ.g/cm3 of GLA had been added there was a statistically significant 
increase in the activity of the linoleoyl-CoA desaturase enzyme 
complex upon the addition of zinc at all level s of zinc addition . 
The cell counts again tended to decrease as the enzyme activity 
increased with the lowest cell count being found to generally 
correlate with the highest enzyme activity. 
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Figure 36 and Table 16 showed the combined effects of added GLA and 
zinc on the linoleoyl-CoA desaturase enzyme complex activities in the 
LLCMK ce 11 s . 
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TABLE 16: THE EFFECTS OF GLA AND ZINC ADDITION (GLA KEPT CONSTANT) ON THE 
LINOLEOYL-CoA DESATURASE ACTIVITY OF BL-6 AND LLCMK CELLS 
[GLA : Zn] 
c.~.g/ cm3) 
0 : 0 
0 : 2 
0 : 3 
0 : 4 
4 : 0 
4 : 2 
4 : 3 
4 : 4 
6 : 0 
6 : 2 
6 : 3 
6 : 4 
8 : 0 
8 : 2 
8 : 3 
8 : 4 
BL-6 
Total Enzyme Activity 
(~mol/min/106 cells) 
X ± SEM 
138.2 ± 34.7 
116.4 ± 7.5 
227.1 ± 8.0 
72.3 ± 1.4 
57.5 ± 2.1 
362.8 ± 90.8* 
838.9 ± 62.9*** 
635.8 ± 121.4*** 
39.0 ± 2.1 
754.1 ± 82.1*** 
2112.2 ± 114.0*** 
834.9 ± 137.6*** 
35.4 ± 2.3 
772.5 ± 51. 9*** 
1563.9 ± 198.o*** 
411.4 ± 47 .2** 
* p > 0.025 
** p > 0.005 
*** p > 0.001 
**** p > 0.001 
LLCMK 
Total Enzyme Activity 
(~mol/min/106 ce 11 s) 
X ± SEM 
243 .2 ± 20.2 
166.1 ± 8.8 
452.6 ± 11.4 
1022 .7 ± 295.2*** 
343.7 ± 6.5 
465.1 ± 0.0 
711.7 ± 9.o** 
547.2 ± 99.8 
940.5 ± 47.9 
220 . 2 ± 66.1*** 
410.2 ± 58.6*** 
357.0 ± 30.3*** 
690.6 ± 24.9 
239.0 ± 75.8*** 
326.5 ± 40.8** 
266.0 ± 30.7** 
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In general the effect on the enzyme activity of added zinc to the 
different GLA supplemented groups was variable . As can be seen in 
Table 16 in the 0 GLA supplemented group, a significant increase in 
enzyme activity was found in the cells supplemented with the highest 
concentrations of zinc. Similarly when 4 ~-'-g/cm3 of GLA was added, 
the addition of higher concentrations of zinc resulted in increased 
enzyme activity. However when 6 or 8 1-1-g/ cm3 of GLA was added, the 
further addition of zinc at all concentrations resulted in significant 
decreases in enzyme activity. In correlating the results with the 
cell counts in each group (see Figure 29 and Table 12 in Chapter 6) a 
general trend that had been found earlier was apparent i e the groups 
with the highest cell counts were those in which the lowest enzyme 
activity was found. 
7.4 Discussion 
The most significant trend that was found in the study of the effect 
of zinc and GLA on linoleoyl-CoA desaturase enzyme activity was that 
when the cell count was lowest, the linoleoyl-CoA desaturase enzyme 
complex activity was highest. This trend was more apparent upon the 
combined addition of zinc and GLA than when either was added 
separately. As was hypothesised in Chapter 1, the addition of zinc 
on i ts own and particularly zinc and GLA together did result in the 
increased activity of the linoleoyl-CoA desaturase enzyme complex. 
These results tend to support the hypothesis that zinc may be a 
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asssociated with the enzyme complex, linoleoyl-CoA desaturase. The 
increased effect on the activity of the enzyme complex with the 
combined addition of zinc and GLA may be the result of an increased 
activity of the rest of the w-6 EFA pathway as a result of the 
addition of GLA to the cells. The addition of zinc may thus in turn 
activate the linoleoyl-CoA desaturase enzyme complex, resulting in a 
further stimulation of the pathway. This could result in an increased 
synthesis of PGE1 (as outlined in Figure 2) which would in turn lead 
to an increased synthesis of cAMP. An increased synthesis of cAMP 
could result in regulation of cell proliferation in the tumour cells . 
Such an effect is more apparent in the tumour cells (BL-6) than the 
normal cells (LLCMK) indicating that the combined effect of GLA and 
zinc may be more important in the regulation of cell proliferation in 
tumour cells. This hypothesis is however very speculative and 
requires a great deal of further study. 
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CHAPTER 8 
GENERAL DISCUSSION AND SUMMARY 
The aim of the first section (Chapters 2 - 5) of this thesis was to 
isolate the enzyme complex, linoleoyl-CoA desaturase and the terminal 
enzyme in this complex, ~6-desaturase. The interest in this enzyme 
complex was the result of the hypothesis that it played a role in the 
loss of regulation of cell proliferation in tumour cells as certain 
tumour cells had been found to have reduced or no linoleoyl-CoA 
desaturase activity, which may be due to a lack of the terminal 
component of the complex , ~6-desaturase (5,22-24). In order to study 
this component of the camp 1 ex in more deta i 1 it was necessary to 
isolate it from cells known to possess linoleoyl-CoA desaturase 
activity. L inoleoyl-CoA desaturase consists of cytochrome b5, 
cytochrome b5 reductase and ~6-desaturase (326). It was decided that 
~6-desaturase could best be isolated from the linoleoyl-CoA desaturase 
complex and in order to achieve this it was necessary to first isolate 
the enzyme complex. It was further decided that once the complex had 
been isolated, the most probable chance of successfully isolating ~6-
desaturase would involve the enzymatic solubilisation of cytochrome b5 
and cytochrome b5 reductase from the complex. It was therefore 
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necessary to first enzymatically solubilise, isolate and purify 
cytochrome bs and cytochrome bs reductase to optimise methodology for 
the purification of ~6-desaturase. 
Cytochrome bs was isolated from rat liver microsomes in a 
catalytically pure form. Cytochrome bs has a major Soret peak at 423 
nm and this was utilised in the assay for the presence of cytochrome 
bs. Smaller quantities of liver was used as starting material, 
requiring smaller number of rats to be sacrificed than in previous 
literature reports (260,264). It was however found that this did not 
adversely affect the isolation procedure, instead it simplified the 
procedure. Cytochrome bs was enzymatically solubilised from the rat 
liver microsomes using trypsin. In contrast to previous literature 
reports (260,264), the solubilisation procedure was conducted at 37°C 
instead of 4 oc. The solubilisation procedure was conducted at this 
temperature as trypsin is most catalytically active at 37°C and it was 
hoped that this would result in increased cytochrome bs solubilisation 
( 12, 294, 295). In order to prevent any mi crobr i a l or bacterial 
contamination antibiotics were utilised during the solubilisation 
procedure . It was hoped that with the increased trypsin activity 
only one form of catalytically active cytochrome bs would be isolated, 
and this proved to be the case. 
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The isolation procedure used for cytochrome b5 showed that it was not 
always necessary to conduct isolation experiments at 4°C as had 
previously been reported (260,264). Working at room temperature 
proved to be less problematic than working in a cold room. Working 
at room temperature did not result in any loss of cytochrome bs, 
although 4°C was utilised for a few critical stages in the isolation 
procedure . 
It was found that during the column chromatography, slower flow rates 
than those cited in a literature report (260) resulted in the 
increased isolation and purification of cytochrome b5. The CM-
cellulose step resulted in the removal of haemoglobin and some other 
protein impurities which bound to this column whi le the cytochrome bs 
was eluted without binding to the column. In this study it was noted 
that the cytochrome b5 band did not separate into two distinct bands 
as previously reported (260,264). This gave an initial indication 
that the cytochrome b5 had been solubilised in one catalytic form, as 
had been hoped. 
Crystallisation of cytochrome bs was attempted, but as expected from 
literature reports (260,264), the methodology cited as well as normal 
organic methods were unsuccessful. It was decided to utilise freeze 
drying to overcome this problem and to facilitate the storage of 
cytochrome b5 for long periods of time. It was found that the freeze 
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dried cytochrome bs was as catalytically active as the cytochrome bs 
solution prior to freeze drying. The freeze dried powder was very 
hydroscopic and, thus, had to be stored in a tightly sealed container. 
Disc gel electrophoresis of the freeze dried cytochrome bs yielded one 
discrete band with a Rf va 1 ue of 0. 90 - 0. 95. This procedure was 
repeated several times with similar results being obtained. This 
indicated that the cytochrome bs had been isolated in a single and 
pure form. 
A fold purification of 7.72 was achieved utilising this modified 
methodology which was a larger increase in that achieved in a previous 
literature report - 1.36 (260). The overall yield in this study was 
three to four times greater than that previously cited (260). This 
methodology therefore resulted in the purification of a catalytically 
active single form of cytochrome bs. The method was repeated several 
times with the same results which ensured the feasibility of using 
enzymatic solubilisation of cytochrome bs from the linoleoyl-CoA 
desaturase complex. 
Cytochrome bs reductase [EC 1.6.2.2.] was isolated from rat liver 
microsomes utilising lysosomal solubilisation of the enzyme from the 
microsomes (311). The presence of cytochrome bs reductase was 
detected by utilising a potassium ferricyanide- assay in preference to 
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a cytochrome bs assay as the former assay does not vary according to 
the quantity of free and bound cytochrome bs reductase, as the latter 
assay does, nor does it assume that cytochrome bs is at any time rate 
controlling (317,318). 
As with the isolation and purification of cytochrome bs, the quantity 
of starting material utilised in the isolation and purification of 
cytochrome bs reductase was less than that previously cited. The 
smaller quantity again did not detrimentally influence the procedure, 
but instead resulted in the simplification of the procedure. 
Lysosomal solubilisation of the cytochrome bs reductase was utilised 
as this involved enzymatic solubilisation with the main enzyme being a 
cathepsin, which had been previously reported to successfully 
solubilise cytochrome bs reductase (311). It was noted that during 
the cytochrome bs reductase solubilisation procedure it was necessary 
that the entire microsome-lysosome pellet be solubilised for efficient 
enzyme solubilisation to occur. The solubilisation procedure was 
conducted at 4°C, but, as with the cytochrome bs isolation and 
purification, the majority of the isolation procedure was conducted at 
room temperature without any detrimental effects on the yield . 
Previous literature reports had cited the necessity of conducting the 
procedure at 4°C (303,311). 
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It was decided not to attempt to crystallise cytochrome bs reductase 
due to the problems experienced with the attempted crystallisation of 
cytochrome bs and the lack of literature reports concerning the 
successful crystallisation of cytochrome bs reductase. 
enzyme solution was consequently freeze dried. 
The purified 
Disc gel electrophoresis of the freeze dried powder yielded one 
discrete band with a Rf value of 0.80 - 0.85. The disc gel 
electrophoresis was repeated several times with very similar results. 
The disc gel electrophoresis indicated that the cytochrome bs 
reductase had been isolated in a single and pure form. Unlike a 
previous literature report (311), only one band of cytochrome bs 
reductase was identified. 
An earlier literature report (311) cited a much greater fold 
purification of this enzyme than was achieved in this study, probably 
due to the very low activities found in that study (311) after the 
solubilisation step of the procedure. The final enzyme yield 
achieved in this study was approximately nine times greater than 
previously achieved (303,311). This isolation and purification 
procedure was repeated several times with reproducable results being 
obtained. This methodology could, thus, be utilised for the 
enzymatic solubilisation of cytochrome bs reductase from the 
linoleoyl-CoA desaturase enzyme complex. 
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The isolation and purification of linoleoyl-CoA desaturase [EC 
1.14. 99. 25.] was expected to be extremely problematic, as this had 
been suggested to be the case in two publications (328,330). A small 
number of rats were consequently sacrificed in order to avoid the 
possible unnecessary sacrificing of large numbers of animals. The 
procedure was not found to be as problematic as expected and the 
enzyme complex was not quickly and totally disrupted at room 
temperature as suggested by other workers (328,330). Room 
temperature was again utilised during certain steps of this isolation 
and purification procedure as it had proved to be extremely successful 
in simplifying the isolation and purification procedures of cytochrome 
b5 and cytochrome b5 reductase, despite previous literature reports to 
the contrary (260,264,303,311). 
This was the first study to utilise the cytochrome b5 reoxidation 
assay as an indication of the presence and activity of linoleoyl-CoA 
desaturase. This assay proved to be very efficient, as it required 
far less chemicals and was less time consuming. This assay was 
very specifi c for linoleoyl-CoA desaturase as the substrate for the 
enzyme complex is utilised in this assay and only when the substrate 
has been converted into the product,GLA, will the cytochrome b5 
mo 1 ecu 1 es become reox i d i sed. Rotenone was added to the as say to 
prevent the possibility of any external involvement of NADH or 
cytochrome b5 reoxidation (275,290,335). 
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Linoleoyl-CoA desaturase was solubilised from rat liver microsomes by 
Triton X-100 as it is a non-ionic detergent and it has been found that 
ionic detergents can denature proteins ( 263, 334) . Sod i urn 
deoxycholate, an ionic detergent, was utilised as the solubilising 
detergent in one attempted isolation procedure, but this resulted in 
total loss of enzyme activity. This loss of enzyme activity was 
presumed to either be the result of protein denaturation or the 
breakage of ionic bonds which could possibly be involved in holding 
the enzyme complex together. Although Triton X-100 was known to 
interfere with protein assays (263), because of the above problems 
with ionic detergents it was still utilised as the solubilising 
detergent. In order to reduce the Triton X-100 interference, very 
small sample volumes were utilised. However yields greater than 100 
% were found, probably as a result of Triton X-100 interference with 
the protein assay. It was not feasible to remove the Triton X-100 
from the samples not only because this would have been time consuming, 
but also because it was used as a stabiliser and, thus, its removal 
could have resulted in the total disruption of the enzyme complex 
(263,334,337,338). 
The Triton X-100 solubilisation of linoleoyl-CoA desaturase resulted 
in a greatly increased fold purification (19.17) than that 
previously reported (328). The use of Triton X-100 also resulted in 
the precipitation of extraneous protein. The DEAE-cellulose 
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chromatography resulted in an 80 % increase in purification, as this 
column bound contaminating proteins and the linoleoyl-CoA desaturase 
was eluted through the column. The greatest fold purification 
increase achieved in this study was with the CM-Sephadex C-50 column. 
Both the columns utilised in the isolation and purification procedure 
therefore resulted in substantial increases in the purification of 
linoleoyl-CoA desaturase. 
The final yield achieved in this study was three to four times greater 
than that cited previously in which study Triton X-100 was also 
utilised to solubilise the enzyme complex (328). An earlier study 
(328) had cited the necessity of utilising affinity chromatography in 
the isolation and purification procedure of this complex, but this was 
deemed unnecessary in this study. The linoleoyl-CoA desaturase 
solution was freeze dried and disc gel electrophoresis was performed 
on fractions from the final column chromatography step and on the 
freeze dried powder. Both of these samples yielded three discrete 
bands upon disc gel electrophoresis indicating that the enzyme 
complex had become disrupted as two of the bands were characteristic 
of cytochrome bs and cytochrome bs reductase (the bands had the 
characteristic Rf values reported earlier). The third band was 
assumed to be that of ~6-desaturase. 
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The freeze dried powder retained most of the linoleoyl-CoA desaturase 
activity for the duration of this study. This was important as this 
purified complex was to be utilised in the next stage of this study, 
it was necessary that the complex be in as stable a form as possible. 
This methodology showed that linoleoyl-CoA desaturase could be 
isolated and purified from rat liver microsomes in a catalytically 
active form using a more simplified methodology than that cited 
previously (328). 
As stated previously the linoleoyl-CoA desaturase enzyme complex was 
to be utilised for the isolation and purification of ~6-desaturase by 
the enzmatic solubilisation of cytochrome bs and cytochrome bs 
reductase from the enzyme complex. The results from this study 
showed that although the ~6-desaturase was not isolated in a totally 
pure form, it was possible to utilise enzymatic solubilisation to 
isolate the enzyme. Cytochrome bs reductase was enzymatically 
solubilised from the enzyme complex utilising cathepsin 0 (298,317). 
It was necessary to utilise two cathepsin 0 solubilisations before the 
cytochrome bs reductase was removed entirely from the enzyme complex. 
Cytochrome bs reductase was removed more easily than cytochrome bs, 
but this was not totally unexpected as it the first enzyme in the 
linoleoyl-CoA desaturase complex and also there is one molecule of 
cytochrome b5 reductase for every two molecules of cytochrome bs. 
Even after two solubilisations of cytochrome bs utilising trypsin 
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there was still a small quanitity of cytochrome bs present with the 
A6-desaturase (260,261). 
It is suggested that future studies should utilise greater quanitites 
of linoleoyl-CoA desaturase as the small quanitity of starting 
material was one of the major problems experienced in attempting to 
purify A6-desaturase. Disc gel electrophoresis of the isolated A6-
desaturase preparation was conducted several times, but no bands were 
detected. This again could be the result of the very small 
quantities of enzymes present. 
The aim of the second section of this thesis (Chapters 6 and 7) was to 
study the effects of added zinc, GLA and the combined effects of added 
zinc and GLA on the activity of the enzyme complex linoleoyl-CoA 
desaturase, and on the in. vitro cell growth of norma 1 and tumour 
cells. 
Initially the effects of added zinc, GLA and zinc and GLA on the cell 
growth of norma 1 and tumour ce 11 lines were studied. Zinc was 
utilised in this study as it had been hypothesised that it was a 
cofactor of linoleoyl-CoA desaturase (133,135) and GLA was utilised as 
it was the product of one of the reactions that linoleoyl-CoA 
desaturase catalyses (35). It has been hypothesised that the loss of 
linoleoyl-CoA desaturase activity in tumour cells could be a result of 
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a zinc deficiency and, thus, the addition of zinc could result in the 
activation of the enzyme complex and thus, the reactivation of the 
regulation of cell proliferation (132,133,136-143). GLA was also 
utilised in this study as it was hypothesised that the regulation of 
cell proliferation via the EFA pathway occurred through a control of 
cAMP synthesis by PGE1 which is synthesised from one of the end 
products of the EFA pathway and it was thought that addition of GLA 
may result in increased synthesis of PGE1 and hence reduced cell 
proliferation (25-30). 
The normal cell line used in this study was LLCMK monkey kidney cells, 
and the tumour cell line was a murine melanoma i e BL-6 melanoma 
cells. AA spectroscopy showed that the GM contained 0.3 J.Lg/cm3 of 
zinc. Zinc supplementation was shown to stimulate the growth of 
LLCMK cells when 3 and 4 J.Lg/cm3 of zinc was added although the 
stimulation was only significant with the former addition. 
Significant inhibition of growth occurred in the LLCMK cells with the 
additions of 2, 5 and 10 J.Lg/cm3 of zinc. In BL-6 cells inhibition 
of growth occurred at all levels of zinc addition. Thus high 
concentrations of added zinc resulted in the inhibition of cell growth 
in both the cell lines whereas low concentrations only reduced cell 
growth in the tumour cells. These results agree with previous 
literature reports (244,252,253,256) and with other experiments 
conducted in this laboratory. 
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The addition of GLA did not dramatically reduce the cell counts of 
LLCMK cells, but the BL-6 cells did show a decrease although this was 
not as significant as with the addition of zinc. All the additions 
of GLA significantly reduced the 3H-thymidine incorporation into DNA 
in the BL-6 cells indicating a reduced level of DNA replication in the 
BL-6 cells. This decrease was not noted in the LLCMK cells except 
when 6 l-Lg/cm3 of GLA was added. GLA had previously been shown to 
inhibit the growth of tumour cells and thus the results achieved in 
this study correlated with previous findings (211-223) . 
The effects of the combined addition of zinc and GLA (the zinc 
concentration was kept constant and the GLA concentration was varied 
initially and then this was reversed) on the growth of the BL-6 and 
LLCMK cells was subsequently studied. When zinc and GLA were added 
in combination the BL-6 cells showed a significant reduction in the 
cell growth compared to that found when GLA was added a 1 one (this 
occurred in both the cell counts and the 3H-thymi dine incorporation 
into DNA in the BL-6 cells). The growth of the LLCMK cells was 
not substantially affected by t he combined addition and the effects 
were variable with no general trend emerging. 
When the GLA concentration was held constant and the zinc 
concentration was varied it was noted that there was a significant 
decrease in the cell counts of the BL-6 cells in cell cultures 
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to which GLA was added except in that group to which 4 ~g/cm3 of zinc 
had been added. The 3H-thymi dine incorporation into DNA generally 
followed the same trend except for the addition of 8 ~g/cm3 of GLA, 
although this did vary with the concentration of zinc added. The 
effect of the combined addition on the cell growth of the LLCMK cells 
was not as noticeable as with the BL-6 cells. The addition of zinc 
and GLA was shown to result in generally increased cell counts of the 
LLCMK cells with the addition of 6 and 8 ~g/cm3 of GLA and varying 
concentrations of zinc, when compared to the control. The effects on 
the values of the 3H-thymidine incorporation into DNA were varied and 
both statistically significant increases and decreases were found. 
This study showed that it could be possible to manipulate the cell 
growth of both the BL-6 and LLCMK cells by varying the concentrations 
of zinc and GLA added to the GM. It was also shown in this study 
that it was possible to inhibit the cell growth of the BL-6 cells 
while maintaining the normal growth of the LLCMK cells. The combined 
addition of zinc and GLA resulted in a general trend of increased cell 
growth inhibition in the BL-6 cells but not in the LLCMK cells. The 
cell growth of tumour cells .in vitro could thus be manipulated by 
varying the supply of zinc and/or GLA. 
A further study concerned the activity of linoleoyl-CoA desaturase in 
BL-6 and LLCMK cell lines and the effect of the addition of zinc, GLA 
and the combined addition of zinc and GLA on this activity. The 
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cytochrome bs reoxidation assay was utilised to assay for the presence 
and activity of the linoleoyl-CoA desaturase enzyme complex. 
In general it was noted that as the cell count decreased the 
linoleoyl-CoA desaturase activity increased with the addition of zinc. 
Although the enzyme activity increased in the BL-6 cells it was always 
lower than that noted in the LLCMK cells except for the controls which 
were very similar. The only significant increase in enzyme activity 
in the BL-6 cells was found with the addition of 10 ~g/cm3 of zinc . 
The addition of zinc resulted in statistically significant increases 
in enzyme activity ofthe linoleoyl-CoA desaturase enzyme complex in 
the LLCMK cells at all concentrations of added zinc except in the 
cells to which the addition of 2 ~g/cm3 of zinc had been added. In 
general the linoleoyl-CoA desaturase activity was lower in the BL-6 
cells than in the LLCMK cells when zinc was added and at various 
concentrations this difference was statistically significant. 
With the addition of GLA the linoleoyl-CoA desaturase activity curve was 
almost identical to the cell count curve of the BL-6 cells. The 
addition of GLA resulted in no significant changes in the linoleoyl-
CoA desaturase activity in the BL-6 cells. In the LLCMK cells 
however, the addition of GLA resulted in statistically significant 
increases in the enzyme activity when 6 and 8 ~g/cm3 of GLA were 
added. 
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When both zinc and GLA were added (the zinc concentration was kept 
constant and the GLA concentration was varied initially and then this 
was reversed) it was noted that there was generally an inverse 
relationship in the BL-6 cells between cell count and linoleoyl-CoA 
desaturase activity i e the inhibition of cancer growth occurred 
simultaneously with the activation of the linoleoyl-CoA desaturase 
enzyme complex. Although it cannot be categorically stated that the 
activation of the enzyme complex resulted in the growth inhibition, 
the relationship is still very interesting. When only GLA was added 
the BL-6 cell count was much greater than when zinc and GLA were added 
together, while the linoleoyl-CoA desaturase activity was 
significantly lower when both the zinc and GLA were added. If the 
cell count curves (when zinc and GLA had been added together) were 
studied it was noted that they were the inverse of the linoleoyl-CoA 
desaturase activity curves of the BL-6 cells. It was noted that the 
addition of both zinc and GLA did not noticeably influence the 
activity of linoleoyl-CoA desaturase in the LLCMK cells except at the 
highest GLA concentration i e 8 1-Lg/ cm3 of GLA which resulted in 
significantly reduced linoleoyl-CoA desaturase activity in all groups 
when compared to the control. 
When the GLA concentration was held constant and the zinc 
concentration was varied, it was again noted that when both GLA and 
zinc were added the cell count curves of the BL-6 cells were almost 
inverse curves of the linoleoyl-CoA desaturase activity curves of the 
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BL-6 cells . The combined addition of zinc and GLA resulted in 
significant increases in the linoleoyl-CoA desaturase activity in the 
BL-6 ce 11 s. This wou 1 d again suggest that cancer ce 11 growth 
inhibition occurs simultaneously with the activation of the linoleoyl-
CoA desaturase enzyme complex. It was also noted that apart from 
when 0 and 8 ~g/cm3 of GLA were added and zinc was added, the LLCMK 
cell count curves were inverse curves of the linoleoyl-CoA desaturase 
activity curves of the LLCMK cells. The combined addition of GLA and 
zinc to the LLCMK cells resu l ted in significant increases in the 
linoleoyl-CoA desaturase activity in all groups to which zinc had been 
·supplemented when 6 or 8 ~g/cm3 of GLA was also added . 
These results suggest an association between the addition of zinc and 
GLA and the inhibition of cancer cell growth. This may occur via the 
reactivation of the linoleoyl -CoA desaturase complex . These results 
also support the hypothesis that zinc is a cofactor of the linoleoyl-
CoA desaturase enzyme complex (133,135). This fits in well with the 
hypothesis that the loss of regulation of cell proliferation in tumour 
cells may be related to the inhibition of linoleoyl-CoA desaturase 
activity and if this acti vity could be restored, it may be possible to 
restore the regulation of cell proliferation. 
While some relationship between the effects of zinc and GLA addition 
on the growth of normal (LLCMK) cells appears to exist and that these 
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effects may be related to an association with the linoleoyl-CoA 
desaturase complex , this relationship is not as significant or as 
consistent as that found with the BL-6 cells. 
The results of this study raise the possibility of a treatment of 
cancer, for certain tumours at least, by the use of dietary 
supplementation of both zinc and GLA. However, for such a 
possibility to be tested, a great deal of further research is required 
on the biochemical sites of action of the two nutrients . It is hoped 
that this study will further support the possible association of zinc 
with the linoleoyl-CoA desaturase enzyme complex as one site of 
biochemical action and that the methods described for the isolation of 
the complex and its components will provide a basis for more in depth 
studies on this enzyme complex. 
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Protein standard curve. The SEM values were not included as 
they were negligible . 
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DNA standard curve. The SEM values were not included as 
they were negligible. 
200 300 
DNA Concentration (~g/cm3) 
Appendix 3. 
1.0 
0 . 8 
E 
c 0.6 
0'1 
. 
M 
r-t 
N 
< 
0.4 
-196-
Zinc standard curve . The SEM values were not included as 
they were negligible. 
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